<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003666.pub4" GROUP_ID="NEONATAL" ID="430702011609081695" MERGED_FROM="" MODIFIED="2017-10-12 19:05:40 +0100" MODIFIED_BY="Colleen Ovelman" NOTES="&lt;p&gt;Exported from Review Manager 4.2.7&lt;br&gt;CL 2/02 (do not remove)&lt;/p&gt;&lt;p&gt;sent to P. Davis Oct 26/04&lt;br&gt;Old title: Volume-targeted versus pressure-limited ventilation in the neonate.&lt;/p&gt;&lt;p&gt;CL 3/05 (review)&lt;/p&gt;" NOTES_MODIFIED="2017-10-12 14:03:42 -0400" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="1" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.2">
<COVER_SHEET MODIFIED="2017-10-12 14:02:39 -0400" MODIFIED_BY="Colleen Ovelman">
<TITLE MODIFIED="2017-09-15 08:46:23 -0400" MODIFIED_BY="Anne Lawson">Volume-targeted versus pressure-limited ventilation in neonates</TITLE>
<CONTACT>
<PERSON ID="12996492932285945943100127171329" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Claus</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Klingenberg</LAST_NAME>
<SUFFIX>MD PHD</SUFFIX>
<POSITION>Consultant Neonatologist</POSITION>
<EMAIL_1>claus.klingenberg@unn.no</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Pediatrics</DEPARTMENT>
<ORGANISATION>University Hospital of North Norway</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Tromsø</CITY>
<ZIP>N-9038</ZIP>
<REGION/>
<COUNTRY CODE="NO">Norway</COUNTRY>
<PHONE_1>47 77 62 60 00</PHONE_1>
<PHONE_2/>
<FAX_1>47 77 62 63 69</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2017-10-12 14:02:39 -0400" MODIFIED_BY="Colleen Ovelman">
<PERSON ID="12996492932285945943100127171329" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Claus</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Klingenberg</LAST_NAME>
<SUFFIX>MD PHD</SUFFIX>
<POSITION>Consultant Neonatologist</POSITION>
<EMAIL_1>claus.klingenberg@unn.no</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Pediatrics</DEPARTMENT>
<ORGANISATION>University Hospital of North Norway</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Tromsø</CITY>
<ZIP>N-9038</ZIP>
<REGION/>
<COUNTRY CODE="NO">Norway</COUNTRY>
<PHONE_1>47 77 62 60 00</PHONE_1>
<PHONE_2/>
<FAX_1>47 77 62 63 69</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="97490ACB82E26AA2016F3F86454CCE27" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kevin</FIRST_NAME>
<MIDDLE_INITIALS>I</MIDDLE_INITIALS>
<LAST_NAME>Wheeler</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant Neonatologist</POSITION>
<EMAIL_1>Kevin.Wheeler@rch.org.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Neonatology</DEPARTMENT>
<ORGANISATION>Royal Children's Hospital Melbourne</ORGANISATION>
<ADDRESS_1>50 Flemington Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Parkville, Melbourne</CITY>
<ZIP>3052</ZIP>
<REGION>Victoria</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15275" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Naomi</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>McCallion</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant Neonatologist</POSITION>
<EMAIL_1>nmccallion@rotunda.ie</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Paediatrics</DEPARTMENT>
<ORGANISATION>Rotunda Hospital</ORGANISATION>
<ADDRESS_1>Parnell Square</ADDRESS_1>
<ADDRESS_2/>
<CITY>Dublin</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="IE">Ireland</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15287" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Colin</FIRST_NAME>
<MIDDLE_INITIALS>J</MIDDLE_INITIALS>
<LAST_NAME>Morley</LAST_NAME>
<SUFFIX>MA DCH MD FRCPCH</SUFFIX>
<POSITION/>
<EMAIL_1>colin@morleys.net</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT>
<ORGANISATION>University of Cambridge</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Cambridge</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="17716" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS>G</MIDDLE_INITIALS>
<LAST_NAME>Davis</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>pgd@unimelb.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Newborn Research Centre and Neonatal Services</DEPARTMENT>
<ORGANISATION>The Royal Women's Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Melbourne</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 3 83453763</PHONE_1>
<PHONE_2/>
<FAX_1>+61 3 83453789</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2017-10-12 14:02:39 -0400" MODIFIED_BY="Colleen Ovelman">
<UP_TO_DATE>
<DATE DAY="13" MONTH="1" YEAR="2017"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="13" MONTH="1" YEAR="2017"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="13" MONTH="1" YEAR="2019"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2002"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2005"/>
<LAST_CITATION_ISSUE ISSUE="10" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-06-29 16:50:07 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-06-29 16:50:07 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="29" MONTH="6" YEAR="2017"/>
<DESCRIPTION>
<P>A total of eight new studies (8 publications: <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>; <LINK REF="STD-Bhat-2016" TYPE="STUDY">Bhat 2016</LINK>; <LINK REF="STD-Jain-2016" TYPE="STUDY">Jain 2016</LINK>) were added. Moreover, additional outcomes from a publication based on one study (<LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>) included in the previous review were added.</P>
<P>The conclusions are not substantially changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-06-29 16:48:39 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="31" MONTH="3" YEAR="2017"/>
<DESCRIPTION>
<P>This updates the review "Volume-targeted versus pressure-limited ventilation in the neonate" first published in the Cochrane Database of Systematic Reviews, Issue 3, 2005 (<LINK REF="REF-McCallion-2005" TYPE="REFERENCE">McCallion 2005</LINK>), and second published version in the Cochrane Database of Systematic Reviews, Issue 4, 2010 (<LINK REF="REF-Wheeler-2010" TYPE="REFERENCE">Wheeler 2010</LINK>).</P>
<P>Searches were conducted in January 2017. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2017-04-23 03:05:11 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-04-23 03:05:11 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="27" MONTH="9" YEAR="2010"/>
<DESCRIPTION>
<P>This updates the review "Volume-targeted versus pressure-limited ventilation in the neonate" published in the Cochrane Database of Systematic Reviews, Issue 3, 2005 (<LINK REF="REF-McCallion-2005" TYPE="REFERENCE">McCallion 2005</LINK>).</P>
<P>The searches were conducted in January 2010. At total of six new trials (seven publications) were added: <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>, Singh 2006 and 2009, <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>, Polimeni 2006, Hummler 2006, Cheema 2007. </P>
<P>Supplemental data from authors has been included to facilitate analysis of duration of ventilation and outcomes of infants &lt; 1000 g. Pooled meta-analysis identified a statistically significant reduction in the primary combined outcome of death and bronchopulmonary dysplasia favouring volume targeted ventilation. The conclusions have been revised.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2016-08-26 16:23:29 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="27" MONTH="9" YEAR="2010"/>
<DESCRIPTION>
<P>Wheeler K, Klingenberg C added to authorship.<BR/>The conclusions have been revised.<BR/>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="1" MONTH="4" YEAR="2005"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2017-10-11 13:51:21 -0400" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Royal Women's Hospital Foundation, Melbourne</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Murdoch Children's Research Institute, Melbourne</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-10-12 14:03:42 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2017-10-11 13:32:38 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2017-09-13 04:56:53 -0400" MODIFIED_BY="Anne Lawson">A comparison of volume-targeted ventilation modes with traditional pressure-limited ventilation modes for newborn babies</TITLE>
<SUMMARY_BODY MODIFIED="2017-10-11 13:32:38 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Review question:</B> Does ventilator therapy of infants using a strategy targeting inflation volume rather than inflation pressure lead to lower rates of death or lung damage (or both) among these infants?</P>
<P>
<B>Background: </B>Preterm babies may need help to breathe. The risk of lung problems increases with increasing immaturity (the earlier the babies are born). For some babies, the assistance of a ventilator (breathing machine) can be life saving; however, ventilators may also injure the infant's immature lungs. Traditionally, ventilators for infants have been used in a pressure-limited mode of ventilation, where the pressure leads to variable amount of air entering the lungs. New volume-targeted methods of ventilation have been developed which aim to reduce lung injury by controlling the amount of air entering the lungs with each inflation.</P>
<P>
<B>Study characteristics: </B>In a search updated to January 2017, review authors identified 20 studies for inclusion in the review. Sixteen studies (977 infants) compared two separate groups of infants treated with a volume-targeted mode of ventilation compared with a pressure-limited mode of ventilation. In four studies (84 infants), the infants were treated with both modes of ventilation in a cross-over design (where infants had ventilation with one method and were then swapped over to the second method). Most of the studies were of moderate to low quality and none of them were blinded to those who assessed therapy. The most important results from this review were based on data from eight to 12 studies including 584 to 771 infants.</P>
<P>
<B>Key results: </B>Babies ventilated using volume-targeted modes of ventilation were more likely to survive free of lung damage. They needed ventilator assistance for a shorter duration and were less likely to develop pneumothorax (a condition when air escapes from the lung into the chest). They had more stable carbon dioxide levels in the blood, and had fewer brain ultrasound abnormalities. There was no evidence that volume-targeted modes were more likely to harm the infant than traditional pressure-limited modes. More research is needed to understand whether volume-targeted modes also lead to improvements in the development of movement and intellect. More research is also needed comparing different volume-targeting techniques.</P>
<P>
<B>Quality of evidence: </B>Low to moderate quality as none of the studies were blinded and there were issues with study design in some of the studies.<BR/>
</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-09-14 15:19:27 -0400" MODIFIED_BY="Anne Lawson">
<ABS_BACKGROUND MODIFIED="2017-09-14 15:19:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Damage caused by lung overdistension (volutrauma) has been implicated in the development of bronchopulmonary dysplasia (BPD). Modern neonatal ventilation modes can target a set tidal volume as an alternative to traditional pressure-limited ventilation (PLV) using a fixed inflation pressure. Volume-targeted ventilation (VTV) aims to produce a more stable tidal volume in order to reduce lung damage and stabilise the partial pressure of carbon dioxide (pCO<SUB>2</SUB>).</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2017-09-13 05:17:05 -0400" MODIFIED_BY="Anne Lawson">
<P>To determine whether VTV compared with PLV leads to reduced rates of death and death or BPD in newborn infants and to determine whether use of VTV affected outcomes including air leak, cranial ultrasound findings and neurodevelopment.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2017-09-13 04:48:59 -0400" MODIFIED_BY="Anne Lawson">
<P>We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL 2016, Issue 12), MEDLINE via PubMed (1966 to 13 January 2017), Embase (1980 to 13 January 2017) and CINAHL (1982 to 13 January 2017). We also searched clinical trials databases, conference proceedings and the reference lists of retrieved articles for randomised controlled trials and quasi-randomised trials<B>. </B>We contacted the principal investigators of studies to obtain supplementary information.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2017-09-13 04:47:57 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomised and quasi-randomised trials comparing VTV versus PLV in infants of less than 44 weeks' postmenstrual age and reporting clinically relevant outcomes.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2017-09-13 04:49:45 -0400" MODIFIED_BY="Anne Lawson">
<P>We assessed risk of bias for each trial using Cochrane methodology. We evaluated quality of evidence for each outcome using GRADE criteria. We tabulated mortality, rates of BPD, short-term clinical outcomes and long-term developmental outcomes.</P>
<P>Statistics: for categorical outcomes, we calculated typical estimates for risk ratios (RR), risk differences (RD) and number needed to treat for an additional beneficial outcome (NNTB). For continuous variables, we calculated typical estimates for mean differences (MD). We used 95% confidence intervals (CI) and assumed a fixed-effect model for meta-analysis.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2017-09-14 13:18:17 -0400" MODIFIED_BY="Anne Lawson">
<P>Twenty randomised trials met our inclusion criteria; 16 parallel trials (977 infants) and four cross-over trials (88 infants). No studies were blinded and the quality of evidence for outcomes assessed varied from moderate to low.</P>
<P>We found no difference in the primary outcome, death before hospital discharge, between VTV modes versus PLV modes (typical RR 0.75, 95% CI 0.53 to 1.07; low quality evidence). However, there was moderate quality evidence that the use of VTV modes resulted in a reduction in the primary outcome, death or BPD at 36 weeks' gestation (typical RR 0.73, 95% CI 0.59 to 0.89; typical NNTB 8, 95% CI 5 to 20) and the following secondary outcomes: rates of pneumothorax (typical RR 0.52, 95% CI 0.31 to 0.87; typical NNTB 20, 95% CI 11 to 100), mean days of mechanical ventilation (MD -1.35 days, 95% CI -1.83 to -0.86), rates of hypocarbia (typical RR 0.49, 95% CI 0.33 to 0.72; typical NNTB 3, 95% CI 2 to 5), rates of grade 3 or 4 intraventricular haemorrhage (typical RR 0.53, 95% CI 0.37 to 0.77; typical NNTB 11, 95% CI 7 to 25) and the combined outcome of periventricular leukomalacia with or without grade 3 or 4 intraventricular haemorrhage (typical RR 0.47, 95% CI 0.27 to 0.80; typical NNTB 11, 95% CI 7 to 33). VTV modes were not associated with any increased adverse outcomes.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2017-09-14 13:18:19 -0400" MODIFIED_BY="Anne Lawson">
<P>Infants ventilated using VTV modes had reduced rates of death or BPD, pneumothoraces, hypocarbia, severe cranial ultrasound pathologies and duration of ventilation compared with infants ventilated using PLV modes. Further studies are needed to identify whether VTV modes improve neurodevelopmental outcomes and to compare and refine VTV strategies.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-10-12 09:20:18 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2017-09-15 08:24:57 -0400" MODIFIED_BY="Anne Lawson">
<CONDITION MODIFIED="2017-09-14 15:48:02 -0400" MODIFIED_BY="Anne Lawson">
<P>Mechanical ventilation remains an essential tool in the care of critically sick and very preterm infants, despite improvements in perinatal care including increased use of antenatal steroids and non-invasive respiratory support. The Neonatal Research Network in the USA reported for the year 2012 that 82% of infants born before 29 weeks' gestation received conventional mechanical ventilation during their stay in the neonatal intensive care unit (<LINK REF="REF-Stoll-2015" TYPE="REFERENCE">Stoll 2015</LINK>). The main indications for mechanical ventilation in preterm infants are respiratory distress syndrome (RDS), lung immaturity and poor respiratory drive. Although the respiratory difficulties resolve in most of these infants, studies show that around 40% of surviving infants 28 weeks' or less gestational age (GA) develop bronchopulmonary dysplasia (BPD) with oxygen dependency at 36 weeks' postmenstrual age (<LINK REF="REF-Stoll-2015" TYPE="REFERENCE">Stoll 2015</LINK>; <LINK REF="REF-Stensvold-2017" TYPE="REFERENCE">Stensvold 2017</LINK>). The resulting burden of BPD includes increased duration of respiratory support and hospital stay, need for home oxygen, impaired neurodevelopmental outcome, more readmissions to hospital and increased mortality.</P>
<P>BPD was first reported in 1967 in a group of preterm infants who developed chronic lung disease after receiving ventilation and high oxygen concentration for RDS (<LINK REF="REF-Northway-1967" TYPE="REFERENCE">Northway 1967</LINK>). More recently, BPD has been defined as the requirement for supplemental oxygen at either 28 days' postnatal age (<LINK REF="REF-NIH-1979" TYPE="REFERENCE">NIH 1979</LINK>) or at 36 weeks' postmenstrual age (<LINK REF="REF-Shennan-1988" TYPE="REFERENCE">Shennan 1988</LINK>). The current definition takes into account total duration of oxygen supplementation, need for positive pressure ventilation (PPV) or nasal continuous positive airway pressure (CPAP) and GA, in addition to oxygen dependency at 36 weeks' postmenstrual age (<LINK REF="REF-Jobe-2001" TYPE="REFERENCE">Jobe 2001</LINK>).</P>
<P>BPD is characterised by the histopathological findings of impaired alveolarisation, altered pulmonary microvasculature and pulmonary fibrosis. The development of BPD has been linked to lung immaturity, intrauterine growth restriction (<LINK REF="REF-Bardin-1997" TYPE="REFERENCE">Bardin 1997</LINK>; <LINK REF="REF-Gortner-1999" TYPE="REFERENCE">Gortner 1999</LINK>), infection (<LINK REF="REF-Hannaford-1999" TYPE="REFERENCE">Hannaford 1999</LINK>), oxidant stress (<LINK REF="REF-Warner-1998" TYPE="REFERENCE">Warner 1998</LINK>), in-utero inflammation (<LINK REF="REF-Watterberg-1996" TYPE="REFERENCE">Watterberg 1996</LINK>), and mechanical ventilation (<LINK REF="REF-Coalson-1999" TYPE="REFERENCE">Coalson 1999</LINK>; <LINK REF="REF-Clark-2000" TYPE="REFERENCE">Clark 2000</LINK>). Ventilation strategies have been identified as potentially modifiable cause of BPD, and research has been devoted to developing ventilation strategies which avoid the overdistension, atelectasis and shear stresses that are thought to lead to lung injury and consequently BPD. The fact that lung injury in a preterm lamb model was demonstrated following only six large inflations immediately after birth (<LINK REF="REF-Bjorklund-1997" TYPE="REFERENCE">Bjorklund 1997</LINK>), highlights the potential importance of early use of protective ventilation strategies in the neonate.</P>
</CONDITION>
<INTERVENTION MODIFIED="2017-09-14 15:17:51 -0400" MODIFIED_BY="Anne Lawson">
<P>Mechanical ventilation is primarily used because an infant is failing to breathe adequately, leading to CO<SUB>2</SUB> retention. CO<SUB>2</SUB> removal is determined by tidal volume (VT) and respiratory or ventilator rate. Volume-targeted ventilation (VTV) strategies aim to deliver a consistent VT. TV-oriented modes have been in use in paediatric and adult practice for many years. However, the technological limitations of older ventilators precluded their use in preterm infants because they were unable to accurately deliver the small VT required when ventilating small preterm infants. Modern microprocessor-controlled neonatal ventilators with flow sensors permit accurate measurement and delivery of a set VT. Earlier designs included a flow sensor built into the ventilator, however, with this design, VT measurements are affected by the compliance of the ventilator circuit. Newer designs include sensors that can be placed at the Wye piece between the ventilator circuit and the endotracheal tube (ETT). With appropriate software, the ventilators measure and control ventilator parameters to target the delivered VT, and reduce VT variability delivery compared with pressure-limited ventilation (PLV) modes (<LINK REF="STD-Abubakar-2001" TYPE="STUDY">Abubakar 2001</LINK>).</P>
<P>When using a ventilator in a VTV mode, the clinician sets a target VT. Different VTV modes measure inflation VT, expired VT or both to control VT delivery. Expired VT is less affected by ETT leaks, and measuring both inspired and expired VT enables ETT leak to be quantified. There are many different forms of VTV. Depending on the ventilator design and the mode selected, the ventilator adjusts one or more of the peak inflation pressure (PIP), inflation time and inflation flow. Some ventilators offer more than one VTV mode. Thus, there are some differences between the mechanisms or algorithms by which different ventilators control and modify VT, but they all provide a similar volume-targeted approach to newborn mechanical ventilation.</P>
</INTERVENTION>
<THEORY MODIFIED="2017-09-14 15:35:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Traditionally, neonatologists treating infants with severe respiratory conditions have employed continuous flow, time-cycled, PLV. In PLV mode, the assistance provided by the ventilator is controlled in two ways. The magnitude of each inflation is determined by the change in airway pressure (i.e. the difference between PIP and the baseline or positive end-expiratory pressure (PEEP)). The VT for any inflation depends on both this pressure difference, which drives gas movement, and the lung compliance. Although VT is indirectly determined by the clinician when the PIP and PEEP are set, VT may not be consistent when the infant breathes, cries, splints, is apnoeic or when compliance and resistance change. For example, following administration of artificial surfactant, improved compliance may result in the delivery of increased VT if the PIP is not reduced.</P>
<P>In the past, there was concern about lung damage caused by high pressures ('barotrauma'). However, several studies have indicated that lung collapse and overdistension (or atelectasis and 'volutrauma') are the major instigators of inflammation in the preterm lung (<LINK REF="REF-Dreyfuss-1993" TYPE="REFERENCE">Dreyfuss 1993</LINK>; <LINK REF="REF-Dreyfuss-1998" TYPE="REFERENCE">Dreyfuss 1998</LINK>). This is supported by animal studies comparing high PIP in an animal model where a cast was used to reduce chest wall compliance and hence VT (<LINK REF="REF-Hernandez-1989" TYPE="REFERENCE">Hernandez 1989</LINK>). Histological examination demonstrated a significant reduction in lung inflammation in the animals that were protected from high VT. Further support came from a randomised controlled trial (RCT) comparing two ventilation strategies, high VT (12 mL/kg) versus low VT (6 mL/kg), in adults with acute lung injury. This study was stopped prematurely when interim analysis revealed a significant reduction in both mortality and duration of ventilation in low-VT group (<LINK REF="REF-ARDS-Network-2000" TYPE="REFERENCE">ARDS Network 2000</LINK>). Lung compliance changes rapidly and substantially during the evolution and treatment of RDS (<LINK REF="REF-Hentschel-2002" TYPE="REFERENCE">Hentschel 2002</LINK>; <LINK REF="REF-Wheeler-2009" TYPE="REFERENCE">Wheeler 2009</LINK>). Ventilation strategies that adapt to these changes may enhance stability and reduce lung injury. Furthermore, avoiding rapid changes in the partial pressure of carbon dioxide in arterial blood (PaCO<SUB>2</SUB>) by maintaining stable minute volume ventilation may stabilise cerebral blood perfusion and reduce brain damage.</P>
<P>There is a paucity of information regarding the optimal VT for preterm infants. An observational study of VT values in infants weighing less than 800 g ventilated using VTV during the first three weeks of life reported obtaining acceptable blood gases using target VT of 5 mL/kg to 6 mL/kg with the Drager Babylog 8000plus (<LINK REF="REF-Keszler-2009" TYPE="REFERENCE">Keszler 2009</LINK>). Other studies have suggested that a VT of 4 mL/kg or less may increase lung inflammation and work of breathing (<LINK REF="REF-Lista-2006" TYPE="REFERENCE">Lista 2006</LINK>; <LINK REF="REF-Patel-2009" TYPE="REFERENCE">Patel 2009</LINK>; <LINK REF="REF-Patel-2010" TYPE="REFERENCE">Patel 2010</LINK>; <LINK REF="REF-Chowdhury-2012" TYPE="REFERENCE">Chowdhury 2012</LINK>). When selecting target VT for devices which measure VT at the ventilator (rather than at the Wye piece), allowance must be made for the additional compressible gas volume and compliance of the ventilator circuit (<LINK REF="REF-Cannon-2000" TYPE="REFERENCE">Cannon 2000</LINK>; <LINK REF="REF-Al_x002d_Majed-2004" TYPE="REFERENCE">Al-Majed 2004</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2017-09-15 08:24:57 -0400" MODIFIED_BY="Anne Lawson">
<P>The uptake of VTV varies between countries and continents. Surveys have shown that 5% to 63% of neonatal units in Europe, Australia and New Zealand routinely use VTV modes and perceptions vary as to whether the use of VTV modes leads to improved outcomes (<LINK REF="REF-Sharma-2007" TYPE="REFERENCE">Sharma 2007</LINK>; <LINK REF="REF-Klingenberg-2011" TYPE="REFERENCE">Klingenberg 2011</LINK>; <LINK REF="REF-Van-Kaam-2010" TYPE="REFERENCE">Van Kaam 2010</LINK>). It is important to understand how outcomes of infants ventilated using VTV modes compare with those of infants ventilated using PLV modes.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2017-09-13 07:02:51 -0400" MODIFIED_BY="Anne Lawson">
<P>To determine whether VTV compared with PLV leads to reduced rates of death and death or BPD in newborn infants and to determine whether use of VTV affected outcomes including air leak, cranial ultrasound findings and neurodevelopment.</P>
</OBJECTIVES>
<METHODS MODIFIED="2017-10-12 09:19:14 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2017-10-12 09:19:14 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2017-09-14 15:35:37 -0400" MODIFIED_BY="Anne Lawson">
<P>We included only RCTs and quasi-RCTs.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2017-09-14 15:48:03 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were intubated newborn infants being mechanically ventilated with PPV at the time of study entry. Infants of all GAs up to 44 weeks' postmenstrual age and both muscle-relaxed and non-muscle-relaxed infants were eligible.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2017-09-13 07:05:14 -0400" MODIFIED_BY="Anne Lawson">
<P>The review only included studies comparing ventilation using VTV modes versus ventilation using PLV modes.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2017-10-12 09:19:14 -0400" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2017-09-13 07:06:31 -0400" MODIFIED_BY="Anne Lawson">
<UL>
<LI>Death, defined in two ways:</LI>
<UL>
<LI>death before discharge from the primary hospital;</LI>
<LI>death before two years' corrected age.</LI>
</UL>
<LI>Death or BPD (BPD defined as need for supplemental oxygen requirement), assessed at two time points:</LI>
<UL>
<LI>BPD at 28 days or death prior to 28 days;</LI>
<LI>BPD at 36 weeks' postmenstrual age or death prior to 36 weeks' postmenstrual age.</LI>
</UL>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2017-10-12 09:19:14 -0400" MODIFIED_BY="[Empty name]">
<UL>
<LI>Failure of mode of ventilation (clinical decision to change to different mode of ventilation).</LI>
<LI>Addition of neuromuscular paralysis where previously not paralysed.</LI>
<LI>Ventilation data:</LI>
<UL>
<LI>days of PPV;</LI>
<LI>days of non-invasive respiratory support;</LI>
<LI>total duration of respiratory support in days.</LI>
</UL>
<LI>Markers of gas exchange as shown on arterial or capillary blood gas sampling:</LI>
<UL>
<LI>any pH less than 7.25;</LI>
<LI>any episode of hypocarbia (partial pressure of carbon dioxide (pCO<SUB>2</SUB>) less than 35 mmHg/4.7 kPa);</LI>
<LI>any episode of respiratory acidosis (pH less than 7.25 with pCO<SUB>2</SUB> greater than 60 mmHg/8 kPa).</LI>
</UL>
<LI>Inspired oxygen concentrations (FiO<SUB>2</SUB>).</LI>
<LI>Patent ductus arteriosus (PDA).</LI>
<LI>Incidence of air leak:</LI>
<UL>
<LI>overall incidence of air leak;</LI>
<LI>incidence of pneumothorax;</LI>
<LI>incidence of pulmonary interstitial emphysema (PIE).</LI>
</UL>
<LI>Growth:</LI>
<UL>
<LI>days to regain birth weight (BW);</LI>
<LI>grams weight gain per week until discharge.</LI>
</UL>
<LI>Intracranial pathology:</LI>
<UL>
<LI>all cranial ultrasound abnormalities (intraventricular haemorrhage (IVH) and periventricular leukomalacia (PVL)).</LI>
<LI>IVH;</LI>
<LI>cystic PVL.</LI>
</UL>
<LI>Adverse neurosensory sequelae at two years:</LI>
<UL>
<LI>cerebral palsy;</LI>
<LI>blindness;</LI>
<LI>deafness;</LI>
<LI>moderate to severe developmental delay as assessed on performance in formal neurodevelopmental testing (Bayley score, Wechsler Preschool and Primary Scale of Intelligence (WIPPSI), etc.).</LI>
</UL>
<LI>Surviving infants with BPD:</LI>
<UL>
<LI>BPD (supplemental oxygen requirement) at 28 days after birth;</LI>
<LI>BPD (supplemental oxygen requirement) at 36 weeks' postmenstrual age.</LI>
</UL>
</UL>
<SUBSECTION>
<HEADING LEVEL="5">Modifications of these outcome measures (post hoc after viewing the available data):</HEADING>
<OL>
<LI>Duration of PPV: measure was calculated in survivors only.</LI>
<LI>Failure of ventilatory mode: was clarified as a change from the assigned mode of ventilation within the study intervention period.</LI>
<LI>Days of non-invasive respiratory support. The outcome was originally defined as days of CPAP. However, none of the included studies reported this consistently in an extractable fashion. Therefore, this outcome was not analysed.</LI>
<LI>IVH: collected outcomes for both total incidence of IVH and incidence of IVH grade 3 or 4.</LI>
<LI>Cystic PVL: most studies did not specify PVL. We included outcomes for studies reporting any PVL.</LI>
<LI>Data from studies reporting BPD rates were included for all participants when data on survivors were unavailable.</LI>
<LI>BPD at 28 days after birth: only four trials reported BPD at 28 days after birth (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>). The vast majority of infants included in these four trials were born before 32 weeks' gestation (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table). The definition of BPD (<LINK REF="REF-Jobe-2001" TYPE="REFERENCE">Jobe 2001</LINK>) was based on diagnostic criteria, and it was only recommended to assess an infant for BPD at 28 days of age if the infant was born at or after 32 weeks' gestation. Thus, we did not find it appropriate to report BPD at 28 days in this updated review.</LI>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2017-09-13 07:23:23 -0400" MODIFIED_BY="Anne Lawson">
<P>We used the criteria and standard methods of Cochrane and Cochrane Neonatal (see <A HREF="http://neonatal.cochrane.org/resources-review-authors">the Cochrane Neonatal search strategy for specialized register</A>). We conducted a comprehensive search including: Cochrane Central Register of Controlled Trials (CENTRAL 2016, Issue 12) in the Cochrane Library; MEDLINE via PubMed (1966 to 13 January 2017); Embase (1980 to 13 January 2017) and CINAHL (1982 to 13 January 2017) using the following search terms: (ventilation OR ventilator OR artificial respiration OR respiratory support) AND volume, plus database-specific limiters for RCTs and neonates (see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for the full search strategies for each database). We did not apply language restrictions. We searched clinical trials registries for ongoing or recently completed trials (<A HREF="https://www.clinicaltrials.gov/">clinicaltrials.gov</A>; the World Health Organization's International Trials Registry and Platform <A HREF="http://www.whoint/ictrp/search/en/">www.whoint/ictrp/search/en/</A>, and <A HREF="http://www.isrctn.com/">the ISRCTN Registry</A>). The previous search was performed using the standard strategy of the Neonatal Review Group of the Cochrane Collaboration. MEDLINE (1966 to January 2010) was searched using the MeSH terms: infant, newborn and respiration, artificial and the text word: volume. These terms were also used in a search of the Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library, 2015, Issue 4) and CINAHL. there were no language restrictions. A review (1981 to 2015) of abstracts published by the Society for Pediatric Research and the European Society for Pediatric Research completed the literature search. This was combined with cross-referencing of previous reviews, use of expert informants and newer additional resources such as ClinicalTrials.gov.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-10-11 13:33:26 -0400" MODIFIED_BY="[Empty name]">
<P>We used the standard methods of the Neonatal Review Group of Cochrane. Two review authors (KW and CK) independently performed trial searches, assessments of methodology and extraction of data with comparison and resolution of any differences found at each stage.</P>
<P>For each included study, we collected information regarding method of randomisation, blinding, intervention, stratification and whether the trial was a single-centre or multi-centre study. We noted information regarding trial participants, including GA criteria, BW criteria and other inclusion or exclusion criteria. We analysed information on clinical outcomes, including death and BPD and other relevant secondary outcomes. We contacted trial authors to obtain supplementary data and to clarify issues.</P>
<SUBSECTION>
<HEADING LEVEL="3">Quality of evidence</HEADING>
<P>We used the GRADE approach to assess the quality of evidence, as outlined in the GRADE Handbook (<LINK REF="REF-Sch_x00fc_nemann-2013" TYPE="REFERENCE">Schünemann 2013</LINK>). Three review authors (CK, NM and KW) independently assessed the quality of the evidence for each of the primary and secondary outcomes. We considered evidence from RCTs as high quality but downgraded the evidence one level for serious (or two levels for very serious) limitations based upon the following: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates and presence of publication bias. We used the <LINK REF="REF-GRADEpro-GDT" TYPE="REFERENCE">GRADEpro GDT</LINK> Guideline Development Tool to create 'Summary of findings' tables to report the quality of the evidence.</P>
<P>The GRADE approach results in an assessment of the quality of a body of evidence in one of four grades:</P>
<UL>
<LI>high: we are very confident that the true effect lies close to that of the estimate of the effect;</LI>
<LI>moderate: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different;</LI>
<LI>low: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect;</LI>
<LI>very low: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.</LI>
</UL>
</SUBSECTION>
<STUDY_SELECTION MODIFIED="2017-09-14 15:35:48 -0400" MODIFIED_BY="Anne Lawson">
<P>We included all RCTs and quasi-RCTs fulfilling the selection criteria. All review authors reviewed results of the search, separately selected studies for inclusion and resolved disagreements by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2017-10-11 13:33:26 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors (KW and CK) independently extracted, assessed and coded all data for each study, for studies newly added to this version of the review, using the same categories as in the previous version. We replaced any standard error of the mean reported with the corresponding standard deviation (SD) and resolved disagreements by discussion.</P>
<P>For each study, one review author (KW) entered final data into Review Manager 5 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>), and the other review authors (CK, NM, CM, PGD) checked the data. All review authors reviewed the analysis and draft manuscript.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2017-09-13 07:31:34 -0400" MODIFIED_BY="Anne Lawson">
<P>Three review authors (CK, KW, NM) independently assessed the risk of bias (low, high or unclear) of all included trials using the Cochrane 'Risk of bias' tool (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) for the following eight domains.</P>
<UL>
<LI>Random sequence generation (selection bias).</LI>
<LI>Allocation concealment (selection bias).</LI>
<LI>Blinding of participants and personnel (performance bias).</LI>
<LI>Blinding of outcome assessment (detection bias).</LI>
<LI>Intervention bias (other differences in ventilator management than purely VTV versus PLV).</LI>
<LI>Incomplete outcome data (attrition bias).</LI>
<LI>Selective reporting (reporting bias).</LI>
<LI>Any other bias.</LI>
</UL>
<P>We resolved any disagreements by discussion or by discussion with a fourth review author (PGD). See <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> for a more detailed description of risk of bias for each domain.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2017-09-13 07:36:25 -0400" MODIFIED_BY="Anne Lawson">
<P>We performed meta-analysis using Review Manager 5 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We analysed categorical data using risk ratio (RR), risk difference (RD) and number needed to treat for an additional beneficial outcome (NNTB) or number needed to treat for an additional harmful outcome (NNTH). We analysed continuous data using mean difference (MD). We reported 95% confidence intervals (CIs) on all estimates. We applied the fixed-effect model.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2017-09-13 07:33:00 -0400" MODIFIED_BY="Anne Lawson">
<P>We combined individually randomised trials in a single meta-analysis using the generic inverse variance method. We identified no cluster randomised trials.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2017-05-02 01:49:38 -0400" MODIFIED_BY="[Empty name]">
<P>We requested supplemental information from authors when data were missing or unclear.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2017-09-13 11:28:44 -0400" MODIFIED_BY="Anne Lawson">
<P>We estimated treatment effects reported by individual trials and examined heterogeneity among trials by inspecting forest plots and quantifying the impact of heterogeneity using the I² statistic. We graded the degree of heterogeneity as less than 25% (no heterogeneity), 25% to 49% (low heterogeneity), 50% to 75% (moderate heterogeneity) or greater than 75% (substantial heterogeneity), as recommended by the Cochrane Neonatal group. When there was evidence of apparent or moderate to substantial heterogeneity (I² greater than 50%), we explored possible causes using sensitivity analysis (e.g. differences between strict and hybrid studies), looking for evidence of bias or methodological differences between trials.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2017-09-15 09:02:52 -0400" MODIFIED_BY="Anne Lawson">
<P>Studies included in this review were performed between 1994 and 2014 (published between 1997 and 2016), across the three eras of when prospective trial registrations were not available, was suggested and is now mandatory. We requested possible trial registration number from authors of all studies. In studies where no prospective trial registration was available we defined the risk of reporting bias as unclear.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2017-05-07 16:35:41 -0400" MODIFIED_BY="[Empty name]">
<P>We used the Mantel-Haenszel method for estimates of typical RR, RD, NNTB and NNTH. When we judged meta-analysis to be inappropriate, we analysed and interpreted outcomes from trials separately.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2017-09-14 15:48:06 -0400" MODIFIED_BY="Anne Lawson">
<P>Three subgroup analyses were originally planned based on:</P>
<UL>
<LI>mode of VTV: in view of the differences between VTV modes, subgroups were defined according to:</LI>
<UL>
<LI>volume-controlled (VC) ventilation;</LI>
<LI>volume-guaranteed (VG) ventilation;</LI>
</UL>
<LI>age at recruitment into study: in view of possible differences in outcomes according to postnatal age at time of study recruitment, subgroups were defined according to:</LI>
<UL>
<LI>early recruitment (i.e. commencement of ventilation strategy at birth or within the first four hours of life);</LI>
<LI>late recruitment (i.e. beyond four hours of age). This subgroup included trials in which VTV was tested as a rescue strategy);</LI>
</UL>
<LI>maturity/BW of the infants: in view of the increased risk of BPD in the smallest/most immature infants, subgroups were defined according to:</LI>
<UL>
<LI>BW, with a cut-off of 1000 g;</LI>
<LI>GA, with a cut-off of 30 weeks' gestation.</LI>
</UL>
</UL>
<SUBSECTION>
<HEADING LEVEL="4">Modifications of these subgroup analyses</HEADING>
<P>Subgroup analysis based on VTV mode was not performed. Since the original protocol was written (<LINK REF="REF-McCallion-2002" TYPE="REFERENCE">McCallion 2002</LINK>), the range of available VTV modes has changed, and the suggested subgroup classification was not appropriate. We analysed all VTV modes together without attempting to subdivide them into different modes.</P>
<P>Subgroup analysis based on postnatal age at time of study recruitment was not performed as the vast majority of parallel studies all had early recruitment.</P>
<P>Subgroup analysis based on BW was performed.</P>
</SUBSECTION>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2017-09-13 08:30:30 -0400" MODIFIED_BY="Anne Lawson">
<P>For major outcomes, we performed sensitivity analyses by running the meta-analysis both with strict studies (13 RCTs), in which volume targeting was the only difference in ventilator strategy or ventilator use between groups and hybrid studies (seven RCTs), in which the ventilators used or ventilator triggering modes were different in the two groups. We decided that there was a higher risk of bias (intervention bias) associated with hybrid studies. See further description of strict and hybrid studies under <LINK TAG="RESULTS" TYPE="SECTION">Results</LINK> and <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. In outcomes with moderate to high heterogeneity, we performed analyses both with and without outlying studies as part of a sensitivity analysis.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-10-12 09:20:18 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2017-10-11 13:45:11 -0400" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2017-09-13 08:31:34 -0400" MODIFIED_BY="Anne Lawson">
<P>The previous version of this review identified 12 RCTs. Updated searches revealed 1877 records after duplicates were removed; after screening of 40 full-text articles/studies, review authors identified eight new RCTs for inclusion in the review (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2017-10-11 13:45:11 -0400" MODIFIED_BY="[Empty name]">
<P>Twenty RCTs (22 publications) met our inclusion criteria and reported one or more outcomes defined in our protocol. Sixteen were parallel studies, resulting in 18 publications (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK> (including two separate publications of follow-up data from the inception cohort: Swamy 2008; Singh 2009); <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>; <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>; <LINK REF="STD-Bhat-2016" TYPE="STUDY">Bhat 2016</LINK>). Four were within-participant cross-over studies (<LINK REF="STD-Herrera-2002" TYPE="STUDY">Herrera 2002</LINK>; <LINK REF="STD-Hummler-2006" TYPE="STUDY">Hummler 2006</LINK>; <LINK REF="STD-Polimeni-2006" TYPE="STUDY">Polimeni 2006</LINK>; <LINK REF="STD-Jain-2016" TYPE="STUDY">Jain 2016</LINK>). Details on all 20 included studies are described in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. In brief, we presented the following general information about the 20 studies.</P>
<UL>
<LI>Study sample size: ranging from 15 infants (<LINK REF="STD-Hummler-2006" TYPE="STUDY">Hummler 2006</LINK>) to 212 infants (<LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>).</LI>
<LI>Inclusion criteria: varied from studies which included only smaller infants (less than 1200 g BW or less than 32 weeks' GA), larger infants (1200 g or greater), any infant less than 2500 g), or infants born at or near term.</LI>
<LI>Time of recruitment: 17 trials recruited infants in the early neonatal period (first three days after birth) (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Herrera-2002" TYPE="STUDY">Herrera 2002</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>; <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>; <LINK REF="STD-Bhat-2016" TYPE="STUDY">Bhat 2016</LINK>). Three cross-over trials enrolled preterm infants with mean postnatal age between 33 and 37 days (<LINK REF="STD-Hummler-2006" TYPE="STUDY">Hummler 2006</LINK>; mean (SD) 33 (13) days of age; <LINK REF="STD-Polimeni-2006" TYPE="STUDY">Polimeni 2006</LINK>; mean (SD) 37 (17) days of age; <LINK REF="STD-Jain-2016" TYPE="STUDY">Jain 2016</LINK>; mean (SD) 33 (22) days of age). All 20 trials studied infants at less than 44 weeks' postmenstrual age.</LI>
<LI>Duration of intervention: for the parallel trials, the duration of intervention ranged from median 95 minutes (<LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>) up to almost the full period of mechanical ventilation. For the cross-over trials, duration of intervention period ranged from 60 minutes (<LINK REF="STD-Herrera-2002" TYPE="STUDY">Herrera 2002</LINK>) up to 24 hours (<LINK REF="STD-Jain-2016" TYPE="STUDY">Jain 2016</LINK>).</LI>
<LI>Exclusion criteria: these were similar across trials and included the following: lethal congenital anomalies, muscle relaxation, suspected sepsis, severe IVH, asphyxia, pneumothorax and meconium aspiration. Some studies specified lack of arterial access or treatment with narcotics as additional exclusion criteria. <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK> specifically noted that an ETT leak less than 20% as an exclusion criterion. We tried to clarify this but have not been able to verify whether this was an error. Antenatal steroids and surfactant were available in all participating units, although, in the studies by <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK> and <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>, financial considerations influenced access.</LI>
<LI>Ventilators used in the trials: the VTV group used a range of ventilators, including the VIP Bird and Bird Gold, Siemens Servo 300, Draeger Babylog 8000plus, Stephanie Infant ventilator, AVEA CareFusion and SLE 5000. The ventilation settings were not always well described in each trial. Further details are shown in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</LI>
</UL>
<P>We decided post hoc to define some of the studies as 'hybrid studies' (also used in the 2010 version of this review) with increased risk of bias based on the fact that in some trials volume targeting was not the only difference between study groups. The differences detected were:</P>
<UL>
<LI>different ventilators: three studies used different ventilators in each groups (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>). This is a potential source of bias;</LI>
<LI>different use of triggering:<B> t</B>he use of triggering in one arm of the trial but not in the other is a potential source of bias (<LINK REF="REF-Greenough-2008" TYPE="REFERENCE">Greenough 2008</LINK>). In the trial of <LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>, the PLV group received non-triggered intermittent mandatory ventilation, whereas the VTV groups received triggered ventilation. <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK> used an assist-control (AC) mode in both arms, but the volume control arm used pressure-triggering and the pressure limited arm used flow-triggering;</LI>
<LI>different trigger modes: two studies used a mode where all inflations were triggered in the VTV group (pressure-regulated volume control (PRVC) mode) and synchronised intermittent mandatory ventilation (SIMV) in the PLV group (<LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>). This difference in trigger modes is a potential source of bias (<LINK REF="REF-Greenough-2008" TYPE="REFERENCE">Greenough 2008</LINK>); however, when the inflation rate in the SIMV mode is high (i.e. 50/minute to 60/minute), the difference between the two modes becomes less clinically important;</LI>
<LI>flow termination: in the studies by <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK> and <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>, the VTV group received pressure support ventilation (PSV) with flow termination and the PLV group received SIMV without flow termination.</LI>
</UL>
<P>In view of these differences, we performed a sensitivity analysis of <B>strict studies</B> (both groups <I>initially</I> ventilated with similar modes/ventilators with VTV being to the only difference) versus <B>hybrid studies</B> (other differences between the groups; different ventilators, different use of triggering and different trigger modes).</P>
<P>Supplemental information: we requested raw data and supplemental information to clarify randomisation procedures, outcomes, permit more detailed analysis of duration of ventilation and facilitate subgroup analysis of infants weighing less than 1000 g. The review authors are grateful to the authors for making supplemental information available, details of which are described in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2017-09-15 08:33:34 -0400" MODIFIED_BY="Anne Lawson">
<P>We excluded 16 studies for the following reasons (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table):</P>
<UL>
<LI>not randomised (<LINK REF="STD-Lista--2000" TYPE="STUDY">Lista 2000</LINK>; <LINK REF="STD-Abubakar-2001" TYPE="STUDY">Abubakar 2001</LINK>; <LINK REF="STD-Wach-2003" TYPE="STUDY">Wach 2003</LINK>; <LINK REF="STD-Abd-El_x002d_Moneim-2005" TYPE="STUDY">Abd El-Moneim 2005</LINK>; <LINK REF="STD-Shah-2013" TYPE="STUDY">Shah 2013</LINK>; <LINK REF="STD-Stefanescu-2015" TYPE="STUDY">Stefanescu 2015</LINK>);</LI>
<LI>randomised, but did not report any of the outcomes specified in the protocol (<LINK REF="STD-Olsen-2002" TYPE="STUDY">Olsen 2002</LINK>; <LINK REF="STD-Dotta-2004" TYPE="STUDY">Dotta 2004</LINK>; <LINK REF="STD-Keszler-2004b" TYPE="STUDY">Keszler 2004b</LINK>; <LINK REF="STD-Ramirez_x002d_Del-Valle-2006" TYPE="STUDY">Ramirez-Del Valle 2006</LINK>; <LINK REF="STD-Colnaghi-2006" TYPE="STUDY">Colnaghi 2006</LINK>; <LINK REF="STD-Sinha-2008" TYPE="STUDY">Sinha 2008</LINK>);</LI>
<LI>randomised, but the PIP setting was the same in both arms, which may have interfered with the ventilator's capacity to deliver the set VT and hence affected the outcomes (<LINK REF="STD-Cheema-2001" TYPE="STUDY">Cheema 2001</LINK>);</LI>
<LI>compared two different modes of VTV, and did not include a comparison with PLV (<LINK REF="STD-Unal-2014" TYPE="STUDY">Unal 2014</LINK>);</LI>
<LI>randomised, but later the studies were terminated (<LINK REF="STD-NCT00157989" TYPE="STUDY">NCT00157989</LINK>; <LINK REF="STD-NCT00295230" TYPE="STUDY">NCT00295230</LINK>).</LI>
</UL>
<P>Two studies are awaiting classification (<LINK REF="STD-Liu-2016" TYPE="STUDY">Liu 2016</LINK>; <LINK REF="STD-Miracle-2016" TYPE="STUDY">Miracle 2016</LINK>; see <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK> table), and two studies are ongoing (<LINK REF="STD-ACTRN12609000986279" TYPE="STUDY">ACTRN12609000986279</LINK>; <LINK REF="STD-Salvia-2006" TYPE="STUDY">Salvia 2006</LINK>; see <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK> table).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2017-10-11 13:35:02 -0400" MODIFIED_BY="[Empty name]">
<P>Details of each study appear in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table and in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<ALLOCATION MODIFIED="2017-10-11 13:35:02 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>Random sequence generation (selection bias):</B> eight studies used block randomisation (<LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK> (supplemental data); <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK> (supplemental data); <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>). Some trials used stratification by BW (<LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>), GA (<LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>), centre (<LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>) or a combination of these (<LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>). Five trials did not specify the pattern of randomisation (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>; <LINK REF="STD-Jain-2016" TYPE="STUDY">Jain 2016</LINK>).</P>
<P>
<B>Allocation concealment (selection bias):</B> the studies by <LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Herrera-2002" TYPE="STUDY">Herrera 2002</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Hummler-2006" TYPE="STUDY">Hummler 2006</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK> (supplemental information); <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>; and <LINK REF="STD-Bhat-2016" TYPE="STUDY">Bhat 2016</LINK> used sealed envelopes for blinding of randomisation. Five trials did not specify blinding of randomisation (<LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-Polimeni-2006" TYPE="STUDY">Polimeni 2006</LINK>; <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2017-09-14 13:55:02 -0400" MODIFIED_BY="Anne Lawson">
<P>
<B>Blinding of participants and personnel (performance bias):</B> none of the studies included in this review attempted to mask the carers to the intervention/group assignment.</P>
<P>
<B>Blinding of outcome assessment (detection bias): </B>in the majority of studies, the allocated treatment method of each participant was known to those assessing the trial outcomes. In <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>, severity of lung disease was assessed by a radiographer blinded to the treatment assignment. In <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>, information regarding masking during interpretation of cranial imaging was not reported. A questionnaire was used to determine neurodevelopmental follow-up. The questionnaire administrator was masked to the original intervention group. <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK> reported neurodevelopment outcomes at six to 18 months as assessed by a paediatric neurologist who was blinded to the treatment assignment (supplemental information).</P>
<SUBSECTION>
<HEADING LEVEL="3">Intervention bias (strict versus hybrid studies)</HEADING>
<P>Some study designs had potential to be biased as they included comparisons between different ventilator devices and ventilator modes (triggering) in the VTV and the PLV groups. These studies are termed 'hybrid studies' in contrast to studies where this was not a problem ('strict studies'). Sensitivity analyses were performed exploring strict and hybrid studies separately.</P>
</SUBSECTION>
</BLINDING>
<EXCLUSIONS MODIFIED="2017-09-13 09:15:00 -0400" MODIFIED_BY="Anne Lawson">
<P>
<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK> excluded three out of 60 enrolled infants after randomisation, two who did not fulfil enrolment criteria and one for whom the allocated ventilator was unavailable. Outcome assessment was otherwise complete.</P>
<P>In the study by <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>, there was an uneven distribution of participants between the VTV (30 infants) and PLV (23 infants) groups. Postrandomisation, seven infants were withdrawn because placental histology confirmed chorioamnionitis (supplemental data).</P>
<P>
<LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK> randomised 213 infants, but one infant was erroneously enrolled without consent and immediately withdrawn from the study at the request of the parents. Follow-up in the hospital was complete for the other 212 infants. However, data on brain ultrasound beyond the first week of life were not available for all infants, and PVL was assessed in only 173 infants. Neurodevelopmental follow-up data at six to 18 months of age were available in 128 infants (64 from each group). These 128 infants represented 83% of the 154 participants that survived to discharge in one of the two study centres.</P>
<P>
<LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK> randomised 110 infants, but one infant (randomised to the PLV mode) was excluded postrandomisation following diagnosis of a major congenital anomaly (trisomy 13). Follow-up in the hospital was complete for the other 109 infants. Of the 94 infants who survived to discharge, mortality and follow-up data at median age of 22 months were reported on 47/52 (90%) infants in the VTV group and 41/42 (98%) infants in the PLV group.</P>
<P>In the studies by <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK> and <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>, the denominators for some outcomes were unclear due to inadequately reported completeness of follow-up (unreported numbers of infant transfers to other hospitals). As the denominators were unclear in these studies, only outcomes reported during the intervention period were included in the meta-analyses.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2017-09-13 09:15:20 -0400" MODIFIED_BY="Anne Lawson">
<P>There was only one trial with prospective trial registration (<LINK REF="STD-Jain-2016" TYPE="STUDY">Jain 2016</LINK>). Four other trials were registered retrospectively in a trial registry (<LINK REF="STD-Polimeni-2006" TYPE="STUDY">Polimeni 2006</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Bhat-2016" TYPE="STUDY">Bhat 2016</LINK>). No other trials were registered.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2017-09-15 09:04:58 -0400" MODIFIED_BY="Anne Lawson">
<P>There were imbalances in the study by <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK> in FiO<SUB>2</SUB> in the first six hours of life, and surfactant use. In the published report, <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK> adjusted for this difference, but in this review, we used the unadjusted outcomes.</P>
<P>There were imbalances in the study by <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> with regard to BW, GA and antenatal steroid use. Participants in the PLV group had lower median GA/BW than participants in the VTV group (median: GA/BW 26 weeks/856 g with PLV versus 28 weeks/1016 g with VTV).</P>
<P>The study by <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK> randomised 90 participants; however, postrandomisation they excluded 15 participants in the PLV group and three participants in the VTV group. After contact with the authors, it seems that randomisation occurred before they had considered exclusion criteria and before parents had given consent.</P>
<P>Weaning strategies: in two trials, both arms were weaned using a PLV mode (<LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-10-12 09:20:18 -0400" MODIFIED_BY="[Empty name]">
<P>The 16 randomised parallel trials recruited 977 infants who were included in the meta-analysis. Two trials including 74 participants had an intervention period of 24 hours or less (<LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>). The mean duration of mechanical ventilation reported by other studies in this review ranged from one to 26 days. We believed that the short duration of intervention in the trials of <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK> and <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK> meant that these trials had a reduced ability to detect differences in longer-term outcomes such as BPD, compared to trials that maintained the two treatment groups for a least 72 hours. Therefore, we only included these two trials in pooled analysis of outcomes that occurred during the intervention period (e.g. blood gas analysis). The study by <LINK REF="STD-Bhat-2016" TYPE="STUDY">Bhat 2016</LINK> included infants born at or near term and duration of ventilation was short. From this study, we included only duration of ventilation and blood gas data. As noted in the 'Risk of bias' section, for the trials of <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK> and <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>, we included only outcomes which occurred during the intervention period in the meta-analysis. The <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK> trial primarily investigated VTV versus PLV in the weaning phase. However, as the weaning phase contributed more than 80% of the total duration of ventilation in both groups, we decided to include longer-term outcomes such as BPD and mortality.</P>
<P>We included outcomes from 11/16 parallel trials (including 771 participants) in meta-analysis of outcomes beyond the intervention period (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>).</P>
<P>Four cross-over trials recruited 88 infants (<LINK REF="STD-Herrera-2002" TYPE="STUDY">Herrera 2002</LINK>; <LINK REF="STD-Hummler-2006" TYPE="STUDY">Hummler 2006</LINK>; <LINK REF="STD-Polimeni-2006" TYPE="STUDY">Polimeni 2006</LINK>; <LINK REF="STD-Jain-2016" TYPE="STUDY">Jain 2016</LINK>). The only prespecified outcome able to be assessed from these studies was inspired oxygen concentration.</P>
<P>There was no disagreement between assessors regarding inclusion/exclusion of studies, quality assessment or data extraction. We pooled and analysed available data as listed below.</P>
<P>A planned subgroup analysis based on age at enrolment (planned before/after four hours) was not performed as the only study with exclusively early recruitment of all infants only studied infants until their first blood gas (<LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>). Age at enrolment varied in the other trials. In the parallel trials, study enrolment mainly occurred within first 24 hours of life. In the cross-over trials, <LINK REF="STD-Herrera-2002" TYPE="STUDY">Herrera 2002</LINK> studied participants at mean (range) five (two to nine) days of age. The other three cross-over trials enrolled preterm infants with mean postnatal ages between 33 and 37 days (<LINK REF="STD-Hummler-2006" TYPE="STUDY">Hummler 2006</LINK>; <LINK REF="STD-Polimeni-2006" TYPE="STUDY">Polimeni 2006</LINK>; <LINK REF="STD-Jain-2016" TYPE="STUDY">Jain 2016</LINK>).</P>
<P>
<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK> and <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK> reported outcomes for subgroup of infants weighing less than 1000 g. Authors of all parallel trials were approached for supplemental data of outcomes in infants weighing less than 1000 g. Data from <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; and <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK> were also included in this subgroup meta-analysis.</P>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Death before discharge from the primary hospital (outcomes 1.1 and 2.1)</HEADING>
<P>Eleven trials (771 participants) provided data for death before discharge from the primary hospital (<LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK> (supplemental data); <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> (supplemental data); <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>; <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>). No individual study demonstrated a difference in mortality between VTV and PLV groups and the pooled analysis also showed no significant difference (typical RR 0.75, 95% CI 0.53 to 1.07; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). We graded the quality of evidence for this outcome as low (unblinded intervention and imprecision of estimates). There was no significant difference in mortality for infants weighing less than 1000 g (typical RR 0.71, 95% CI 0.42 to 1.21; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Death before two years' corrected age</HEADING>
<P>None of the trials formally reported death before two years' corrected age, although <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK> (reported in Singh 2009) reported mortality from discharge to follow-up at a median age of 22 months. Overall, there were seven (12%) deaths in the VTV group versus 11 (21%) deaths in the PLV group (odds ratio 0.5, 95% CI 0.1 to 1.4; P = 0.13) (calculated by Singh 2009).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Death or bronchopulmonary dysplasia at 28 days age</HEADING>
<P>Only four trials reported BPD at 28 days after birth (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>). However, none of them reported age of death (days) in those not surviving to discharge. Thus, we cannot report data for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Death or bronchopulmonary dysplasia at 36 weeks' postmenstrual age (outcomes 1.2 and 2.2)</HEADING>
<P>Eight trials (584 participants) reported the combined outcome of death or BPD at 36 weeks' postmenstrual age (<LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> (all supplemental data); <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>). The trial by <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK> was an outlier and reported a significant reduction in this outcome in the VTV group. No other individual trial reported a difference between groups. However, pooled meta-analysis revealed a reduction in the combined outcome (typical RR 0.73, 95% CI 0.59 to 0.89; typical RD -0.12, 95% CI -0.20 to -0.05; typical NNTB 8, 95% CI 5 to 20; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). There was moderate heterogeneity (I<SUP>2</SUP> = 52%) between hybrid trials, but no heterogeneity between strict trials. Sensitivity analysis revealed that exclusion of the <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK> study reduced heterogeneity between hybrid studies (I<SUP>2</SUP> = 30%), but the overall RR of the remaining seven studies remained in favour of VTV (typical RR 0.77, 95% CI 0.62 to 0.95). We graded the quality of evidence for this outcome as moderate (unblinded intervention).</P>
<P>For infants weighing less than 1000 g, there was no difference between groups (typical RR 0.79, 0.62 to 1.01; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Failure of mode of ventilation (outcome 1.3)</HEADING>
<P>Five trials (445 participants) provided data for failure of ventilatory mode (<LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK> (only data from the 24-hour intervention period); <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>). <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK> reported that no infants needed to be rescued with high-frequency ventilation during the intervention period, but these data were not included in meta-analysis due to the short intervention period (median 95 minutes, and before a blood gas analysis was available for the treating physician). Overall, there was no difference between groups, but there was a 'trend' towards less failure of primarily assigned ventilatory mode in the VTV group (typical RR 0.69, 95% CI 0.48 to 1.00; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). Subgroup analysis for infants weighing less than 1000 g could not be performed. We graded the quality of evidence for this outcome as moderate (unblinded intervention).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Addition of neuromuscular paralysis where previously not paralysed (outcome 1.4)</HEADING>
<P>Two trials reported addition of new neuromuscular paralysis (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>). Overall, there was no difference between groups (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). We graded the quality of evidence for this outcome as low (unblinded intervention and imprecision of estimates).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Duration of positive pressure (endotracheal) ventilation (outcomes 1.5, 1.6, 2.3 and 2.4)</HEADING>
<P>Twelve trials (736 participants) provided data for the duration of positive pressure (endotracheal) ventilation (<LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>; and <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK> presented data in their publications; supplemental data obtained from <LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Bhat-2016" TYPE="STUDY">Bhat 2016</LINK>).</P>
<P>The trials analysed data in survivors only, with the exception of <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK> and <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>, where this information was unavailable. In the trial by <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>, only one participant died in each arm, and the results are likely to be similar. Methods of meta-analysis assume normally distributed values, but reported data on duration of PPV were skewed. Meta-analysis performed on the skewed data gave a mathematical MD of -1.35 days (95% CI -1.83 to -0.86) of reduced duration of ventilation using VTV (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). There was low heterogeneity between studies. The trial by <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK> was the only trial that reported a non-significant increase in mean duration of ventilation in the VTV group. Sensitivity analysis revealed that exclusion of the <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK> trial did not change the level of heterogeneity and did not affect the result of the meta-analysis. We graded the quality of evidence for this outcome as low (unblinded intervention and imprecision of estimates).</P>
<P>Geometrically normally distributed data were achieved by log transformation of supplemental raw data from five trials (381 participants) provided by <LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; and <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK> (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). Using this method, after untransforming the log meta-analysis (MD -0.08, 95% CI -0.16 to 0), the MD for ventilation with the VTV modes was 0.8 days (95% CI 0.7 to 1.0) shorter. There was evidence of heterogeneity (I<SUP>2</SUP> = 52%) (strict studies 20%, hybrid studies 62%) in the subset of trials where this analysis was possible.</P>
<P>For infants weighing less than 1000 g, meta-analysis of skewed data from the five trials (199 participants) did not show a statistically significant difference between groups (MD -0.82 days, 95% CI -4.43 to 2.80 days; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>). In this analysis, there was evidence of heterogeneity, particularly in the hybrid studies (I<SUP>2</SUP> = 78%) (strict 0%, hybrid 92%). Using log transformed data, the MD corresponded to -0.01 (95% CI -0.12 to 0.10) fewer days of ventilation with VTV (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>; I<SUP>2</SUP> = 83%) (strict 0%, hybrid 94%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other ventilation data including abnormal blood gas measurements (1.7 to 1.11 and 2.5 to 2.8)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Inspired oxygen concentration</HEADING>
<P>Three parallel studies (<LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK> (reported in Swamy 2008); <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>; <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK>) and four cross-over studies (<LINK REF="STD-Herrera-2002" TYPE="STUDY">Herrera 2002</LINK>; <LINK REF="STD-Hummler-2006" TYPE="STUDY">Hummler 2006</LINK>; <LINK REF="STD-Polimeni-2006" TYPE="STUDY">Polimeni 2006</LINK>; <LINK REF="STD-Jain-2016" TYPE="STUDY">Jain 2016</LINK>) representing 332 infants reported inspired oxygen concentration. The oxygen targeting strategies varied; however, no trials reported a difference between groups. The study by <LINK REF="STD-Herrera-2002" TYPE="STUDY">Herrera 2002</LINK> used the same participant for multiple comparisons (VTV 3.0 mL/kg and 4.5 mL/kg versus PLV). Meta-analysis was only performed using the measurements from the 4.5 mL/kg group (nine infants), and the eight infants in the 3.0 mL/kg were excluded from meta-analysis, leaving 324 infants for meta-analysis. <LINK REF="STD-Polimeni-2006" TYPE="STUDY">Polimeni 2006</LINK> used different groups of participants for the comparisons of VTV 4.5 mL/kg with PLV, and VTV 6.0 mL/kg with PLV. During meta-analysis, any statistical power gained by using an infant as their own control in a cross-over trial is lost. Meta-analysis showed no difference between groups (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). We graded the quality of evidence for this outcome as moderate (unblinded intervention).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Blood gas data</HEADING>
<P>We requested supplemental blood gas data for four trials (<LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Bhat-2016" TYPE="STUDY">Bhat 2016</LINK>).</P>
<P>
<LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK> reported the frequency of blood gases falling outside the target range using the number of blood gases as the denominator. He found a reduced rate of hypocarbia (pCO<SUB>2</SUB> less than 35 torr = mmHg) in blood gases from the VTV group versus PLV group (16/77 vs 29/80, p &lt; 0.05). Supplemental data were analysed using the participant as the denominator (a participant event was defined as any out of range result).</P>
<P>
<LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK> reported the incidence of out of range PaCO<SUB>2</SUB> (PaCO<SUB>2</SUB> less than 5 kPa or PaCO<SUB>2</SUB> greater than 7 kPa) and of hypocarbia (PaCO<SUB>2</SUB> less than 5 kPa) on the first blood gas of 40 enrolled infants. Comparison of all infants showed no statistically significant difference, but for a post hoc subgroup analysis of infants at 26 to 33 weeks of gestation, there was a reported reduction for both outcomes. Supplemental data were analysed to identify the incidence of out of range CO<SUB>2</SUB> by the criteria in this protocol (hypocarbia CO<SUB>2 </SUB>less than 35 mmHg, 4.7 kPa, hypercarbia CO<SUB>2</SUB> greater than 60 mmHg, 8 kPa).</P>
<P>
<LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> reported the number of episodes of hypocarbia per participant (PaCO<SUB>2</SUB> less than 4.5 kPa) and reported fewer episodes of hypocarbia in the VTV group. Although the definition of hypocarbia used in the review is 4.7 kPa, we have included the data in the meta-analysis.</P>
<P>
<LINK REF="STD-Bhat-2016" TYPE="STUDY">Bhat 2016</LINK> (40 participants) reported that in the VTV group, there was a 'median of 1.5 (range 0.8 [sic]) episodes of hypocarbia' compared to a median of 4 (range 1 to 13) episodes of hypocarbia in the PLV group (P = 0.005), but data were not extractable for meta-analysis. We did not receive raw data for meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Any pH less than 7.25</HEADING>
<P>Three trials (98 participants) reported data for any pH less than 7.25 (<LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>). Meta-analysis showed no difference between groups (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). Likewise, for infants weighing less than 1000 g, there was no difference between groups (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>). We graded the quality of evidence for this outcome as low (unblinded intervention and imprecision of estimates).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Hypocarbia (any PaCO<SUB>2</SUB> less than 35 mmHg/4.7 kPa)</HEADING>
<P>Three trials (98 participants) reported extractable data on hypocardia for meta-analysis (<LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>). There was a significant reduction in rates of hypocarbia in the VTV group (typical RR 0.49, 95% CI 0.33 to 0.72; typical RD -0.38, 95% CI -0.54 to -0.22; typical NNTB 3, 95% CI 2 to 5; <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). For the subgroup of infants weighing less than 1000 g, there was no statistically significant difference between groups (<LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). We graded the quality of evidence for this outcome as moderate (unblinded intervention, small trials but large effect and biologically plausible).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Respiratory acidosis (pH less than 7.25 and pCO<SUB>2 </SUB>greater than 60 mmHg/8 kPa)</HEADING>
<P>Three trials (98 participants) reported data on respiratory acidosis (<LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>). There was no significant difference between groups (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>). Likewise, for the subgroup of infants weighing less than 1000 g, there was no difference between groups (<LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>). We graded the quality of evidence for this outcome as low (unblinded intervention and imprecision of estimates).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Either hypocarbia or respiratory acidosis</HEADING>
<P>Two trials (37 participants) reported data on either hypocarbia or respiratory acidosis (<LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>). There was no difference between groups (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>). Likewise, for infants weighing less than 1000 g, there was no statistically significant difference between groups (<LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>). There was no quality assessment done as analysis included only 37 participants.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Patent ductus arteriosus (outcomes 1.12 and 2.9)</HEADING>
<P>Ten trials (754 participants) reported data on PDA (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>; <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>). The definition of PDA was not consistent, and the reported incidence varied between studies. There was no statistically significant difference in any of the individual trials or the pooled analysis (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>). Likewise, there was no difference for infants weighing less than 1000 g (<LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>). We graded the quality of evidence for this outcome as low (unblinded intervention, variable and unvalidated diagnostic criteria employed).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Air leak (outcomes 1.13 to 1.15 and 2.10 to 2.12)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Overall incidence of air leak (pneumothorax or pulmonary interstitial emphysema, or both)</HEADING>
<P>Five trials (374 infants) reported data for overall incidence of any air leak (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK> (supplemental data, only including events during intervention period)). Pooled data showed no statistically significant difference between groups (<LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>). We graded the quality of evidence for this outcome as low (unblinded intervention and imprecision of estimates). Likewise, for infants weighing less than 1000 g, there was no difference between groups (<LINK REF="CMP-002.10" TYPE="ANALYSIS">Analysis 2.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Incidence of pneumothorax</HEADING>
<P>Thirteen trials (575 infants) reported data on incidence of pneumothorax (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK> (supplemental data, only including events during intervention period); <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>). There was a significant reduction in infants ventilated using VTV modes (typical RR 0.52, 95% CI 0.31 to 0.87; typical RD -0.05, 95% CI -0.08 to -0.01; typical NNTB 20, 95% CI 12 to 100; <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>). There were no concerns regarding heterogeneity between trials. We graded the quality of evidence for this outcome as moderate (unblinded intervention). In the subgroup of infants weighing less than 1000 g, there was no significant difference (<LINK REF="CMP-002.11" TYPE="ANALYSIS">Analysis 2.11</LINK>) (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK> (supplemental data); <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK> (supplemental data)).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Incidence of pulmonary interstitial emphysema</HEADING>
<P>Six trials (430 infants) reported incidence of PIE (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK> (supplemental analysis of events occurring during intervention period); <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>). There was no difference for any study or for overall pooled data (<LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>). We graded the quality of evidence for this outcome as low (unblinded intervention and imprecision of estimates). Likewise, for infants weighing less than 1000 g, there was no difference between groups (<LINK REF="CMP-002.12" TYPE="ANALYSIS">Analysis 2.12</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Growth</HEADING>
<P>None of the studies assessed time taken to regain BW or weight gain.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Intracranial pathology (outcomes 1.16 to 1.20 and 2.13 to 2.17)</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Any intraventricular haemorrhage</HEADING>
<P>Six trials (501 participants) reported data on any IVH (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK> (supplemental data); <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>). <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK> reported only the combined outcome of large IVH or PVL (or both) and <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK> reported only grade 3 or 4 IVH; the outcomes from these trials are not included in meta-analysis of 'any IVH' but are included in the relevant meta-analyses below. None of the individual studies showed any difference between groups and the meta-analysis did not show a difference in any IVH between groups (<LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>).</P>
<P>There was moderate heterogeneity (I<SUP>2</SUP> = 53%) between hybrid trials, no heterogeneity between strict trials and low heterogeneity (I<SUP>2</SUP> = 40%) for all trials included. <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK> reported a non-significant increase in 'any IVH' in the VTV group. However, in this study, participants in the VTV group had increased oxygen requirements at enrolment and increased surfactant use compared with the PLV group. This indicates that infants in the VTV group were unlikely to have been at equal inception risk. Sensitivity analysis revealed that exclusion of the <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK> study reduced heterogeneity between hybrid studies (I<SUP>2</SUP> = 0%). The overall RR of the remaining five trials still showed no difference in 'any IVH' between groups. We graded the quality of evidence for this outcome as low (unblinded intervention and imprecision of estimates).</P>
<P>For infants weighing less than 1000 g, there was no statistically significant difference between groups (<LINK REF="CMP-002.13" TYPE="ANALYSIS">Analysis 2.13</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Cystic periventricular leukomalacia</HEADING>
<P>Seven trials (508 participants) reported data on cystic PVL (<LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK> (supplemental data); <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>). No individual study showed a difference between groups. However, meta-analysis showed a significant reduction in PVL in the VTV group (typical RR 0.45, 95% CI 0.21 to 0.98; typical RD -0.04, 95% CI -0.08 to -0.00; <LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>). We graded the quality of evidence for this outcome as moderate (unblinded intervention). For infants weighing less than 1000 g, there was no significant difference between groups (<LINK REF="CMP-002.15" TYPE="ANALYSIS">Analysis 2.15</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Severe intraventricular haemorrhage grade 3 or 4</HEADING>
<P>Ten trials (712 participants) reported data on severe IVH grade 3 or 4 (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK> (supplemental data); <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>). No individual study showed a difference between groups. However meta-analysis showed a significant reduction in IVH grade 3 or 4 in the VTV group (typical RR 0.53, 95% CI 0.37 to 0.77; typical RD -0.09, 95% CI -0.14 to -0.04; typical NNTB 11, 95% CI 7 to 25; <LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>). In addition, there was evidence of heterogeneity in the 'hybrid studies' (I<SUP>2</SUP> = 49%). As for 'any IVH,' <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK> reported a non-significant increase in 'IVH grade 3 or 4' in the VTV group, but infants in the VTV group were unlikely to have been at equal inception risk. Sensitivity analysis revealed that exclusion of the <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK> study eliminated heterogeneity, both between hybrid studies and overall (I<SUP>2</SUP> = 0%). The overall RR of the remaining nine trials showed an even stronger reduction in IVH grade 3 or 4 in the VTV group (typical RR 0.42, 95% CI 0.28 to 0.65). We graded the quality of evidence for this outcome as moderate (unblinded intervention).</P>
<P>There was no significant difference for infants weighing less than 1000 g (typical RR 0.53, 95% CI 0.27 to 1.04; <LINK REF="CMP-002.14" TYPE="ANALYSIS">Analysis 2.14</LINK>). There was evidence of heterogeneity in the subgroup of hybrid studies (overall I<SUP>2</SUP> = 10%; strict studies 0%; hybrid studies 57%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Any intraventricular haemorrhage or periventricular leukomalacia</HEADING>
<P>Three trials (298 participants) reported data on any IVH or PVL (<LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK> (supplemental data); <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>). Pooled analysis showed no statistically significant difference between groups (<LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>). Likewise, for infants weighing less than 1000 g, there was no difference between groups (<LINK REF="CMP-002.16" TYPE="ANALYSIS">Analysis 2.16</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Intraventricular haemorrhage grade 3 or 4 or periventricular leukomalacia</HEADING>
<P>Six trials (441 participants) reported data on IVH grade 3 or 4 or PVL (<LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK> (supplemental data); <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK> (supplemental data)). No individual study showed a difference between groups. However, meta-analysis showed a significant reduction in IVH grade 3 or 4 or PVL in the VTV group (typical RR 0.47, 95% CI 0.27 to 0.80; typical RD -0.09, 95% CI -0.15 to -0.03; typical NNTB 11, 95% CI 7 to 33; <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>). We graded the quality of evidence for this outcome as moderate (unblinded intervention).</P>
<P>In the subgroup of infants weighing less than 1000 g, there was also a statistically significant reduction in the VTV group (typical RR 0.44, 95% CI 0.20 to 0.99; typical RD -0.12, 95% CI -0.24 to -0.01; typical NNTB 8, 95% CI 4 to 100; <LINK REF="CMP-002.17" TYPE="ANALYSIS">Analysis 2.17</LINK>). For this outcome, there was overall moderate heterogeneity between studies (I<SUP>2</SUP> = 69%). This was primarily caused by infants weighing less than 1000 g from the <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK> study where there was a marked difference in this outcome (VTV group 0/12 infants and PLV group 3/5 infants). Sensitivity analysis revealed that exclusion of the <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK> trial eliminated heterogeneity (I<SUP>2</SUP> = 0%), but also changed the significance level of this outcome in infants weighing less than 1000 g (typical RR 0.56, 95% CI 0.20 to 1.57).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Neurodevelopmental outcome (outcomes 3.1 and 2.2)</HEADING>
<P>No studies reported neurodevelopmental outcome as defined by the review criteria.</P>
<P>Two trials (209 participants) reported neurological follow-up using their own definition (<LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>). We performed a post-hoc meta-analysis on these outcomes using the individual study criteria. There was no statistically significant difference between groups (typical RR 0.86, 95% CI 0.47 to 1.59; typical RD -0.02, 95% CI -0.12 to 0.08; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
<P>One study (109 participants) also reported the combined outcome of death or severe disability (<LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>). There was no statistically significant difference between groups (typical RR 0.54, 95% CI 0.27 to 1.06; typical RD -0.15, 95% CI -0.31 to 0.01; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>). This study had unequal postdischarge follow-up, which could be a potential source of bias.</P>
<P>One study (128 participants) reported gross motor delay (<LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>). The results from this single trial demonstrated no statistically significant difference between groups (typical RR 1.00, 95% CI 0.47 to 2.14; typical RD 0.00, 95% CI -0.13 to 0.13; <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Surviving infants with bronchopulmonary dysplasia (outcomes 1.21 and 2.18)</HEADING>
<P>Nine trials (620 participants) reported data on BPD at 36 weeks' postmenstrual age (<LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>; <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>). The trial by <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK> reported a significant reduction in 36 weeks' postmenstrual age in the VTV group. No other individual trial reported a difference between groups. However, pooled meta-analysis revealed a reduction in BPD at 36 weeks' postmenstrual age (typical RR 0.68, 95% CI 0.53 to 0.87; typical RD -0.11, 95% CI -0.18 to -0.04; typical NNTB 9, 95% CI 6 to 25; <LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>). We graded the quality of evidence for this outcome as low (unblinded intervention and possible publication bias with asymmetrical funnel plot). Subgroup analysis for infants weighing less than 1000 g showed no difference between groups (<LINK REF="CMP-002.18" TYPE="ANALYSIS">Analysis 2.18</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Post hoc analyses on related outcomes (outcomes 3.4 and 3.5)</HEADING>
<P>One trial (203 participants) reported data on postnatal glucocorticoids for treating BPD (<LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>). There was no statistically significant difference between groups (typical RR 0.93, 95% CI 0.65 to 1.31; typical RD -0.03, 95% CI -0.16 to 0.10; <LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>).</P>
<P>Two trials (270 participants) reported data on need for home oxygen (<LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK>). Neither individual studies nor pooled analysis showed a statistically significant difference between groups (pooled analysis: typical RR 0.64, 95% CI 0.30 to 1.36; typical RD -0.04, 95 % CI -0.11 to 0.03; <LINK REF="CMP-003.05" TYPE="ANALYSIS">Analysis 3.5</LINK>). Only supplemental data from <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK> were available for the subgroup of infants weighing less than 1000 g. There was no statistically significant difference between groups (RR 0.75, 95% CI 0.25 to 2.23; RD -0.03, 95% CI -0.13 to 0.08; <LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Subgroup analyses</HEADING>
<P>We reported subgroup analysis in infants weighing less than 1000 g, where possible, alongside the results for primary and secondary outcomes.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-09-15 09:07:35 -0400" MODIFIED_BY="Anne Lawson">
<SUMMARY_OF_RESULTS MODIFIED="2017-09-13 12:21:30 -0400" MODIFIED_BY="Anne Lawson">
<P>Meta-analyses performed for this updated review showed that use of VTV, compared with PLV, reduced rates of death or BPD, BPD alone, pneumothorax, severe cranial ultrasound pathologies (IVH grade 3 or 4, or PVL, or both), mean duration of mechanical ventilation and hypocarbia. It is plausible that VTV modes, by controlling VT and avoiding volutrauma, may contribute to a reduction in BPD and death. Additionally, by improving the stability of blood gas parameters and reducing hypocarbia, these modes may stabilise cerebral perfusion and reduce neonatal brain injury. Studies to date have not been powered to assess longer-term neurodevelopmental outcomes. We found no evidence of harm associated with the use of VTV modes.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2017-09-13 12:22:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Most modern ventilators offer VTV modes targeting expired VT. VTV modes have been implemented as a strategy to avoid lung injury due to overinflation or underinflation. However, the target VT set for the whole lung is based on the infant's weight. Regional distribution of VT may vary depending on lung disease. In non-homogeneous lung disease, using a VTV mode does not eliminate the regional risk of lung injury from local volutrauma or shear stress. Strategies to manage these local variations in lung mechanics may be important.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2017-09-15 08:23:53 -0400" MODIFIED_BY="Anne Lawson">
<P>The overall quality of evidence for outcomes in this review varied from moderate to low. Most researchers and ethics committees agree that neonatal ventilation studies should not be blinded from the clinical personnel. Using the GRADE assessment tool, 'moderate' is the highest quality assessment possible for evidence from well-conducted randomised but unblinded studies.</P>
<P>Because of the nature of the interventions, blinding of carers to allocated treatment is impossible. There were no major methodological limitations with seven out of 20 studies (<LINK REF="STD-Herrera-2002" TYPE="STUDY">Herrera 2002</LINK>; <LINK REF="STD-Keszler-2004a" TYPE="STUDY">Keszler 2004a</LINK>; <LINK REF="STD-Hummler-2006" TYPE="STUDY">Hummler 2006</LINK>; <LINK REF="STD-Cheema-2007" TYPE="STUDY">Cheema 2007</LINK>; <LINK REF="STD-Duman-2012" TYPE="STUDY">Duman 2012</LINK>; <LINK REF="STD-Bhat-2016" TYPE="STUDY">Bhat 2016</LINK>; <LINK REF="STD-Jain-2016" TYPE="STUDY">Jain 2016</LINK>). In seven other studies, the ventilators or the triggering modes/devices used (or both) were different in the VTV and the PLV arm, leading to potential intervention bias (defined as hybrid studies) (<LINK REF="STD-Piotrowski-1997" TYPE="STUDY">Piotrowski 1997</LINK>; <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK>; <LINK REF="STD-D_x0027_Angio-2005" TYPE="STUDY">D'Angio 2005</LINK>; <LINK REF="STD-Nafday-2005" TYPE="STUDY">Nafday 2005</LINK>; <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>; <LINK REF="STD-Erdemir-2014" TYPE="STUDY">Erdemir 2014</LINK>). However, sensitivity analysis revealed similar results both when we analysed separately studies using the same ventilator and patient triggering modes/device in the VTV and PLV arms, and when we analysed 'hybrid studies.' In the trials by <LINK REF="STD-Piotrowski-2007" TYPE="STUDY">Piotrowski 2007</LINK> and <LINK REF="STD-Chowdhury-2013" TYPE="STUDY">Chowdhury 2013</LINK>, despite randomisation, there was an imbalance in participant characteristics between the VTV and PLV groups. This may have introduced a bias. The studies by <LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK> and <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK> excluded a substantial number of randomised participants (<LINK REF="STD-Lista-2004" TYPE="STUDY">Lista 2004</LINK>: 7/60; <LINK REF="STD-Guven-2013" TYPE="STUDY">Guven 2013</LINK>: 15/90) after randomisation. The trials by <LINK REF="STD-Sinha-1997" TYPE="STUDY">Sinha 1997</LINK> and <LINK REF="STD-Singh-2006" TYPE="STUDY">Singh 2006</LINK> weaned both arms using PLV mode. Three trials had potential selection bias (<LINK REF="STD-Polimeni-2006" TYPE="STUDY">Polimeni 2006</LINK>; <LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>), and two of these trials also had other biases (<LINK REF="STD-Zhou-2007" TYPE="STUDY">Zhou 2007</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>), thus reducing their quality.</P>
<P>Most trials included were small, single- or dual-centre studies, and some used ventilation modes that are no longer used in modern neonatal ventilators. For some outcomes, with small numbers of participants, there was evidence of imprecision. We did not identify any large multi-centre studies which were adequately powered to address important long-term outcomes. Some clinicians will require evidence from such trials before changing practice.</P>
<P>For the vast majority of outcomes, there was no evidence of publication bias. However, the funnel plot for the outcome BPD at 36 weeks' GA in survivors was asymmetrical. We have no evidence to believe that there was publication bias, but based on the funnel plot this cannot be excluded.</P>
<P>A further limitation with this review is that VT delivery in the VTV group was different depending on the ventilators used and additional ventilator modes. Moreover, studies started at different time points after birth and had different weaning approaches. Studies were also conducted in many different countries (England, Germany, Poland, Turkey, the USA and China). However, these factors also represent a strength of this review. Even with a substantial mixture of trial design and inclusion of infants from three different continents, there was little evidence of heterogeneity, the results clearly favour use of VTV and should be generalisable for a wide population of neonates.</P>
<P>We received supplementary data permitting more extensive subgroup analysis of infants weighing less than 1000 g. However, the relatively low numbers of infants weighing less than 1000 g (247) in this subgroup limit the power to identify differences between interventions.</P>
</QUALITY_OF_EVIDENCE>
<AGREEMENT MODIFIED="2017-09-15 09:07:35 -0400" MODIFIED_BY="Anne Lawson">
<P>Three previous systematic reviews have compared the efficacy of VTV versus PLV; two previous Cochrane reviews (<LINK REF="REF-McCallion-2005" TYPE="REFERENCE">McCallion 2005</LINK>; <LINK REF="REF-Wheeler-2010" TYPE="REFERENCE">Wheeler 2010</LINK>), and the review by <LINK REF="REF-Peng-2014" TYPE="REFERENCE">Peng 2014</LINK>. The first Cochrane Review included four RCTs with 178 infants (<LINK REF="REF-McCallion-2005" TYPE="REFERENCE">McCallion 2005</LINK>). There was no significant difference for death by the time of hospital discharge, and no trials reported the combined outcome of death or BPD. However, there were reduced rates of pneumothorax and IVH grade 3 or 4, and there was reduced days of ventilation in the VTV group. The second Cochrane Review included 12 RCTs with 693 infants (<LINK REF="REF-Wheeler-2010" TYPE="REFERENCE">Wheeler 2010</LINK>). There was no significant difference for death by the time of hospital discharge. However, the use of VTV resulted in reduced rates of death or BPD, pneumothorax, days of ventilation, hypocarbia and IVH grade 3 or 4 or PVL. <LINK REF="REF-Peng-2014" TYPE="REFERENCE">Peng 2014</LINK> included 18 RCTs with 954 infants. The authors reported no difference in incidence of death. However, the use of VTV resulted in reduced rates of BPD, duration of ventilation, any IVH, IVH grade 3 or 4, PVL, pneumothorax, failure of primary mode of ventilation, hypocarbia, mean airway pressure and days of supplemental oxygen administration.</P>
<P>In this updated review in 2017, with 20 RCTs and 1065 infants, we confirm the previously reported beneficial effects of VTV with reductions in clinically relevant outcomes. There was no disagreement with previous reports.</P>
<P>Very few observational trials have compared VTV and PLV, and reported relevant clinical outcomes. <LINK REF="STD-Stefanescu-2015" TYPE="STUDY">Stefanescu 2015</LINK> studied two cohorts of participants treated with PLV (pressure controlled ventilation) and VTV (PSV with volume guarantee), both modes were provided by the Drager Babylog 8000 plus. Both cohorts included 135 participants. In this trial, the VTV cohort had significantly lower mortality, and lower rates of PIE and hypotension. However, there were no differences in neurodevelopmental impairment at 18 months of age.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-09-15 09:08:57 -0400" MODIFIED_BY="Anne Lawson">
<IMPLICATIONS_PRACTICE MODIFIED="2017-09-13 12:34:43 -0400" MODIFIED_BY="Anne Lawson">
<P>Since the previous review, more studies evaluating short- and longer-term outcomes of volume-targeted ventilation (VTV) have been published. In this updated systematic review, we found stronger evidence favouring the use of VTV strategies. Use of VTV compared with pressure-limited ventilation (PLV) reduces the incidence of death or bronchopulmonary dysplasia (BPD), BPD alone, rates of pneumothorax and rates of severe cranial ultrasound pathology. Moreover, it reduces duration of mechanical ventilation and leads to less hypocarbia. This review identified no increase in any adverse outcomes associated with VTV compared with PLV. Increasing experience with VTV means that volume targeting in neonatal intensive care is no longer experimental. However, careful education is important in units considering using VTV.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-09-15 09:08:57 -0400" MODIFIED_BY="Anne Lawson">
<P>Further multi-centre randomised controlled trials, powered to assess effects on important clinical outcomes, are still required, although these will be increasing difficult to conduct as increasing numbers of clinicians lose equipoise. Further research may be best conducted by units that currently do not use volume targeting as their main ventilation modality. Future research should also compare different volume-targeting strategies. We note that some data have been presented at conferences and urge researchers to complete and publish these studies. Ventilator manufacturers can assist researchers and clinicians by making all specifications of their VTV modes freely available.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2017-09-13 12:35:30 -0400" MODIFIED_BY="Anne Lawson">
<P>KI Wheeler was supported in part by a Monash International Postgraduate Research Scholarship. PG Davis was supported in part by an Australian National Health and Medical Research Council Practitioner Fellowship. The project was supported by Australian National Health and Medical Research Council Program Grant No. 384100.</P>
<P>We acknowledge the assistance of Roberto Chiletti and Hania Czerwinska who freely gave their time to assist with translating articles published in Italian and Polish.</P>
<P>The Cochrane Neonatal Review Group has been funded in part with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN267200603418C.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2017-10-12 14:03:42 -0400" MODIFIED_BY="[Empty name]">
<P>CJM: has acted as a consultant to Drager Medical and Acutronic Medical Instruments, both manufacturers of neonatal ventilators. The companies had no involvement with the funding, design or conduct of this review.</P>
<P>CK: None</P>
<P>KIW: None</P>
<P>PGD: None</P>
<P>NMC: None</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2017-10-11 13:40:21 -0400" MODIFIED_BY="[Empty name]">
<P>NMC: wrote the protocol with assistance from CJM and PGD.<BR/>For the 2005 review, NMC wrote the review with assistance from PGD and CJM.</P>
<P>For the 2010 update, KIW and CK performed the search, assessed articles, liaised with study authors regarding supplemental information, extracted and analysed data. PGD supervised the research. CJM and NMC assisted with reviewing the manuscript.</P>
<P>For the 2017 update, KIW and CK performed the search, assessed articles, liaised with study authors regarding supplemental information, extracted and analysed data. CK and KIW wrote the review. PGD, CJM and NMC assisted with reviewing the manuscript.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2017-09-14 13:22:43 -0400" MODIFIED_BY="Anne Lawson">
<P>The original protocol limited PLV to time-cycled modes. In view of development of modern PLV modes that may be flow cycled (e.g. PSV mode with the Draeger Babylog Plus ventilator), we have chosen to include all trials comparing VTV with PLV, independent of PLV being provided in a time-cycled or flow-cycled manner.</P>
<P>The following <B>subgroup analysis</B> was performed, which was not specified in the initial protocol.</P>
<UL>
<LI>Subgroup analysis for strict versus hybrid trial designs, within Analyses 1 and 2 where applicable.</LI>
</UL>
<P>The following <B>outcomes</B> included above were not included in the original protocol for this review.</P>
<UL>
<LI>
<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK> Severe disability (arbitrary).</LI>
<LI>
<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK> Severe disability (arbitrary definition) or death.</LI>
<LI>
<LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK> Gross motor developmental issue (arbitrary definition).</LI>
<LI>
<LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK> Steroids for BPD.</LI>
<LI>
<LINK REF="CMP-003.05" TYPE="ANALYSIS">Analysis 3.5</LINK> Need for home oxygen (survivors).</LI>
<LI>
<LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK> Need for home oxygen (survivors weighing less than 1000 g).</LI>
</UL>
<P>We also added the methodology and plan for 'Summary of findings' tables and GRADE recommendations, which were not included in the original protocol or previous versions of the review.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-10-12 19:05:40 +0100" MODIFIED_BY="Colleen Ovelman">
<STUDIES MODIFIED="2017-10-11 13:45:12 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2017-10-11 13:45:12 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Bhat-2016" MODIFIED="2017-06-06 15:06:32 -0400" MODIFIED_BY="[Empty name]" NAME="Bhat 2016" YEAR="2015">
<REFERENCE MODIFIED="2017-06-06 15:06:32 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bhat P, Chowdhury O, Shetty S, Hannam S, Rafferty GF, Peacock J, et al</AU>
<TI>Volume-targeted versus pressure-limited ventilation in infants born at or near term</TI>
<SO>European Journal of Pediatrics</SO>
<YR>2016</YR>
<VL>175</VL>
<NO>1</NO>
<PG>89-95</PG>
<IDENTIFIERS MODIFIED="2017-06-06 15:06:11 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4291646"/><IDENTIFIER MODIFIED="2017-06-06 15:06:11 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s00431-015-2596-3"/><IDENTIFIER MODIFIED="2017-06-06 15:05:58 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="26239663"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4291645"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Cheema-2007" MODIFIED="2017-06-14 08:46:09 -0400" MODIFIED_BY="[Empty name]" NAME="Cheema 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-06-14 08:46:09 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheema IU, Sinha AK, Kempley ST, Ahluwalia JS</AU>
<TI>Impact of volume guarantee ventilation on arterial carbon dioxide tension in newborn infants: a randomised controlled trial</TI>
<SO>Early Human Development</SO>
<YR>2007</YR>
<VL>83</VL>
<NO>3</NO>
<PG>183-9</PG>
<IDENTIFIERS MODIFIED="2017-06-14 08:40:32 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255072"/><IDENTIFIER MODIFIED="2017-06-14 08:40:14 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.earlhumdev.2006.05.013"/><IDENTIFIER MODIFIED="2017-06-14 08:40:32 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16815649"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255071"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Chowdhury-2013" MODIFIED="2017-06-06 15:08:36 -0400" MODIFIED_BY="[Empty name]" NAME="Chowdhury 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-06-06 15:08:36 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chowdhury O, Patel DS, Hannam S, Lee S, Rafferty GF, Peacock JL, et al</AU>
<TI>Randomised trial of volume-targeted ventilation versus pressure-limited ventilation in acute respiratory failure in prematurely born infants</TI>
<SO>Neonatology</SO>
<YR>2013</YR>
<VL>104</VL>
<NO>4</NO>
<PG>290-4</PG>
<IDENTIFIERS MODIFIED="2017-06-06 15:08:36 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4291647"/><IDENTIFIER MODIFIED="2017-06-06 15:08:36 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1159/000353956"/><IDENTIFIER MODIFIED="2017-06-06 15:08:23 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="24107474"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-06-17 07:00:56 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255073"/><IDENTIFIER MODIFIED="2014-06-17 07:00:56 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1159/000353956"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-D_x0027_Angio-2005" MODIFIED="2017-06-06 15:10:06 -0400" MODIFIED_BY="[Empty name]" NAME="D'Angio 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-06-06 15:10:06 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>D'Angio CT, Chess PR, Kovacs SJ, Sinkin RA, Phelps DL, Kendig JW, et al</AU>
<TI>Pressure-regulated volume control ventilation vs synchronized intermittent mandatory ventilation for very low-birth-weight infants: a randomized controlled trial</TI>
<SO>Archives of Pediatrics and Adolescent Medicine</SO>
<YR>2005</YR>
<VL>159</VL>
<NO>9</NO>
<PG>868-75</PG>
<IDENTIFIERS MODIFIED="2017-06-06 15:10:06 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255076"/><IDENTIFIER MODIFIED="2017-06-06 15:10:06 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1001/archpedi.159.9.868"/><IDENTIFIER MODIFIED="2017-06-06 15:09:56 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16143747"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255075"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Duman-2012" MODIFIED="2017-06-06 15:27:45 -0400" MODIFIED_BY="[Empty name]" NAME="Duman 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-06-06 15:27:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Duman N, Tuzun F, Sutcuoglu, Yesilirmak CD, Kumral A, Ozkan H</AU>
<TI>Impact of volume guarantee on synchronized ventilation in preterm infants: a randomized controlled trial</TI>
<SO>Intensive Care Medicine</SO>
<YR>2012</YR>
<VL>38</VL>
<NO>8</NO>
<PG>1358-64</PG>
<IDENTIFIERS MODIFIED="2017-06-06 15:27:45 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4291649"/><IDENTIFIER MODIFIED="2017-06-06 15:27:45 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s00134-012-2601-5"/><IDENTIFIER MODIFIED="2017-06-06 15:27:33 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22618094"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-09-20 14:54:19 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4291648"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Erdemir-2014" MODIFIED="2017-06-08 08:18:20 -0400" MODIFIED_BY="[Empty name]" NAME="Erdemir 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-06-08 08:18:20 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Erdemir A, Kahramaner Z, Turkoglu E, Cosar H, Sutcuoglu S, Ozer E</AU>
<TI>Effects of synchronized intermittent mandatory ventilation versus pressure support plus volume guarantee ventilation in the weaning phase of preterm infants</TI>
<SO>Pediatric Critical Care Medicine</SO>
<YR>2014</YR>
<VL>15</VL>
<NO>3</NO>
<PG>236-41</PG>
<IDENTIFIERS MODIFIED="2017-06-08 08:18:18 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255080"/><IDENTIFIER MODIFIED="2017-06-08 08:17:42 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1097/PCC.0b013e3182a5570e"/><IDENTIFIER MODIFIED="2017-06-08 08:18:18 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="24608494"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-06-25 01:45:25 -0400" MODIFIED_BY="Kevin Wheeler"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255079"/><IDENTIFIER MODIFIED="2014-06-25 01:45:25 -0400" MODIFIED_BY="Kevin Wheeler" TYPE="DOI" VALUE="10.1097/PCC.0b013e3182a5570e"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Guven-2013" MODIFIED="2017-06-08 08:21:20 -0400" MODIFIED_BY="[Empty name]" NAME="Guven 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-06-08 08:21:20 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Guven S, Bozdag S, Saner H, Cetinkaya M, Yazar AS, Erguven M</AU>
<TI>Early neonatal outcomes of volume guaranteed ventilation in preterm infants with respiratory distress syndrome</TI>
<SO>Journal of Maternal-fetal &amp; Neonatal Medicine</SO>
<YR>2013</YR>
<VL>26</VL>
<NO>4</NO>
<PG>396-401</PG>
<IDENTIFIERS MODIFIED="2017-06-08 08:20:09 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4291651"/><IDENTIFIER MODIFIED="2017-06-08 08:20:09 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.3109/14767058.2012.733778"/><IDENTIFIER MODIFIED="2017-06-08 08:19:33 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23039373"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-09-20 00:33:43 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4291650"/><IDENTIFIER MODIFIED="2014-09-20 00:33:43 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.3109/14767058.2012.733778"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herrera-2002" MODIFIED="2017-09-14 12:14:54 -0400" MODIFIED_BY="Anne Lawson" NAME="Herrera 2002" YEAR="2002">
<REFERENCE MODIFIED="2017-09-14 12:14:54 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herrera CM, Gerhardt T, Claure N, Everett R, Musante G, Thomas C, et al</AU>
<TI>Effects of volume-guaranteed synchronized intermittent mandatory ventilation in preterm infants recovering from respiratory failure</TI>
<SO>Pediatrics</SO>
<YR>2002</YR>
<VL>110</VL>
<NO>3</NO>
<PG>529-33</PG>
<IDENTIFIERS MODIFIED="2017-06-08 08:22:58 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255102"/><IDENTIFIER MODIFIED="2017-06-08 08:22:39 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12205255"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255101"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Hummler-2006" MODIFIED="2017-06-08 08:24:49 -0400" MODIFIED_BY="[Empty name]" NAME="Hummler 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-06-08 08:24:49 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hummler HD, Engelmann A, Pohlandt F, Franz AR</AU>
<TI>Volume-controlled intermittent mandatory ventilation in preterm infants with hypoxemic episodes</TI>
<SO>Intensive Care Medicine</SO>
<YR>2006</YR>
<VL>32</VL>
<NO>4</NO>
<PG>577-84</PG>
<IDENTIFIERS MODIFIED="2017-06-08 08:24:49 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255104"/><IDENTIFIER MODIFIED="2017-06-08 08:24:49 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s00134-006-0079-8"/><IDENTIFIER MODIFIED="2017-06-08 08:24:37 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16501947"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255103"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Jain-2016" MODIFIED="2017-06-08 08:43:29 -0400" MODIFIED_BY="[Empty name]" NAME="Jain 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-06-08 08:43:29 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jain D, Claure N, D'Ugard C, Bello J, Bancalri E</AU>
<TI>Volume guarantee ventilation: effect on preterm infants with frequent hypoxemia episode</TI>
<SO>Neonatology</SO>
<YR>2016</YR>
<VL>110</VL>
<NO>2</NO>
<PG>129-34</PG>
<IDENTIFIERS MODIFIED="2017-06-08 08:43:29 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6863054"/><IDENTIFIER MODIFIED="2017-06-08 08:28:00 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1159/000444844"/><IDENTIFIER MODIFIED="2017-06-08 08:43:29 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="27088487"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-03-01 04:50:13 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6863053"/><IDENTIFIER MODIFIED="2017-03-01 04:50:13 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE=" OI: 10.1159/000444844 "/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Keszler-2004a" MODIFIED="2017-09-15 08:23:53 -0400" MODIFIED_BY="Anne Lawson" NAME="Keszler 2004a" YEAR="2004">
<REFERENCE MODIFIED="2017-06-08 08:54:07 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keszler M, Abubakar K</AU>
<TI>Volume guarantee: stability of tidal volume and incidence of hypocarbia</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2004</YR>
<VL>38</VL>
<NO>3</NO>
<PG>240-5</PG>
<IDENTIFIERS MODIFIED="2017-06-08 08:54:07 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255084"/><IDENTIFIER MODIFIED="2017-06-08 08:54:07 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE=" 10.1002/ppul.20063"/><IDENTIFIER MODIFIED="2017-06-08 08:53:50 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15274104"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255083"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lista-2004" MODIFIED="2017-06-08 08:56:04 -0400" MODIFIED_BY="[Empty name]" NAME="Lista 2004" YEAR="2004">
<REFERENCE MODIFIED="2017-06-08 08:56:04 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lista G, Colnaghi M, Castoldi F, Condo V, Reali R, Compagnoni G, et al</AU>
<TI>Impact of targeted-volume ventilation on lung inflammatory response in preterm infants with respiratory distress syndrome (RDS)</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2004</YR>
<VL>37</VL>
<NO>6</NO>
<PG>510-4</PG>
<IDENTIFIERS MODIFIED="2017-06-08 08:56:04 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255086"/><IDENTIFIER MODIFIED="2017-06-08 08:56:04 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/ppul.10458"/><IDENTIFIER MODIFIED="2017-06-08 08:55:42 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15114551"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255085"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Liu-2011" MODIFIED="2017-06-08 08:58:58 -0400" MODIFIED_BY="[Empty name]" NAME="Liu 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-06-08 08:58:58 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu CQ, Cui Z, Xia YF, Ma L, Fan LL</AU>
<TI>Randomized controlled study of targeted tidal volume ventilation for treatment of severe neonatal respiratory distress syndrome</TI>
<SO>Zhongguo Dang Dai Er Ke za Zhi [Chinese Journal of Contemporary Pediatrics]</SO>
<YR>2011</YR>
<VL>13</VL>
<NO>9</NO>
<PG>1-8</PG>
<IDENTIFIERS MODIFIED="2017-06-08 08:57:50 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4291652"/><IDENTIFIER MODIFIED="2017-06-08 08:57:50 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21924013"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255087"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Nafday-2005" MODIFIED="2017-06-08 09:02:50 -0400" MODIFIED_BY="[Empty name]" NAME="Nafday 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-06-08 09:02:50 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nafday SM, Green RS, Lin J, Brion LP, Ochshorn I, Holzman IR</AU>
<TI>Is there an advantage of using pressure support ventilation with volume guarantee in the initial management of premature infants with respiratory distress syndrome? A pilot study</TI>
<SO>Journal of Perinatology</SO>
<YR>2005</YR>
<VL>25</VL>
<NO>3</NO>
<PG>193-7</PG>
<IDENTIFIERS MODIFIED="2017-06-08 09:02:50 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255090"/><IDENTIFIER MODIFIED="2017-06-08 09:02:50 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1038/sj.jp.7211233"/><IDENTIFIER MODIFIED="2017-06-08 09:01:44 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15674409"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-05-19 23:14:32 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255089"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Piotrowski-1997" MODIFIED="2017-06-08 09:05:07 -0400" MODIFIED_BY="[Empty name]" NAME="Piotrowski 1997" YEAR="1997">
<REFERENCE MODIFIED="2017-06-08 09:05:07 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Piotrowski A, Sobala W, Kawczynski P</AU>
<TI>Patient-initiated, pressure-regulated, volume-controlled ventilation compared with intermittent mandatory ventilation in neonates: a prospective, randomised study</TI>
<SO>Intensive Care Medicine</SO>
<YR>1997</YR>
<VL>23</VL>
<NO>9</NO>
<PG>975-81</PG>
<IDENTIFIERS MODIFIED="2017-06-08 09:05:07 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255092"/><IDENTIFIER MODIFIED="2017-06-08 09:05:07 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9347370"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255091"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Piotrowski-2007" MODIFIED="2017-06-08 09:23:47 -0400" MODIFIED_BY="[Empty name]" NAME="Piotrowski 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-06-08 09:23:47 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Piotrowski A, Bernas S, Fendler W</AU>
<TI>A randomised trial comparing two synchronised ventilation modes in neonates with respiratory distress syndrome</TI>
<SO>Anestezjologia Intensywna Terapia</SO>
<YR>2007</YR>
<VL>39</VL>
<NO>2</NO>
<PG>58-63</PG>
<IDENTIFIERS MODIFIED="2017-06-08 09:21:10 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255094"/><IDENTIFIER MODIFIED="2017-06-08 09:21:10 -0400" MODIFIED_BY="[Empty name]" TYPE="EMBASE" VALUE="2007370596"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-02-23 18:57:00 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255093"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Polimeni-2006" MODIFIED="2017-06-08 09:34:52 -0400" MODIFIED_BY="[Empty name]" NAME="Polimeni 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-06-08 09:34:52 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Polimeni V, Claure N, D'Ugard C, Bancalari E</AU>
<TI>Effects of volume-targeted synchronized intermittent mandatory ventilation on spontaneous episodes of hypoxemia in preterm infants</TI>
<SO>Biology of the Neonate</SO>
<YR>2006</YR>
<VL>89</VL>
<NO>1</NO>
<PG>50-5</PG>
<IDENTIFIERS MODIFIED="2017-06-08 09:34:52 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255106"/><IDENTIFIER MODIFIED="2017-06-08 09:34:07 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1159/000088198"/><IDENTIFIER MODIFIED="2017-06-08 09:34:18 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16155386"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255105"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Singh-2006" MODIFIED="2017-09-14 12:16:08 -0400" MODIFIED_BY="Anne Lawson" NAME="Singh 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-06-08 09:36:43 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singh J, Sinha SK, Alsop E, Gupta S, Misra A, Donn SM</AU>
<TI>Long term follow-up of very low birthweight infants from a neonatal volume versus pressure mechanical ventilation trial</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2009</YR>
<VL>94</VL>
<NO>5</NO>
<PG>F360-2</PG>
<IDENTIFIERS MODIFIED="2017-06-08 09:36:43 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255096"/><IDENTIFIER MODIFIED="2017-06-08 09:36:10 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/adc.2008.150938"/><IDENTIFIER MODIFIED="2017-06-08 09:36:43 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19321507"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-08 09:37:57 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Singh J, Sinha SK, Clarke P, Byrne S, Donn SM</AU>
<TI>Mechanical ventilation of very low birth weight infants: is volume or pressure a better target variable?</TI>
<SO>Journal of Pediatrics</SO>
<YR>2006</YR>
<VL>149</VL>
<NO>3</NO>
<PG>308-13</PG>
<IDENTIFIERS MODIFIED="2017-06-08 09:37:57 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255097"/><IDENTIFIER MODIFIED="2017-06-08 09:37:45 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.jpeds.2006.01.044"/><IDENTIFIER MODIFIED="2017-06-08 09:37:57 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16939738"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-09-14 12:16:08 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Swamy R, Gupta S, Singh J, Donn SM, Sinha SK</AU>
<TI>Tidal volume delivery and peak inspiratory pressure in babies receiving volume targeted or time cycled, pressure limited ventilation: a randomized controlled trial</TI>
<SO>Journal of Neonatal-Perinatal Medicine</SO>
<YR>2008</YR>
<VL>1</VL>
<NO>4</NO>
<PG>239-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255098"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-07-14 23:57:12 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255095"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sinha-1997" MODIFIED="2017-06-08 09:40:01 -0400" MODIFIED_BY="[Empty name]" NAME="Sinha 1997" YEAR="1997">
<REFERENCE MODIFIED="2017-06-08 09:40:01 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sinha SK, Donn SM, Gavey J, McCarty M</AU>
<TI>Randomised trial of volume controlled versus time cycled, pressure limited ventilation in preterm infants with respiratory distress syndrome</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>1997</YR>
<VL>77</VL>
<NO>3</NO>
<PG>F202-5</PG>
<IDENTIFIERS MODIFIED="2017-06-08 09:40:01 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255100"/><IDENTIFIER MODIFIED="2017-06-08 09:40:01 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9462190 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255099"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Zhou-2007" MODIFIED="2017-06-13 15:29:00 -0400" MODIFIED_BY="[Empty name]" NAME="Zhou 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-06-13 15:29:00 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhou XJ, Zhou YR, Hu DY, Chen XW, Jin YM, Lu ZQ</AU>
<TI>Effects of different ventilation modes on the lung injury in infants with very low birth weight</TI>
<SO>Chinese Journal of Emergency Medicine</SO>
<YR>2007</YR>
<VL>16</VL>
<NO>7</NO>
<PG>703-5</PG>
<IDENTIFIERS MODIFIED="2017-03-03 20:35:27 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4291653"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-06-24 20:48:25 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255107"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2017-09-14 12:30:58 -0400" MODIFIED_BY="Anne Lawson">
<STUDY DATA_SOURCE="PUB" ID="STD-Abd-El_x002d_Moneim-2005" MODIFIED="2017-06-08 09:57:15 -0400" MODIFIED_BY="[Empty name]" NAME="Abd El-Moneim 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-06-08 09:57:15 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abd El-Moneim ES, Fuerste HO, Krueger M, Elmagd AA, Brandis M, Schulte-Moenting J, et al</AU>
<TI>Pressure support ventilation combined with volume guarantee versus synchronized intermittent mandatory ventilation: a pilot crossover trial in premature infants in their weaning phase</TI>
<SO>Pediatric Critical Care Medicine</SO>
<YR>2005</YR>
<VL>6</VL>
<NO>3</NO>
<PG>286-92</PG>
<IDENTIFIERS MODIFIED="2017-06-08 09:57:15 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255110"/><IDENTIFIER MODIFIED="2017-06-08 09:57:03 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1097/01.PCC.0000161071.47031.61"/><IDENTIFIER MODIFIED="2017-06-08 09:57:15 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15857526 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-02-04 22:29:20 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255109"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Abubakar-2001" MODIFIED="2017-06-08 09:58:11 -0400" MODIFIED_BY="[Empty name]" NAME="Abubakar 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-06-08 09:58:11 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abubakar KM, Keszler M</AU>
<TI>Patient-ventilator interactions in new modes of patient-triggered ventilation</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2001</YR>
<VL>32</VL>
<NO>1</NO>
<PG>71-5</PG>
<IDENTIFIERS MODIFIED="2017-06-08 09:58:11 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255112"/><IDENTIFIER MODIFIED="2017-06-08 09:58:11 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11416879"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255111"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Abubakar-2006" MODIFIED="2017-09-14 12:22:49 -0400" MODIFIED_BY="Anne Lawson" NAME="Abubakar 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-09-14 12:22:49 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="OTHER">
<AU>Abubakar KM, Montazami S, Keszler M</AU>
<TI>Volume guarantee accelerates recovery from endotracheal tube suctioning in ventilated preterm infants</TI>
<SO>Pediatric Academic Societies Annual Meeting; 2006 April 29-May 2; San Francisco (CA)</SO>
<YR>2006</YR>
<IDENTIFIERS MODIFIED="2017-06-08 10:06:31 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255114"/><IDENTIFIER MODIFIED="2017-06-08 10:06:31 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="E-PAS2006:5560.343"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255113"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheema-2001" MODIFIED="2017-06-08 10:15:32 -0400" MODIFIED_BY="[Empty name]" NAME="Cheema 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-06-08 10:15:32 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheema IU, Ahluwahlia JS</AU>
<TI>Feasibility of tidal volume-guided ventilation in newborn infants: a randomised crossover trial using the volume guarantee modality</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<NO>6</NO>
<PG>1323-8</PG>
<IDENTIFIERS MODIFIED="2017-06-08 10:15:32 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255116"/><IDENTIFIER MODIFIED="2017-06-08 10:15:32 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11389251"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255115"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colnaghi-2006" MODIFIED="2017-09-14 12:23:25 -0400" MODIFIED_BY="Anne Lawson" NAME="Colnaghi 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-09-14 12:23:25 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="OTHER">
<AU>Colnaghi M, Weissmann G, Ciralli F, Matassa PG, Condo V, Messina D, et al</AU>
<TI>Volume-targeted ventilation and lung inflammatory injury in preterm infants with RDS</TI>
<SO>Pediatric Academic Societies Annual Meeting; 2006 April 29-May 2; San Francisco (CA)</SO>
<YR>2006</YR>
<IDENTIFIERS MODIFIED="2017-06-08 10:18:49 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255118"/><IDENTIFIER MODIFIED="2017-06-08 10:18:49 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="E-PAS2006:5506.340"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255117"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dotta-2004" MODIFIED="2017-09-14 12:24:25 -0400" MODIFIED_BY="Anne Lawson" NAME="Dotta 2004" YEAR="2004">
<REFERENCE MODIFIED="2017-09-14 12:24:25 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Dotta A, Crescenzi F, Braguglia A, Campi F, Rechichi J, Orzalesi M</AU>
<TI>Cerebral haemodynamics in preterm infants during synchronized intermittent mandatory ventilation (SIMV) and synchronized intermittent positive pressure ventilation (SIPPV), with and without volume guarantee (VG)</TI>
<SO>Pediatric Academic Societies' Annual Meeting; 2004 May 1-4; San Francisco (CA)</SO>
<YR>2004</YR>
<IDENTIFIERS MODIFIED="2017-06-08 10:40:15 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255120"/><IDENTIFIER MODIFIED="2017-06-08 10:40:15 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="PAS2004:3061"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255119"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keszler-2004b" MODIFIED="2017-09-14 12:24:17 -0400" MODIFIED_BY="Anne Lawson" NAME="Keszler 2004b" YEAR="2004">
<REFERENCE MODIFIED="2017-09-14 12:24:17 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Keszler M, Abubakar KM</AU>
<TI>Volume guarantee accelerates recovery from forced exhalation episodes</TI>
<SO>Pediatric Academic Societies' Annual Meeting; 2004 May 1-4, 2004; San Francisco (CA)</SO>
<YR>2004</YR>
<IDENTIFIERS MODIFIED="2017-06-08 10:37:53 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255124"/><IDENTIFIER MODIFIED="2017-06-08 10:37:53 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="PAS2004:3092"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255123"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lista--2000" MODIFIED="2017-09-14 12:24:45 -0400" MODIFIED_BY="Anne Lawson" NAME="Lista  2000" YEAR="2000">
<REFERENCE MODIFIED="2017-09-14 12:24:45 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lista G, Marangione P, Azzali A, Castoldi F, Pogliani L, Compagnoni G</AU>
<TI>The "guaranteed volume" in pressure support ventilation reduces the risk of barotrauma in premature children with severe respiratory syndrome</TI>
<SO>Acta Bio-medica de l'Ateneo Parmense</SO>
<YR>2000</YR>
<VL>71</VL>
<NO>Suppl 1</NO>
<PG>453-6</PG>
<IDENTIFIERS MODIFIED="2017-06-08 10:44:13 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255126"/><IDENTIFIER MODIFIED="2017-06-08 10:44:13 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11424787"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255125"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-NCT00157989" MODIFIED="2017-09-14 12:26:07 -0400" MODIFIED_BY="Anne Lawson" NAME="NCT00157989" YEAR="2005">
<REFERENCE MODIFIED="2017-09-14 12:26:07 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00157989</AU>
<TI>Study to assess safety and feasibility of resuscitation of preterm infants with controlled volume of air/oxygen</TI>
<SO>clinicaltrials.gov/show/NCT00157989</SO>
<YR>Date first received: 8 September 2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6863056"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6863055"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-NCT00295230" MODIFIED="2017-09-14 12:26:40 -0400" MODIFIED_BY="Anne Lawson" NAME="NCT00295230" YEAR="2006">
<REFERENCE MODIFIED="2017-09-14 12:26:40 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00295230</AU>
<TI>Effects of volume guarantee with pressure supported vs. synchronized intermittent mandatory ventilation in VLBW infants</TI>
<SO>clinicaltrials.gov/show/NCT00295230</SO>
<YR>Date first received: 21 February 2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4291655"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4291654"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olsen-2002" MODIFIED="2017-06-08 10:55:32 -0400" MODIFIED_BY="[Empty name]" NAME="Olsen 2002" YEAR="2002">
<REFERENCE MODIFIED="2017-06-08 10:55:32 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Excluded because change mode of triggering entirely as well as changing volume/ no volume strategy&lt;/p&gt;" NOTES_MODIFIED="2017-06-08 10:55:32 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SL, Thibeault DW, Truog WE</AU>
<TI>Crossover trial comparing pressure support with synchronized intermittent ventilation</TI>
<SO>Journal of Perinatology</SO>
<YR>2002</YR>
<VL>22</VL>
<NO>6</NO>
<PG>461-6</PG>
<IDENTIFIERS MODIFIED="2017-06-08 10:55:32 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255128"/><IDENTIFIER MODIFIED="2017-06-08 10:55:32 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1038/sj.jp.7210772"/><IDENTIFIER MODIFIED="2017-06-08 10:55:19 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12168123"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255127"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramirez_x002d_Del-Valle-2006" MODIFIED="2017-09-14 12:27:07 -0400" MODIFIED_BY="Anne Lawson" NAME="Ramirez-Del Valle 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-09-14 12:27:07 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Ramirez-Del Valle JO, Villa-Guillen M, Reyes A, Murguia-de Sierra T</AU>
<TI>Tidal volume (V<SUB>T</SUB>) delivery and stability of different ventilatory parameters during synchronized mechanical ventilation with or without volume guarantee (VG). Is V<SUB>T</SUB> stability always associated to peak inspiratory changes?</TI>
<SO>Pediatric Academic Societies Annual Meeting; 2006 April 29-May 2; San Francisco (CA)</SO>
<YR>2006</YR>
<IDENTIFIERS MODIFIED="2017-06-08 10:57:35 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255130"/><IDENTIFIER MODIFIED="2017-06-08 10:57:35 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="E-PAS2006:4843.186"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255129"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shah-2013" MODIFIED="2017-06-08 10:59:44 -0400" MODIFIED_BY="[Empty name]" NAME="Shah 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-06-08 10:59:44 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shah S, Kaul A</AU>
<TI>Volume targeted ventilation and arterial carbon dioxide in extremely preterm infants</TI>
<SO>Journal of Neonatal and Perinatal Medicine</SO>
<YR>2013</YR>
<VL>6</VL>
<NO>4</NO>
<PG>339-44</PG>
<IDENTIFIERS MODIFIED="2017-06-08 10:59:44 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6863058"/><IDENTIFIER MODIFIED="2017-06-08 10:59:44 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.3233/NPM-1372713"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-04-10 16:29:40 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6863057"/><IDENTIFIER MODIFIED="2017-04-10 16:29:40 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.3233/NPM-1372713"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sinha-2008" MODIFIED="2017-09-14 12:29:22 -0400" MODIFIED_BY="Anne Lawson" NAME="Sinha 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-09-14 12:29:22 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Sinha AK, Kempley ST</AU>
<TI>A randomised trial comparing the effects of volume guided ventilation and synchronised intermittent positive pressure ventilation on the cerebral and mesenteric circulation following surfactant administration</TI>
<SO>2nd Congress of the European Academy of Paediatrics; 2008 Oct 24-28; Nice (France)</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255132"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255131"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stefanescu-2015" MODIFIED="2017-06-08 11:11:08 -0400" MODIFIED_BY="[Empty name]" NAME="Stefanescu 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-06-08 11:11:08 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stefanescu BM, Frewan N, Slaughter JC, O'Shea TM</AU>
<TI>Volume guarantee pressure support ventilation in extremely preterm infants and neurodevelopmental outcome at 18 months</TI>
<SO>Journal of Perinatology</SO>
<YR>2015</YR>
<VL>35</VL>
<NO>6</NO>
<PG>419-23</PG>
<IDENTIFIERS MODIFIED="2017-06-08 11:11:08 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6863060"/><IDENTIFIER TYPE="DOI" VALUE="10.1038/jp.2014.228"/><IDENTIFIER MODIFIED="2017-06-08 11:11:08 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="25569681"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6863059"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Unal-2014" MODIFIED="2017-09-14 12:30:36 -0400" MODIFIED_BY="Anne Lawson" NAME="Unal 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-09-14 12:30:36 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="OTHER">
<AU>Unal S, Ergenekon E, Aktas S, Altuntas N, Beken S, Kazanci E, et al</AU>
<TI>Evaluation of ventilatory parameters, short and long term morbidities in preterms ventilated with either PSV+VG or SIMV+VG</TI>
<SO>5th Congress of the European Academy of Paediatric Societies; 2014 Oct 17-21 October; Barcelona (Spain)</SO>
<YR>2014</YR>
<IDENTIFIERS MODIFIED="2017-06-08 11:22:25 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4291659"/><IDENTIFIER MODIFIED="2017-06-08 11:22:25 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT01514331"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4291658"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wach-2003" MODIFIED="2017-09-14 12:30:58 -0400" MODIFIED_BY="Anne Lawson" NAME="Wach 2003" YEAR="2003">
<REFERENCE MODIFIED="2017-09-14 12:30:58 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Wach RA, Osiovich HC</AU>
<TI>Can assist control plus volume guarantee (AC+VG) avoid large tidal volumes (TV) in ventilated spontaneously breathing infants with BPD?</TI>
<SO>Pediatric Academic Societies' Annual Meeting; 2003 May 3-6; Seattle (Washington)</SO>
<YR>2003</YR>
<IDENTIFIERS MODIFIED="2017-06-08 11:41:52 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255134"/><IDENTIFIER MODIFIED="2017-06-08 11:41:52 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="PAS2003:2896"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255133"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2017-09-14 12:31:15 -0400" MODIFIED_BY="Anne Lawson">
<STUDY DATA_SOURCE="UNPUB" ID="STD-Liu-2016" MODIFIED="2017-09-14 12:31:15 -0400" MODIFIED_BY="Anne Lawson" NAME="Liu 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-09-14 12:31:15 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu CZ, Huang BY, Tan BY, Guan HF, Xu XH, Guo QY</AU>
<TI>Efficacy of volume-targeted ventilation for the treatment of neonatal respiratory distress syndrome</TI>
<SO>Zhongguo Dang Dai Er Ke za Zhi [Chinese Journal of Contemporary Pediatrics]</SO>
<YR>2016</YR>
<VL>18</VL>
<NO>1</NO>
<PG>6-9</PG>
<IDENTIFIERS MODIFIED="2017-06-08 11:47:28 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6863062"/><IDENTIFIER MODIFIED="2017-06-08 11:47:28 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="26781404"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-03-01 05:01:36 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6863061"/><IDENTIFIER MODIFIED="2017-03-01 05:01:36 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.7499/j.issn.1008-8830.2016.01.002"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miracle-2016" MODIFIED="2017-06-13 13:12:43 -0400" MODIFIED_BY="[Empty name]" NAME="Miracle 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-06-13 13:12:43 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miracle X, Salvia MD, Figueras J, Rodriguez JM, Carbonell X</AU>
<TI>Effects of pressure support plus volume guarantee ventilation versus synchronized intermittent mandatory ventilation in extremely low birth weight infants with respiratory distress syndrome: a prospective, randomized study</TI>
<SO>Journal of Maternal-Fetal and Neonatal Medicine</SO>
<YR>2016</YR>
<VL>29</VL>
<NO>Supple 1</NO>
<PG>236-7</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:12:28 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6863064"/><IDENTIFIER MODIFIED="2017-06-13 13:12:09 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1080/14767058.2016.1191212"/><IDENTIFIER MODIFIED="2017-06-13 13:12:28 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="27633796"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-13 13:11:54 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6863063"/><IDENTIFIER MODIFIED="2017-03-01 04:53:19 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1080/14767058.2016.1191212"/></IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2017-09-15 09:23:42 -0400" MODIFIED_BY="Anne Lawson">
<STUDY DATA_SOURCE="UNPUB" ID="STD-ACTRN12609000986279" MODIFIED="2017-09-15 09:23:42 -0400" MODIFIED_BY="Anne Lawson" NAME="ACTRN12609000986279" YEAR="">
<REFERENCE MODIFIED="2017-09-15 09:23:42 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="OTHER">
<AU>ACTRN12609000986279</AU>
<TI>A randomized controlled trial of modes of ventilatory support in preterm babies from point of delivery to the neonatal intensive care unit</TI>
<SO>www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=308342&amp;isReview=true</SO>
<YR>Date first received: 9 July 2009</YR>
<IDENTIFIERS MODIFIED="2010-09-20 20:13:35 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255138"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-09-20 20:13:11 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255137"/><IDENTIFIER MODIFIED="2010-09-20 20:12:31 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ACTRN12609000986279"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Salvia-2006" MODIFIED="2017-09-14 12:32:00 -0400" MODIFIED_BY="Anne Lawson" NAME="Salvia 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-09-14 12:32:00 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salvia MD, Figueras J, Miracle X, Rodríguez-Miguélez JM, Carbonell X</AU>
<TI>Effect of volume guarantee combined with synchronized intermittent mandatory ventilation vs synchronized intermittent mandatory ventilation in the extremely premature</TI>
<SO>European Journal of Pediatrics</SO>
<YR>2006</YR>
<VL>165</VL>
<NO>Suppl 1</NO>
<PG>376</PG>
<IDENTIFIERS MODIFIED="2017-06-08 12:11:08 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3255136"/><IDENTIFIER MODIFIED="2017-06-08 12:11:08 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s00431-006-0349-z"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3255135"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-10-12 09:26:27 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2017-09-15 09:24:03 -0400" MODIFIED_BY="Anne Lawson">
<REFERENCE ID="REF-Al_x002d_Majed-2004" MODIFIED="2017-06-13 13:14:42 -0400" MODIFIED_BY="[Empty name]" NAME="Al-Majed 2004" TYPE="JOURNAL_ARTICLE">
<AU>Al-Majed SI, Thompson JE, Watson KF, Randolph AG</AU>
<TI>Effect of lung compliance and endotracheal tube leakage on measurement of tidal volume</TI>
<SO>Critical Care</SO>
<YR>2004</YR>
<VL>8</VL>
<NO>6</NO>
<PG>R398-402</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:14:42 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:14:42 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/cc2954"/><IDENTIFIER MODIFIED="2017-06-08 14:27:56 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="15566583"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-ARDS-Network-2000" MODIFIED="2017-06-13 13:17:20 -0400" MODIFIED_BY="[Empty name]" NAME="ARDS Network 2000" TYPE="JOURNAL_ARTICLE">
<AU>Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A</AU>
<TI>Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome</TI>
<SO>New England Journal of Medicine</SO>
<YR>2000</YR>
<VL>342</VL>
<NO>2</NO>
<PG>1301-8</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:15:58 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:15:58 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1056/NEJM200005043421801"/><IDENTIFIER MODIFIED="2017-06-13 13:15:46 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10793162"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bardin-1997" MODIFIED="2017-06-13 13:18:13 -0400" MODIFIED_BY="[Empty name]" NAME="Bardin 1997" TYPE="JOURNAL_ARTICLE">
<AU>Bardin C, Zelkowitz P, Papageorgiou A</AU>
<TI>Outcome of small-for-gestational age and appropriate-for-gestational age infants born before 27 weeks of gestation</TI>
<SO>Pediatrics</SO>
<YR>1997</YR>
<VL>100</VL>
<NO>2</NO>
<PG>E4</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:18:13 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:18:13 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9233975"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bjorklund-1997" MODIFIED="2017-06-13 13:20:02 -0400" MODIFIED_BY="[Empty name]" NAME="Bjorklund 1997" TYPE="JOURNAL_ARTICLE">
<AU>Bjorklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O, et al</AU>
<TI>Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs</TI>
<SO>Pediatric Research</SO>
<YR>1997</YR>
<VL>42</VL>
<NO>3</NO>
<PG>348-55</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:20:02 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:19:48 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1203/00006450-199709000-00016"/><IDENTIFIER MODIFIED="2017-06-13 13:20:02 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9284276"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cannon-2000" MODIFIED="2017-09-14 12:32:38 -0400" MODIFIED_BY="Anne Lawson" NAME="Cannon 2000" TYPE="JOURNAL_ARTICLE">
<AU>Cannon ML, Cornell J, Tripp-Hamel DS, Gentile MA, Hubble CL, Meliones JN, et al</AU>
<TI>Tidal volumes for ventilated infants should be determined with a pneumotachometer placed at the endotracheal tube</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2000</YR>
<VL>162</VL>
<NO>6</NO>
<PG>2109-12</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:21:16 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:21:16 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1164/ajrccm.162.6.9906112"/><IDENTIFIER MODIFIED="2017-06-13 13:20:53 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11112123"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chowdhury-2012" MODIFIED="2017-06-13 13:23:08 -0400" MODIFIED_BY="[Empty name]" NAME="Chowdhury 2012" TYPE="JOURNAL_ARTICLE">
<AU>Chowdhury O, Rafferty GF, Lee S, Hannam S, Milner AD, Greenough A</AU>
<TI>Volume-targeted ventilation in infants born at or near term</TI>
<SO>Archives of Diseases in Childhood Fetal and Neonatal Edition</SO>
<YR>2012</YR>
<VL>97</VL>
<PG>F264.266</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:23:08 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:23:08 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/archdischild-2011-301041"/><IDENTIFIER MODIFIED="2017-06-13 13:22:49 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22194469"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Clark-2000" MODIFIED="2017-06-13 13:23:57 -0400" MODIFIED_BY="[Empty name]" NAME="Clark 2000" TYPE="JOURNAL_ARTICLE">
<AU>Clark RH, Slutsky AS, Gerstmann DR</AU>
<TI>Lung protective strategies of ventilation in the neonate: what are they?</TI>
<SO>Pediatrics</SO>
<YR>2000</YR>
<VL>105</VL>
<NO>1 Pt 1</NO>
<PG>112-4</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:23:57 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:23:57 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10617711"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Coalson-1999" MODIFIED="2017-06-13 13:25:02 -0400" MODIFIED_BY="[Empty name]" NAME="Coalson 1999" TYPE="JOURNAL_ARTICLE">
<AU>Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA</AU>
<TI>Neonatal chronic lung disease in extremely immature baboons</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1999</YR>
<VL>160</VL>
<NO>4</NO>
<PG>1333-46</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:25:02 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:25:02 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1164/ajrccm.160.4.9810071"/><IDENTIFIER MODIFIED="2017-06-13 13:24:47 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10508826"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dreyfuss-1993" MODIFIED="2017-06-13 13:27:09 -0400" MODIFIED_BY="[Empty name]" NAME="Dreyfuss 1993" TYPE="JOURNAL_ARTICLE">
<AU>Dreyfuss D, Saumon G</AU>
<TI>Role of tidal volume, FRC and end-inspiratory volume in the development of pulmonary edema following mechanical ventilation</TI>
<SO>American Review of Respiratory Disease</SO>
<YR>1993</YR>
<VL>148</VL>
<NO>5</NO>
<PG>1194-203</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:27:09 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:27:09 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1164/ajrccm/148.5.1194"/><IDENTIFIER MODIFIED="2017-06-13 13:26:51 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8239153"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dreyfuss-1998" MODIFIED="2017-09-14 12:34:17 -0400" MODIFIED_BY="Anne Lawson" NAME="Dreyfuss 1998" TYPE="JOURNAL_ARTICLE">
<AU>Dreyfuss D, Saumon G</AU>
<TI>Ventilator-induced lung injury: lessons from experimental studies</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1998</YR>
<VL>157</VL>
<NO>1</NO>
<PG>294-323</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:29:11 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:29:11 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1164/ajrccm.157.1.9604014"/><IDENTIFIER MODIFIED="2017-06-13 13:28:50 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9445314"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gortner-1999" MODIFIED="2017-06-13 13:30:51 -0400" MODIFIED_BY="[Empty name]" NAME="Gortner 1999" TYPE="JOURNAL_ARTICLE">
<AU>Gortner L, Wauer RR, Stock GJ, Reiter HL, Reiss I, Jorch G, et al</AU>
<TI>Neonatal outcome in small for gestational age infants: do they really do better?</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>1999</YR>
<VL>27</VL>
<NO>6</NO>
<PG>484-9</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:30:51 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:30:51 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1515/JPM.1999.065"/><IDENTIFIER MODIFIED="2017-06-13 13:30:33 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10732308"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-GRADEpro-GDT" MODIFIED="2017-09-14 12:34:34 -0400" MODIFIED_BY="Anne Lawson" NAME="GRADEpro GDT" TYPE="COMPUTER_PROGRAM">
<TI>GRADEpro GDT</TI>
<YR>2014</YR>
<EN>accessed 14 September 2016</EN>
<PB>Grade Working Group, McMaster University</PB>
<CY>Hamilton (ON)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greenough-2008" MODIFIED="2017-04-23 03:36:26 -0400" MODIFIED_BY="[Empty name]" NAME="Greenough 2008" TYPE="COCHRANE_REVIEW">
<AU>Greenough A, Dimitriou G, Prendergast M, Milner AD</AU>
<TI>Synchronised mechanical ventilation for respiratory support in newborn infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2010-03-25 18:13:19 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2010-03-25 18:13:19 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000456.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hannaford-1999" MODIFIED="2017-06-13 13:50:18 -0400" MODIFIED_BY="[Empty name]" NAME="Hannaford 1999" TYPE="JOURNAL_ARTICLE">
<AU>Hannaford K, Todd DA, Jeffery H, John E, Byth K, Gilbert G</AU>
<TI>Role of ureaplasma urealyticum in lung disease of prematurity</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>1999</YR>
<VL>81</VL>
<NO>3</NO>
<PG>F162-7</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:50:18 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:50:18 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10525015"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hentschel-2002" MODIFIED="2017-06-13 13:57:39 -0400" MODIFIED_BY="[Empty name]" NAME="Hentschel 2002" TYPE="JOURNAL_ARTICLE">
<AU>Hentschel R, Brune T, Franke N, Harms E, Jorch G</AU>
<TI>Sequential changes in compliance and resistance after bolus administration or slow infusions of surfactant in preterm infants</TI>
<SO>Intensive Care Medicine</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>5</NO>
<PG>622-8</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:57:39 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:57:39 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s00134-002-1277-7"/><IDENTIFIER MODIFIED="2017-06-13 13:57:24 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12029412"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hernandez-1989" MODIFIED="2017-06-13 13:59:59 -0400" MODIFIED_BY="[Empty name]" NAME="Hernandez 1989" TYPE="JOURNAL_ARTICLE">
<AU>Hernandez LA, Peevy KJ, Moise AA, Parker JC</AU>
<TI>Chest wall restriction limits high airway pressure-induced lung injury in young rabbits</TI>
<SO>Journal of Applied Physiology</SO>
<YR>1989</YR>
<VL>66</VL>
<NO>5</NO>
<PG>2364-8</PG>
<IDENTIFIERS MODIFIED="2017-06-13 13:59:59 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 13:59:59 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2745302"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2017-09-14 12:35:24 -0400" MODIFIED_BY="Anne Lawson" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JP, Green S, editor(s)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<IDENTIFIERS MODIFIED="2017-03-06 16:45:06 -0500" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Jobe-2001" MODIFIED="2017-06-13 14:01:56 -0400" MODIFIED_BY="[Empty name]" NAME="Jobe 2001" TYPE="JOURNAL_ARTICLE">
<AU>Jobe AH, Bancalari E</AU>
<TI>Bronchopulmonary Dysplasia</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2001</YR>
<VL>163</VL>
<NO>7</NO>
<PG>1723-9</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:01:56 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:01:56 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1164/ajrccm.163.7.2011060"/><IDENTIFIER MODIFIED="2017-03-27 17:04:16 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="11401896"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Keszler-2009" MODIFIED="2017-09-14 12:35:37 -0400" MODIFIED_BY="Anne Lawson" NAME="Keszler 2009" TYPE="JOURNAL_ARTICLE">
<AU>Keszler M, Nassabeh-Montazami S, Abubakar K</AU>
<TI>Evolution of tidal volume requirement during the first 3 weeks of life in infants &lt;800 g ventilated with volume guarantee</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2009</YR>
<VL>94</VL>
<NO>4</NO>
<PG>F279-82</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:03:14 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:03:14 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/adc.2008.147157"/><IDENTIFIER MODIFIED="2017-06-13 14:02:57 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19060010"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Klingenberg-2011" MODIFIED="2017-06-13 14:04:41 -0400" MODIFIED_BY="[Empty name]" NAME="Klingenberg 2011" TYPE="JOURNAL_ARTICLE">
<AU>Klingenberg C, Wheeler KI, Owen LS, Kaaresen PI, Davis PG</AU>
<TI>An international survey on neonatal volume-targeted ventilation</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2011</YR>
<VL>96</VL>
<NO>2</NO>
<PG>F146-8</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:04:41 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:04:41 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/adc.2009.181081"/><IDENTIFIER MODIFIED="2017-03-27 17:06:11 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="20584800"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lista-2006" MODIFIED="2017-06-13 14:06:16 -0400" MODIFIED_BY="[Empty name]" NAME="Lista 2006" TYPE="JOURNAL_ARTICLE">
<AU>Lista G, Castoldi F, Fontana P, Reali R, Reggiani A, Bianchi S, et al</AU>
<TI>Lung inflammation in preterm infants with respiratory distress syndrome: effects of ventilation with different tidal volumes</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2006</YR>
<VL>41</VL>
<NO>4</NO>
<PG>357-63</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:06:16 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:06:16 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/ppul.20363"/><IDENTIFIER MODIFIED="2017-06-13 14:06:03 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16477653"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McCallion-2002" MODIFIED="2017-06-13 14:06:41 -0400" MODIFIED_BY="[Empty name]" NAME="McCallion 2002" TYPE="COCHRANE_PROTOCOL">
<AU>McCallion N, Davis PG, Morley CJ</AU>
<TI>Volume-targeted versus pressure-limited ventilation in the neonates</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2010-10-04 14:19:25 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2010-10-04 14:19:25 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003666.pub2 "/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-NIH-1979" MODIFIED="2017-09-14 12:36:08 -0400" MODIFIED_BY="Anne Lawson" NAME="NIH 1979" TYPE="OTHER">
<AU>National Institutes of Health</AU>
<TI>Report of workshop on bronchopulmonary dysplasia</TI>
<SO>NIH Publication No 80-1660</SO>
<YR>1979</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Northway-1967" MODIFIED="2017-09-14 12:36:21 -0400" MODIFIED_BY="Anne Lawson" NAME="Northway 1967" TYPE="JOURNAL_ARTICLE">
<AU>Northway WH Jr, Rosan RC, Porter DY</AU>
<TI>Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia</TI>
<SO>New England Journal of Medicine</SO>
<YR>1967</YR>
<VL>276</VL>
<NO>7</NO>
<PG>357-68</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:11:01 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:11:01 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1056/NEJM196702162760701"/><IDENTIFIER MODIFIED="2017-06-13 14:10:47 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="5334613"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Patel-2009" MODIFIED="2017-06-13 14:12:07 -0400" MODIFIED_BY="[Empty name]" NAME="Patel 2009" TYPE="JOURNAL_ARTICLE">
<AU>Patel DS, Sharma A, Prendergast M, Rafferty GF, Greenough A</AU>
<TI>Work of breathing and different levels of volume-targeted ventilation</TI>
<SO>Pediatrics</SO>
<YR>2009</YR>
<VL>123</VL>
<NO>4</NO>
<PG>e679-84</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:12:07 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:12:07 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1542/peds.2008-2635"/><IDENTIFIER MODIFIED="2017-06-13 14:11:54 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19254970"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Patel-2010" MODIFIED="2017-06-13 14:14:09 -0400" MODIFIED_BY="[Empty name]" NAME="Patel 2010" TYPE="JOURNAL_ARTICLE">
<AU>Patel D, Rafferty G, Lee S, Hannam S, Greenough A</AU>
<TI>Work of breathing and volume targeted ventilation in respiratory distress</TI>
<SO>Archives of Disease in Childhood Fetal and Neonatal Edition</SO>
<YR>2010</YR>
<VL>95</VL>
<NO>6</NO>
<PG>F443-6</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:14:09 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-03-01 05:13:44 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/adc.2009.176875"/><IDENTIFIER MODIFIED="2017-06-13 14:14:09 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="20688862"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Peng-2014" MODIFIED="2017-09-15 09:23:54 -0400" MODIFIED_BY="Anne Lawson" NAME="Peng 2014" TYPE="JOURNAL_ARTICLE">
<AU>Peng W, Zhu H, Shi H, Liu E</AU>
<TI>Volume-targeted ventilation is more suitable than pressure-limited ventilation for preterm infants: a systematic review and meta-analysis</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2014</YR>
<VL>99</VL>
<NO>2</NO>
<PG>F158-65</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:16:13 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:16:13 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/archdischild-2013-304613"/><IDENTIFIER MODIFIED="2017-05-05 12:59:11 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="24277660"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2017-09-13 07:36:11 -0400" MODIFIED_BY="Anne Lawson" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2013" MODIFIED="2017-09-14 12:37:48 -0400" MODIFIED_BY="Anne Lawson" NAME="Schünemann 2013" TYPE="OTHER">
<AU>Schünemann H, Bro&#380;ek J, Guyatt G, Oxman A, editor(s); GRADE Working Group</AU>
<TI>GRADE handbook for grading quality of evidence and strength of recommendations</TI>
<SO>gdt.gradepro.org/app/handbook/handbook.html</SO>
<YR>Updated October 2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sharma-2007" MODIFIED="2017-06-13 14:18:41 -0400" MODIFIED_BY="[Empty name]" NAME="Sharma 2007" TYPE="JOURNAL_ARTICLE">
<AU>Sharma A, Greenough A</AU>
<TI>Survey of neonatal respiratory support strategies</TI>
<SO>Acta Paediatrica</SO>
<YR>2007</YR>
<VL>96</VL>
<NO>8</NO>
<PG>1115-7</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:18:41 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:18:41 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1111/j.1651-2227.2007.00388.x"/><IDENTIFIER MODIFIED="2017-06-13 14:18:30 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17590191"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Shennan-1988" MODIFIED="2017-06-13 14:25:29 -0400" MODIFIED_BY="[Empty name]" NAME="Shennan 1988" TYPE="JOURNAL_ARTICLE">
<AU>Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM</AU>
<TI>Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period</TI>
<SO>Pediatrics</SO>
<YR>1988</YR>
<VL>82</VL>
<NO>4</NO>
<PG>527-32</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:25:29 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:25:29 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="3174313"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stensvold-2017" MODIFIED="2017-06-13 14:28:31 -0400" MODIFIED_BY="[Empty name]" NAME="Stensvold 2017" TYPE="JOURNAL_ARTICLE">
<AU>Stensvold HJ, Klingenberg C, Stoen R, Moster D, Braekke K, Guthe HJ, et al</AU>
<TI>Neonatal morbidity and 1-year survival of extremely preterm infants</TI>
<SO>Pediatrics</SO>
<YR>2017</YR>
<VL>139</VL>
<NO>3</NO>
<PG>e20161821</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:28:31 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:28:15 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1542/peds.2016-1821"/><IDENTIFIER MODIFIED="2017-06-13 14:28:31 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="28228499"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stoll-2015" MODIFIED="2017-06-13 14:38:19 -0400" MODIFIED_BY="[Empty name]" NAME="Stoll 2015" TYPE="JOURNAL_ARTICLE">
<AU>Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network</AU>
<TI>Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012</TI>
<SO>JAMA</SO>
<YR>2015</YR>
<VL>314</VL>
<NO>10</NO>
<PG>1039-51</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:38:19 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-03-27 16:33:21 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1001/jama.2015.10244"/><IDENTIFIER MODIFIED="2017-06-13 14:38:19 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="26348753"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Van-Kaam-2010" MODIFIED="2017-09-15 09:24:03 -0400" MODIFIED_BY="Anne Lawson" NAME="Van Kaam 2010" TYPE="JOURNAL_ARTICLE">
<AU>van Kaam AH, Rimensberger PC, Borensztajn D, De Jaegere AP</AU>
<TI>Ventilation practices in the neonatal intensive care unit: a cross-sectional study</TI>
<SO>Journal of Pediatrics</SO>
<YR>2010</YR>
<VL>157</VL>
<NO>5</NO>
<PG>767-71</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:34:41 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:34:19 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.jpeds.2010.05.043"/><IDENTIFIER MODIFIED="2017-06-13 14:34:41 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="20619854"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Warner-1998" MODIFIED="2017-06-13 14:39:29 -0400" MODIFIED_BY="[Empty name]" NAME="Warner 1998" TYPE="JOURNAL_ARTICLE">
<AU>Warner BB, Stuart LA, Papes RA, Wispe JR</AU>
<TI>Functional and pathological effects of prolonged hyperoxia in neonatal mice</TI>
<SO>American Journal of Physiology</SO>
<YR>1998</YR>
<VL>275</VL>
<NO>1 Pt 1</NO>
<PG>L110-7</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:39:29 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:39:29 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="9688942"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Watterberg-1996" MODIFIED="2017-06-13 14:40:28 -0400" MODIFIED_BY="[Empty name]" NAME="Watterberg 1996" TYPE="JOURNAL_ARTICLE">
<AU>Watterberg KL, Demers LM, Scott SM, Murphy S</AU>
<TI>Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops</TI>
<SO>Pediatrics</SO>
<YR>1996</YR>
<VL>97</VL>
<NO>2</NO>
<PG>210-5</PG>
<IDENTIFIERS MODIFIED="2017-06-13 14:40:28 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-13 14:40:28 -0400" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8584379"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wheeler-2009" MODIFIED="2010-10-04 14:25:46 -0400" MODIFIED_BY="[Empty name]" NAME="Wheeler 2009" TYPE="JOURNAL_ARTICLE">
<AU>Wheeler KI, Davis PG, Kamlin CO, Morley CJ</AU>
<TI>Assist control volume guarantee ventilation during surfactant administration</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2009</YR>
<VL>94</VL>
<NO>5</NO>
<PG>F336-8</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2017-10-12 09:26:27 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-McCallion-2005" MODIFIED="2010-09-27 13:06:45 -0400" MODIFIED_BY="[Empty name]" NAME="McCallion 2005" TYPE="COCHRANE_REVIEW">
<AU>McCallion N, Davis PG, Morley C</AU>
<TI>Volume-targeted versus pressure-limited ventilation in the neonate</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2010-03-03 23:56:20 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2010-03-03 23:56:20 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003666.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wheeler-2010" MODIFIED="2017-10-12 09:26:27 -0400" MODIFIED_BY="[Empty name]" NAME="Wheeler 2010" TYPE="COCHRANE_REVIEW">
<AU>Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG</AU>
<TI>Volume-targeted versus pressure-limited ventilation in the neonate</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2017-10-12 09:26:27 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-10-12 09:26:27 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003666.pub3"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-10-11 13:46:04 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-10-11 13:46:04 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="YES" USER_DEF_1_NAME="Supplemental data" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2017-09-15 09:10:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bhat-2016">
<CHAR_METHODS MODIFIED="2017-04-24 02:16:32 -0400" MODIFIED_BY="[Empty name]">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 14:07:49 -0400" MODIFIED_BY="Anne Lawson">
<P>40 infants.</P>
<P>Inclusion criteria: &#8805; 34 weeks of GA and mechanically ventilated &lt; 24 h in the first 2 weeks of life.</P>
<P>Exclusion criteria: &gt; 2 weeks of age, ventilated &gt; 24 h with or without supported by high-frequency ventilation or diagnosed with congenital diaphragmatic hernia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:10:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: SLE5000 (software 4.3). Both groups initially: inflation time 0.3-0.4 sec, inflation rate 40-60/min, PEEP not reported.</P>
<UL>
<LI>VTV group (n = 20): non-synchronised mode. Set inflation VT<SUB>target</SUB> 5 mL/kg. P<SUB>max</SUB> set 5 cmH<SUB>2</SUB>O above PIP used during previous conventional ventilation mode to allow a VT delivery of 5 mL/kg.</LI>
</UL>
<UL>
<LI>PLV group (n = 20): non-synchronised mode. PIP adjusted to achieve PaCO<SUB>2</SUB> levels 4.5-7 kPa and pH &gt; 7.25.</LI>
</UL>
<P>Both groups: predefined weaning strategy either VTV mode or PLV mode. Not mentioned whether synchronisation used during weaning.</P>
<P>Duration of intervention: until extubation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-13 13:49:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary outcome: time to extubation.</P>
<P>Secondary outcomes: physiological measurements including work of breathing (assessed by transdiaphragmatic pressure time product), blood gas analyses and failure of ventilation mode.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-13 13:49:37 -0400" MODIFIED_BY="Anne Lawson">
<P>Data on duration of ventilation presented as mean (SD).</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-04-24 02:16:32 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-15 09:10:38 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Cheema-2007">
<CHAR_METHODS MODIFIED="2017-09-13 13:49:59 -0400" MODIFIED_BY="Anne Lawson">
<P>Dual-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-13 13:50:25 -0400" MODIFIED_BY="Anne Lawson" NOTES="&lt;p&gt;complete this&lt;/p&gt;" NOTES_MODIFIED="2017-09-13 13:50:25 -0400" NOTES_MODIFIED_BY="Anne Lawson">
<P>40 infants.</P>
<P>Inclusion criteria: GA &lt; 34 weeks and ventilated for RDS.</P>
<P>Exclusion criteria: major surgical or congenital anomalies.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:10:38 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used Drager Babylog 8000plus in SIPPV (AC) mode.</P>
<UL>
<LI>VTV group (n = 19): SIPPV (AC) + VG. Set expired VT<SUB>target</SUB> 4.0 mL/kg. P<SUB>max</SUB> described as "a balance between enabling the ventilator to deliver the desired tidal volume and preventing excessive PIP."</LI>
<LI>PLV group (n = 21): SIPPV (AC). PIP determined by clinical team.</LI>
</UL>
<P>Duration of intervention: from onset of mechanical ventilation after admission to neonatal unit to first blood gas result (median duration 95 min).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-13 13:52:06 -0400" MODIFIED_BY="Anne Lawson">
<P>Data only collected from time between onset of ventilation and until first blood gas analysis.</P>
<P>Primary: PaCO<SUB>2</SUB> and proportion of infants with PaCO<SUB>2</SUB> within target range (5-7 kPa).</P>
<P>Others: first pH, PaO<SUB>2.</SUB>
</P>
<P>Post hoc subgroup analysis 23-25, 26-33 weeks.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-05-07 02:52:16 -0400" MODIFIED_BY="[Empty name]">
<P>Blood gas data and data on randomisation procedure. Information about trial registration.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-04-24 02:12:48 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-14 14:07:50 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Chowdhury-2013">
<CHAR_METHODS MODIFIED="2017-04-24 02:15:18 -0400" MODIFIED_BY="[Empty name]">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 14:07:50 -0400" MODIFIED_BY="Anne Lawson">
<P>40 infants.</P>
<P>Inclusion criteria: &lt; 34 weeks GA, mechanically ventilated in the first week after birth.</P>
<P>Exclusion criteria: major congenital anomalies, ventilated &gt; 24 h or supported by high-frequency ventilation or both.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-14 13:15:30 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: SLE5000 (software 4,3). Both groups: inflation time 0.3-0.4 sec, inflation rate 40-60/min, PEEP not reported.</P>
<UL>
<LI>VTV group (n = 20): SIMV + TTV at 5 mL/kg.</LI>
<LI>PLV group (n = 20): SIMV.</LI>
</UL>
<P>Both groups: predefined weaning strategy; underlying trigger mode changed from SIMV to AC.</P>
<P>Duration of intervention: until extubation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-13 13:55:31 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary: time to reach specified weaning criteria.</P>
<P>Other: survival to discharge, BPD at 28 days, IVH grade 3 or 4, cystic PVL, PDA treated (medication/ligation), pneumothorax, postnatal steroids, duration of ventilation, failure of initial ventilation mode, blood gas analyses and work of breathing (assessed by transdiaphragmatic pressure time product).</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-13 13:55:48 -0400" MODIFIED_BY="Anne Lawson">
<P>Mortality, BPD at 36 weeks, detailed blood gas, duration of ventilation presented as mean (SD).</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-09-14 13:15:36 -0400" MODIFIED_BY="Anne Lawson">
<P>Imbalance with regard to BW, GA and antenatal steroid use despite randomisation.</P>
<P>Participants in the PLV group had lower median GA/BW than participants in the VTV group (median GA/BW 26 weeks/856 g vs 28 weeks/1016 g). In the published report, authors adjusted for this difference, but this review used the unadjusted outcomes.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-14 14:07:51 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-D_x0027_Angio-2005">
<CHAR_METHODS MODIFIED="2017-09-13 13:57:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Dual-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 14:07:51 -0400" MODIFIED_BY="Anne Lawson">
<P>213 infants enrolled, but 1 infant immediately withdrawn, see below. Data on 212 infants.</P>
<P>Inclusion criteria: BW 500-1249 g, GA &#8805; 24 weeks and in need of mechanical ventilation. Enrolled before 6 h of age.</P>
<P>Exclusion criteria: not specified.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-14 13:56:55 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used primarily the Siemens Servo 300 ventilator. However, participants in the SIMV group were changed over to a VIP Bird ventilator (SIMV mode) if requiring a ventilator rate &gt; 40/min.</P>
<P>Target: PaO<SUB>2</SUB> (mmHg): 45-60 (GA 24-26 weeks), 50-70 (GA 27-28 weeks), 60-80 (GA &gt; 28 weeks). PaCO<SUB>2</SUB>: 45-55 mmHg (all GAs).</P>
<UL>
<LI>VTV group (n = 104): synchronised, pressure-limited AC mode (PRVC). Sequential variation of the delivered PIP to approximate a target inspiratory VT (measured at ventilator). Target VT values not specified in the publication.</LI>
<LI>PLV group (n = 108): SIMV with only PEEP support between synchronised inflations.</LI>
</UL>
<P>Duration of intervention: remained on randomised method until extubated, died or met failure criteria (hypoxia, hypercapnia or hypocapnia, or decision of clinical team).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-13 14:44:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary: proportion of infants alive and extubated at 14 days.</P>
<P>Other: FiO<SUB>2</SUB>, ventilator rate, PIP, VT, PaCO<SUB>2</SUB>, PaO<SUB>2</SUB>, oxygenation index, AaDO<SUB>2</SUB>, proportion alive and extubated at 28 days or 36 weeks, proportion died before discharge, age at final extubation, proportion extubated at 14 days without requiring subsequent reintubation.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-13 14:44:29 -0400" MODIFIED_BY="Anne Lawson">
<P>BW, age of death in non-survivors, BPD, duration of ventilation, pneumothorax, PIE, PVL, IVH.</P>
<P>Information regarding blinding of assessors. Study protocol.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-09-14 13:15:45 -0400" MODIFIED_BY="Anne Lawson">
<P>1 infant in VTV group enrolled in error and immediately withdrawn from study. No data collected on this participant. As such, study reported data on 212 infants; 104 in the VTV group and 108 in the PLV group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-15 09:10:54 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Duman-2012">
<CHAR_METHODS MODIFIED="2017-04-24 02:14:16 -0400" MODIFIED_BY="[Empty name]">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 14:07:53 -0400" MODIFIED_BY="Anne Lawson">
<P>45 infants.</P>
<P>Inclusion criteria: GA &lt; 32 weeks and mechanical ventilation for severe RDS for &gt; 24 h.</P>
<P>Exclusion criteria: major congenital anomalies and mechanical ventilation &lt; 24 h.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:10:54 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used Drager Babylog 8000plus. Initially in SIPPV(AC) mode and then switched to SIMV mode during weaning. Inflation time 0.3-0.4 sec and PEEP 4-6 cmH<SUB>2</SUB>O. During weaning, respiratory rate was gradually reduced to 18/min. Clear protocol for ventilation and weaning.</P>
<P>Target: PaCO<SUB>2</SUB> 40-60 mmHg.</P>
<UL>
<LI>VTV group (n = 23): SIPPV(AC) + VG and SIMV + VG. Set expired VT<SUB>target</SUB> 4 mL/kg. P<SUB>max</SUB> set 15-20% above mean PIP used to achieve VT. Adjustments done with VT increments/decrements of 0.5 mL/kg.</LI>
<LI>PLV group (n = 22): SIPPV(AC) and SIMV. PIP adjustments in increments/decrements of 1-2 cmH<SUB>2</SUB>O.</LI>
</UL>
<P>Duration of intervention: until extubation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-13 14:49:45 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary: duration of ventilation (median and IQR).</P>
<P>Other: mortality, BPD, PDA, IVH grade 3 or 4, PVL, pneumothorax.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-13 14:50:00 -0400" MODIFIED_BY="Anne Lawson">
<P>Duration of ventilation (mean and SD), clarification about the randomisation process and inclusions/exclusions.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-04-26 17:29:33 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-15 09:10:04 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Erdemir-2014">
<CHAR_METHODS MODIFIED="2017-04-24 02:15:34 -0400" MODIFIED_BY="[Empty name]">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 14:07:53 -0400" MODIFIED_BY="Anne Lawson">
<P>60 infants.</P>
<P>Inclusion criteria: GA &lt; 33 weeks or BW &lt; 1500 g (or both); ventilated for RDS.</P>
<P>Exclusion criteria: admission at &gt; 6 h of age; congenital cardiac, respiratory or CNS malformations; congenital metabolic diseases, congenital pneumonia, sepsis, perinatal asphyxia and leak &lt; 20% around the ETT.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:10:04 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: Babylog 8000plus.</P>
<P>All participants initially ventilated using SIPPV (AC) mode (PEEP 4 cmH<SUB>2</SUB>O, inflation time 0.4 sec). Intervention started in weaning phase when FiO<SUB>2</SUB> &lt; 0.40, inflation rate &lt; 60/min, PIP 16 cmH<SUB>2</SUB>O and PEEP 4 cmH<SUB>2</SUB>O with blood gas values within targeted area. Infants then switched to 2 randomised 'weaning modes.'</P>
<UL>
<LI>VTV group (n = 30): PSV + VG. Set expired VT<SUB>target</SUB> 5 mL/kg. Expired VT then reduced during weaning in decrements of 0.5 mL/kg down to expired VT of 3.0 mL/kg. P<SUB>max</SUB> set 15-20% above mean PIP needed to achieve target VT. Ti<SUB>max</SUB> 0.5 sec.</LI>
<LI>PLV group (n = 30): SIMV. PIP 16 cmH<SUB>2</SUB>O, PEEP 4 cmH<SUB>2</SUB>O, Ti 0.4 sec. Inflation rate weaned stepwise from 40/min.</LI>
</UL>
<P>Duration of intervention: From "start of weaning" until extubation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-13 14:56:37 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary: "Reduction in ventilator-associated lung injury."</P>
<P>Other: mortality, BPD, pneumothorax, IVH (any), PDA and duration of ventilation.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-04-24 02:15:34 -0400" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2017-09-14 13:15:53 -0400" MODIFIED_BY="Anne Lawson">
<P>Initial ventilation with SIPPV, before start of weaning, lasted 7.8 h in PLV group and 4.4 h in VTV group.</P>
<P>Weaning phase lasted 32.4 h in PLV group and 21.1 h in VTV group. Intervention mode consisted of 80% of total duration of ventilation in PLV group and 83% of total duration of ventilation in VTV group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-15 09:15:47 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Guven-2013">
<CHAR_METHODS MODIFIED="2017-04-24 02:14:27 -0400" MODIFIED_BY="[Empty name]">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-13 15:04:39 -0400" MODIFIED_BY="Anne Lawson">
<P>72 infants.</P>
<P>Inclusion criteria: GA &lt; 32 weeks or BW &lt; 1500 g (or both), and admitted with RDS and given surfactant within first 2 h of life.</P>
<P>Exclusion criteria: major congenital anomalies, perinatal asphyxia and meconium aspiration.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:15:47 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used Drager Babylog 8000plus in SIMV mode.</P>
<UL>
<LI>VTV group (n = 42): SIMV + VG. Set expired VT<SUB>target</SUB> 4-5 mL/kg. P<SUB>max</SUB> set 10 cmH<SUB>2</SUB>O above PIP used for conventional mode.</LI>
<LI>PLV group (n = 30): SIMV. PIP manually set to achieve an expired VT of 4-5 mL/kg and targeting "adequate" blood gases.</LI>
</UL>
<P>Duration of intervention: until extubation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-13 15:05:30 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary outcome: duration of ventilation (days) and need of total oxygen supplementation.</P>
<P>Secondary outcomes: survival to discharge, air leak, BPD (36 weeks), IVH grade 3 or 4, PVL, PDA, ROP and NEC.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-13 15:06:00 -0400" MODIFIED_BY="Anne Lawson">
<P>Information about postrandomisation loss sought from authors, see "Other bias."</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-04-24 02:14:27 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-15 09:12:39 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Herrera-2002">
<CHAR_METHODS MODIFIED="2017-09-13 15:06:49 -0400" MODIFIED_BY="Anne Lawson">
<P>Single-centre randomised cross-over study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 14:07:54 -0400" MODIFIED_BY="Anne Lawson">
<P>17 infants.</P>
<P>Inclusion criteria: appropriate for GA infants of 600-1200 g, ventilated for RDS, &gt; 48 h of age and clinically stable.</P>
<P>Exclusion criteria: congenital malformations, sepsis, pneumothorax, other air leak, meconium aspiration and terminal state.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:12:39 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used Draeger Babylog 8000plus. Prestudy settings, SIMV rate 16/min, PIP 15 cmH<SUB>2</SUB>O.</P>
<P>Cross-over study:</P>
<UL>
<LI>VTV epoch: SIMV + VG. Set expired VT<SUB>target </SUB>4.5 mL//kg. P<SUB>max</SUB> set 10 cmH<SUB>2</SUB>O above preventilation PIP.</LI>
<LI>PLV epoch: SIMV.</LI>
</UL>
<P>Duration of intervention: 1 + 1 h.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-13 15:09:54 -0400" MODIFIED_BY="Anne Lawson">
<P>Airflow, pressure, FiO<SUB>2</SUB>, TcCO<SUB>2</SUB>, minute volume.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-04-24 02:10:02 -0400" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2017-09-13 15:14:17 -0400" MODIFIED_BY="Anne Lawson">
<P>Last 8 infants (of 17) randomised to an additional third VTV epoch of SIMV-VG 3.0 mL/kg. For meta-analysis, only SIMV-VG 4.5 mL/kg (9 infants) vs SIMV data of all 17 infants used.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-15 09:12:59 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Hummler-2006">
<CHAR_METHODS MODIFIED="2017-09-14 04:11:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Single-centre randomised cross-over study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 05:21:19 -0400" MODIFIED_BY="Anne Lawson">
<P>15 infants.</P>
<P>Inclusion criteria: infants &#8804; 1500 g. Ventilator dependent with a ventilator rate &#8805; 10/min and having recurrent hypoxaemic episodes (study definition).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:12:59 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: Stephanie infant ventilator. Pressure controlled SIMV prior to study.</P>
<P>Target: SpO<SUB>2</SUB> 82-90%. Standardised protocols for FiO<SUB>2</SUB> adjustment.</P>
<P>Cross-over study:</P>
<UL>
<LI>VTV epoch: volume controlled-SIMV. P<SUB>max</SUB> limit up to 40 cmH<SUB>2</SUB>O. Inspired VT<SUB>target</SUB> set from prestudy VT (7.8 ± 1.4 mL/kg).</LI>
<LI>PLV epoch: pressure controlled SIMV. Rate 39/min (± 13).</LI>
</UL>
<P>Duration of intervention: 4 + 4 h.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 04:57:55 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary: time with SpO<SUB>2</SUB> &lt; lower limit of target range (80-92%).</P>
<P>Other: time with SpO<SUB>2</SUB> above/within target range, incidence/duration/severity of desaturation episodes, FiO<SUB>2</SUB>, number of FiO<SUB>2</SUB> adjustment necessary to target SpO<SUB>2</SUB>, VT, compliance, resistance.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-04-24 02:12:00 -0400" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2017-04-24 02:12:00 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-14 14:08:27 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Jain-2016">
<CHAR_METHODS MODIFIED="2017-09-14 04:59:12 -0400" MODIFIED_BY="Anne Lawson">
<P>Single-centre randomised cross-over study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 14:07:56 -0400" MODIFIED_BY="Anne Lawson">
<P>24 infants.</P>
<P>Inclusion criteria: &lt; 32 weeks' GA receiving PLV &gt; 20/min, &#8805; 4 episodes of hypoxaemia (SpO<SUB>2</SUB> &lt; 75%) in 8 h prior to study.</P>
<P>Exclusion criteria: major congenital abnormalities, inotropes, sepsis or air leak within previous 72 h prior to study.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-14 14:07:57 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: AVEA, CareFusion. Infants remained on mode of ventilation set by clinical team before study. Volume targeting was only difference between groups.</P>
<P>Cross-over study:</P>
<UL>
<LI>PLV epoch: SIMV with pressure support or AC.</LI>
<LI>VTV epoch: SIMV with pressure support + VG or AC + VG. Target VT set to match mean expired VT of mechanical inflations before study (while infants were on PLV). PIP limit set 10 cmH<SUB>2</SUB>O above the PIP provided during PLV before study, and remained unchanged for 24 h.</LI>
</UL>
<P>Duration of intervention: 24 + 24 h.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 14:08:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary outcomes: proportion of time spent with arterial SpO<SUB>2</SUB> &lt; 75%.</P>
<P>Secondary outcomes: number and characteristics of hypoxaemic episodes; FiO<SUB>2</SUB> median and IQR, VT and minute ventilation.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-14 05:01:25 -0400" MODIFIED_BY="Anne Lawson">
<P>FiO<SUB>2</SUB>, mean and SD.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-04-24 02:17:11 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-14 14:06:50 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Keszler-2004a">
<CHAR_METHODS MODIFIED="2017-09-14 05:01:42 -0400" MODIFIED_BY="Anne Lawson">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 14:06:50 -0400" MODIFIED_BY="Anne Lawson">
<P>18 infants.</P>
<P>Inclusion criteria: &lt; 34 weeks' GA, ventilated for RDS before 6 h of age.<BR/>Exclusion criteria: congenital cardiac, respiratory or CNS anomalies, paralysis or sedation or ETT leak &gt; 30%.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-14 13:15:58 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used Drager Babylog 8000 plus with set backup rate 40/min.</P>
<P>Target: PaCO<SUB>2</SUB> of 35-45 torr (mmHg).<BR/>
</P>
<UL>
<LI>VTV group (n = 9): AC-VG. Set expired VT<SUB>target</SUB> 5 mL/kg, adjusted by 0.5 mL/kg to maintain target PaCO<SUB>2</SUB>.</LI>
<LI>PLV group (n = 9): AC. PIP set to achieve 4-6 mL/kg expired VT, using PIP changes of 1-2 cmH<SUB>2</SUB>O to maintain target PaCO<SUB>2</SUB>.</LI>
</UL>
<P>Duration of intervention: 72 h or until extubation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 05:03:16 -0400" MODIFIED_BY="Anne Lawson">
<P>Blood gas results, pneumothorax, PIE, mortality, cranial ultrasound scan.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-14 05:03:37 -0400" MODIFIED_BY="Anne Lawson">
<P>BW, age of death in non-survivors, BPD, duration of ventilation, pneumothorax, PIE, PVL, IVH, blood gas data.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-09-14 05:03:39 -0400" MODIFIED_BY="Anne Lawson">
<P>Requested trial registration.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-14 13:18:34 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Lista-2004">
<CHAR_METHODS MODIFIED="2017-09-14 05:04:00 -0400" MODIFIED_BY="Anne Lawson">
<P>Dual-centre randomised trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 05:04:53 -0400" MODIFIED_BY="Anne Lawson">
<P>53 infants.</P>
<P>Inclusion criteria: 25-32 weeks' GA, received &#8805; 1 course of antenatal steroids, ventilated for RDS in first 24 h, treated with surfactant within 3 h.</P>
<P>Exclusion criteria: lethal anomalies, receiving muscle relaxants at entry, IVH grade &#8805; 2, actual or suspected sepsis.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-14 13:18:34 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used Draeger Babylog 8000plus with set backup rate 40/min, PEEP 3.5-4 cmH<SUB>2</SUB>O. Mean inflation time 0.4-0.5 sec (upper limit in PSV mode).</P>
<P>Target: FiO<SUB>2</SUB> to maintain SpO<SUB>2</SUB> 90-96%, pH &gt; 7.25, PaO<SUB>2</SUB> 50-75 mmHg, PaCO<SUB>2</SUB> 40-65 mmHg.</P>
<UL>
<LI>VTV group (n = 30): PSV + VG. Set expired VT<SUB>target</SUB> 5 mL/kg throughout study.</LI>
<LI>PLV group (n = 23): PSV. PIP set manually to achieve expired VT of around 5 mL/kg, and PIP weaned to achieve blood gas targets.</LI>
</UL>
<P>Duration of intervention: until extubation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 05:06:56 -0400" MODIFIED_BY="Anne Lawson">
<P>Lung inflammatory markers.</P>
<P>Other outcomes reported: death in hospital, PDA, BPD/receiving oxygen at 28 days and 36 weeks, IVH, PVL, ROP, PIE, PVL, need for postnatal steroids.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-14 05:07:20 -0400" MODIFIED_BY="Anne Lawson">
<P>BW, age of death in non-survivors, BPD, duration of ventilation, pneumothorax, PIE, PVL, IVH, postrandomisation loss.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-09-14 13:16:01 -0400" MODIFIED_BY="Anne Lawson">
<P>Mean GA in PLV group was 29 weeks and mean GA in VTV group was 28 weeks.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-15 09:17:23 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Liu-2011">
<CHAR_METHODS MODIFIED="2017-04-24 02:13:42 -0400" MODIFIED_BY="[Empty name]">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-15 09:17:23 -0400" MODIFIED_BY="Anne Lawson">
<P>84 infants allocated to 3 ventilation groups: VTV (n = 31), PLV (n = 30) and high-frequency ventilation (n = 23).</P>
<P>Only data from the 61 infants ventilated with PLV and VTV are included in meta-analysis.</P>
<P>Inclusion criteria: neonatal RDS, defined blood gas/oxygenation criteria, age &lt; 12 h, consent to surfactant.</P>
<P>Exclusion criteria: congenital respiratory/cardiac malformations, pulmonary haemorrhage/gas leak/congenital pneumonia/meconium aspiration/wet lung/congenital heart disease/IVH grade III-IV.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:13:19 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: Draeger Babylog 8000 (VTV group) and VIP Bird (PLV group).</P>
<UL>
<LI>VTV group (n = 31): SIPPV-VG. Set expired VT<SUB>target</SUB> 4.0-6.0 mL/kg, rate 30-40/min. P<SUB>max</SUB> limit: not described.</LI>
<LI>PLV group (n = 30): IMV, PIP 20-25 cmH<SUB>2</SUB>O, rate 30-40/min.</LI>
</UL>
<P>Duration of intervention: not stated.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 05:19:51 -0400" MODIFIED_BY="Anne Lawson">
<P>No clearly reported primary outcome.</P>
<UL>
<LI>Included in meta-analysis: duration PPV, air leak, IVH grade 3-4</LI>
<LI>Excluded from meta-analysis: mortality, data on oxygenation, ventilator-associated pneumonia.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-04-29 18:52:15 -0400" MODIFIED_BY="[Empty name]">
<P>Protocol and clarification on methods and results sought, but not received.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-09-14 13:13:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Denominators of outcomes beyond intervention periods were unclear due to challenges following up participants who had transferred to other hospitals or who were withdrawn from active clinical management for financial reasons. Only outcomes which occurred during intervention period were included in meta-analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-15 09:39:03 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Nafday-2005">
<CHAR_METHODS MODIFIED="2017-09-14 05:20:47 -0400" MODIFIED_BY="Anne Lawson">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-15 09:39:01 -0400" MODIFIED_BY="Anne Lawson">
<P>34 infants.</P>
<P>Inclusion criteria: BW &lt; 1500 g, clinical and radiographic RDS, &lt; 12 h old, about to receive surfactant.</P>
<P>Exclusion criteria: major congenital malformations, congenital heart disease, confirmed/suspected sepsis/pneumonia, pneumothorax, other air leak, requiring paralysis/heavy sedation, moribund.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:39:03 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used Drager Babylog 8000plus. Ventilator rate adjusted to target blood gas values.</P>
<P>Target: pH 7.25-7.35, PaCO<SUB>2</SUB> 45-55 mmHg, PaO<SUB>2</SUB> 50-70 mmHg, SpO<SUB>2</SUB> 88-95%.</P>
<UL>
<LI>VTV group (n = 16): PSV-VG. Set expired VT<SUB>target</SUB> 5 mL/kg.</LI>
<LI>PLV group (n = 18): SIMV. Measured VT not used to adjust PIP during intervention.</LI>
</UL>
<P>Duration of intervention: 24 h.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 14:07:58 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary: ventilatory pressures during first 24 h after surfactant administration or randomisation.</P>
<P>Others: survival to discharge, BPD (36 weeks), IVH, PDA (requiring indomethacin or ligation), NEC (Bell &#8805; 2), air leak (PIE, pneumothorax, pneumomediastinum).</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-14 05:23:22 -0400" MODIFIED_BY="Anne Lawson">
<P>BW, failure of assigned mode, pneumothorax, PIE, IVH.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-04-24 02:11:39 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-10-11 13:45:48 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Piotrowski-1997">
<CHAR_METHODS MODIFIED="2017-09-14 05:24:03 -0400" MODIFIED_BY="Anne Lawson">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 14:07:59 -0400" MODIFIED_BY="Anne Lawson">
<P>57 infants.</P>
<P>Inclusion criteria: BW &lt; 2500 g, postnatal age &lt; 72 h, and need for mechanical ventilation for lung disease at randomisation and Servo ventilator available.</P>
<P>Exclusion criteria: sepsis/pneumonia, congenital malformation, pneumothorax or any other air leak, meconium aspiration.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-10-11 13:45:48 -0400" MODIFIED_BY="[Empty name]">
<P>Ventilator: different ventilators used for experimental group (Siemens Sevo 300 ventilator) and control group (Bear Cub or Sechrist ventilator). Both groups ventilated using PEEP 3-5 cmH<SUB>2</SUB>O and inflation time 0.5 sec.</P>
<P>Target: SpO<SUB>2</SUB> 88-95%, pCO<SUB>2</SUB> &lt; 55 mmHg. Infants extubated once ventilator rate &lt; 12/min, FiO<SUB>2</SUB> &lt; 0.25, and after 30-60 min trial of ETT-CPAP.</P>
<UL>
<LI>VTV group (n = 27): synchronised, pressure-limited AC mode (PRVC). Sequentially variation of the delivered PIP to approximate a target inspiratory VT<SUB>target</SUB> of 5-6 mL/kg plus 4-5 mL of compressible volume. VT<SUB>target </SUB>adjusted to achieve "normal excursion of the chest."</LI>
<LI>PLV group (n = 30): non-synchronised IMV mode. PIP set to achieve "normal excursion of the chest."</LI>
</UL>
<P>Duration of intervention: until extubation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-06 10:36:52 -0400" MODIFIED_BY="[Empty name]">
<P>Death in hospital, oxygen at 28 days, any air leak, pneumothorax, PIE, any IVH, IVH grade 3-4, PDA, sepsis, use of muscle relaxants, duration of ventilation.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-14 05:30:26 -0400" MODIFIED_BY="Anne Lawson">
<P>BW, age of death in non-survivors, duration of ventilation.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-09-14 13:16:07 -0400" MODIFIED_BY="Anne Lawson">
<P>Mean GA in PLV group was 29 weeks and mean GA in VTV group was 30 weeks.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-10-11 13:46:04 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Piotrowski-2007">
<CHAR_METHODS MODIFIED="2017-04-24 02:13:18 -0400" MODIFIED_BY="[Empty name]">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 14:08:00 -0400" MODIFIED_BY="Anne Lawson">
<P>56 infants.</P>
<P>Inclusion criteria: GA 24-32 weeks with RDS, requiring ventilation for &#8805; 24 h.</P>
<P>Exclusion criteria: severe congenital malformation, lack of parental consent and pulmonary air leak on admission.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-14 13:18:36 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: VTV group (PRVC) used Siemens Servo 300. PLV group (SIMV) used 1 of the 4 different ventilators (depending on availability): Bear Cub (CEM)/Bear 750 PSV, Sechrist Millenium, Draeger Babylog 8000 plus or SLE 5000.</P>
<P>Both groups: inflation time 0.4 sec, inflation rate 40/min, PEEP 3-5 cmH<SUB>2</SUB>O.</P>
<UL>
<LI>VTV group (n = 30): synchronised, pressure-limited AC mode (PRVC). Sequentially variation of the delivered PIP to approximate a target inspiratory VT<SUB>target</SUB> 8-10 mL/kg (included allowance for circuit compliance).</LI>
<LI>PLV group (n = 26): SIMV.</LI>
</UL>
<P>Duration of intervention: until extubation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-10-11 13:46:04 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: &#8805; 12 h with "effective ventilation" (SpO<SUB>2</SUB> &gt; 90 %, PaCO<SUB>2</SUB> &lt; 50 mmHg) with FiO<SUB>2 </SUB>&lt; 0.23 and PIP &lt; 15 cmH<SUB>2</SUB>O.</P>
<P>Secondary outcomes: time to extubation, BPD (28 days), air leak, IVH and PDA.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-04-26 17:27:36 -0400" MODIFIED_BY="[Empty name]">
<P>Results translated into English. Information regarding stratification sought.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-09-14 14:08:02 -0400" MODIFIED_BY="Anne Lawson">
<P>Despite randomisation, there were imbalances between VTV and PLV groups in FiO<SUB>2</SUB> in first 6 h of life and surfactant use (higher FiO<SUB>2</SUB> and more surfactant used in the VTV group). In published report, authors adjusted for this difference, but in this review the unadjusted outcomes were used.</P>
<P>Median GA in PLV group was 28 weeks and median GA in VTV group was 28 weeks.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-15 09:13:56 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Polimeni-2006">
<CHAR_METHODS MODIFIED="2017-09-14 05:34:08 -0400" MODIFIED_BY="Anne Lawson">
<P>Single-centre randomised cross-over study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 05:21:26 -0400" MODIFIED_BY="Anne Lawson">
<P>32 Infants.</P>
<P>Inclusion criteria: BW &lt;1500 g, recovered from RDS, presenting with hypoxaemic episodes.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:13:56 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used Draeger Babylog 8000plus.</P>
<P>Cross-over study: 12 infants with expired VT<SUB>target</SUB> 4.5 mL/kg. 20 infants with expired VT<SUB>target</SUB> 6.0 mL/kg.</P>
<P>1st group (n = 12)</P>
<UL>
<LI>VTV epoch: SIMV-VG (4.5 mL/kg). P<SUB>max</SUB> set to 10 cmH<SUB>2</SUB>O above prerandomisation PIP.</LI>
<LI>PLV epoch: SIMV as previous ventilation.</LI>
</UL>
<P>2nd group (n = 20)</P>
<UL>
<LI>VTV epoch: SIMV-VG (6.0 mL/kg). P<SUB>max</SUB> set to 10 cmH<SUB>2</SUB>O above prerandomisation PIP.</LI>
<LI>PLV epoch: SIMV as previous ventilation.</LI>
</UL>
<P>Duration of intervention: 2 + 2 h.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 05:34:59 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary: frequency and severity of hypoxaemic episodes.</P>
<P>Other: PIP, distribution of VT, frequency and duration of hypoxaemia (SpO<SUB>2</SUB> &lt; 88%, &lt; 75%), FiO<SUB>2.</SUB>
</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-05-07 02:47:09 -0400" MODIFIED_BY="[Empty name]">
<P>Study protocol.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-04-24 02:12:11 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-10-04 10:35:02 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Singh-2006">
<CHAR_METHODS MODIFIED="2017-09-14 05:35:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Dual-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 13:13:24 -0400" MODIFIED_BY="Anne Lawson">
<P>Initially 2 centres, but reduced to one; 109 infants.</P>
<P>Inclusion criteria: BW 600-1500 g, GA 24-31 weeks with RDS requiring mechanical ventilation.</P>
<P>Exclusion criteria: severe congenital malformations.</P>
<P>All participants included as intention to treat. Some analyses only performed for participants from main centre.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:18:50 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used VIP Bird Gold.</P>
<UL>
<LI>VTV group (n = 57): volume-controlled ventilation, inspired VT<SUB>target</SUB> 4-6 mL/kg. P<SUB>max</SUB> setting not described.</LI>
<LI>PLV group (n = 52): PLV. PIP was manually adjusted to target VT 4-6 mL/kg.</LI>
</UL>
<P>Duration of intervention: until infants were recovering from their acute respiratory illness. At that point, the ventilatory mode was changed to SIMV with pressure support ("weaning mode") for participants in both groups.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 14:16:11 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary outcome criteria: time from entry into the study until achievement of either AaDO<SUB>2 </SUB>&lt; 13 kPa for &gt; 12 h <U>or</U> MAP &lt; 8.0 cmH<SUB>2</SUB>O for &gt; 12 h.</P>
<P>Other: total duration of mechanical ventilation, duration of MV + CPAP, survival to discharge, frequency of complications: BPD (36 weeks), IVH, PVL, PDA (requiring treatment), NEC (Bell grade &#8805; 2), FiO<SUB>2</SUB> (data from Swamy 2008).</P>
<P>Follow-up (Singh 2009): need for home oxygen, cough, wheeze, inhaler use, rate of hospital readmission, rate of respiratory readmission, neurodisability (cerebral palsy, deaf, behavioural problems, blindness) by questionnaire.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-14 05:44:57 -0400" MODIFIED_BY="Anne Lawson">
<P>BW, age of death in non-survivors, BPD, duration of ventilation, pneumothorax, PIE, PVL, IVH, PDA.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-10-04 10:35:02 -0400" MODIFIED_BY="[Empty name]">
<P>109 infants enrolled in Singh 2006, of whom 94 survived to discharge. 3 infants died post-discharge.</P>
<P>Follow-up studies:</P>
<P>Singh 2009: 85/91 (93%) infants eligible for follow-up assessed at median of 22 months' corrected age; 45 in VTV group and 40 in PLV group (Singh 2009). Reported on pulmonary morbidities and gross neurodevelopmental outcomes and mortality</P>
<P>Swamy 2008: reported on respiratory parameters</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-14 15:40:43 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Sinha-1997">
<CHAR_METHODS MODIFIED="2017-09-14 05:46:17 -0400" MODIFIED_BY="Anne Lawson">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 05:47:43 -0400" MODIFIED_BY="Anne Lawson">
<P>50 infants.</P>
<P>Inclusion criteria: BW &gt; 1200 g and had RDS requiring mechanical ventilation.</P>
<P>Exclusion criteria: confirmed/suspected sepsis/pneumonia, congenital malformation or lack of arterial access.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-14 15:40:43 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used VIP Bird ventilator in AC mode with inflation time at 0.3-0.5 sec.</P>
<P>Target: pH 7.27-7.40, PaCO<SUB>2</SUB> 4.5 to 6 kPa, PaO<SUB>2</SUB> 8-11 kPa.<BR/>
</P>
<UL>
<LI>VTV group (n = 25): volume-controlled ventilation, pressure triggered). Set inspired VT<SUB>target</SUB> at 5-8 mL/kg.</LI>
<LI>PLV group (n = 25): PLV, flow triggered. PIP adjusted to achieve inspired VT 5-8 mL/kg.</LI>
</UL>
<P>Duration of intervention: until weaning from ventilation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 14:08:05 -0400" MODIFIED_BY="Anne Lawson">
<P>"Success" criteria outcome: time from entry into study until achievement of either AaDO<SUB>2</SUB>&lt; 13 kPa for &gt; 12 h <U>or</U> MAP &lt; 8.0 cmH<SUB>2</SUB>O for &gt; 12 h <U>or</U> extubation.</P>
<P>Other outcome criteria: death in hospital, failed allocated treatment, IVH or PVL (not reported separately), BPD (in oxygen at 36 weeks), pneumothorax, PDA.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-09-14 05:48:54 -0400" MODIFIED_BY="Anne Lawson">
<P>Requested study protocol/trial registration.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-04-24 02:09:32 -0400" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-09-15 09:19:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Zhou-2007">
<CHAR_METHODS MODIFIED="2017-04-24 02:13:27 -0400" MODIFIED_BY="[Empty name]">
<P>Single-centre randomised trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-15 09:19:22 -0400" MODIFIED_BY="Anne Lawson">
<P>30 infants.</P>
<P>Inclusion criteria: very low BW (&#8804; 1500 g, &#8804; 32 weeks GA) infants with hyaline membrane disease.</P>
<P>Exclusion criteria: perinatal infection, positive lower respiratory tract culture, blood in ETT secretion or pulmonary haemorrhage, severe congenital malformation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-15 09:14:06 -0400" MODIFIED_BY="Anne Lawson">
<P>Ventilator: both groups used Drager Babylog 8000plus in SIMV mode.</P>
<UL>
<LI>VTV group (n = 15): SIMV + VG. Set expired VT<SUB>target</SUB> 5.0 mL/kg. P<SUB>max</SUB> not described.</LI>
<LI>PLV group (n = 15): SIMV. PIP determined by clinical team.</LI>
</UL>
<P>Rest of ventilator parameters regulated according to blood gases analysis.</P>
<P>Duration of intervention: not described.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 05:50:31 -0400" MODIFIED_BY="Anne Lawson">
<P>Primary: proinflammatory cytokines in bronchoalveolar lavage fluid.</P>
<P>Other: FiO<SUB>2</SUB>, pneumothorax (data included in meta-analysis).</P>
<P>BPD and IVH (incomplete information), death (data not included in meta-analysis).</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-04-26 17:28:27 -0400" MODIFIED_BY="[Empty name]">
<P>Protocol and clarification on methods and results sought, but not received.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-09-14 13:13:30 -0400" MODIFIED_BY="Anne Lawson">
<P>Denominators of outcomes beyond intervention periods were unclear due to challenges following up participants who had transferred to other hospitals or who were withdrawn from active clinical management for financial reasons. Only outcomes which occurred during intervention period were included in meta-analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AaDO<SUB>2</SUB>: alveolar to arterial oxygen pressure difference; AC: assist control; BPD: bronchopulmonary dysplasia; BW: birth weight; CPAP: continuous positive airway pressure; CNS: central nervous system; ETT: endotracheal tube; FiO<SUB>2</SUB>: fraction of inspired oxygen; GA: gestational age; h: hour; IQR: interquartile range; IMV: intermittent mandatory ventilation; IVH: intraventricular haemorrhage; MAP: mean airway pressure; min: minute; MV: mandatory ventilation; n: number of infants; NEC: necrotising enterocolitis; P<SUB>max</SUB>: maximum peak inflation pressure; pCO<SUB>2</SUB>: partial pressure of carbon dioxide; PaCO<SUB>2</SUB>: partial pressure of carbon dioxide in arterial blood; PaO<SUB>2</SUB>: partial pressure of oxygen in arterial blood; PDA: patent ductus arteriosus; PEEP: positive end-expiratory pressure; PIE: pulmonary interstitial emphysema; PIP: peak inflation pressure; PLV: pressure-limited ventilation; P<SUB>max</SUB>: maximum peak inflation pressure; PRVC: pressure-regulated volume control; PSV: pressure support ventilation; PVL: periventricular leukomalacia; RDS: respiratory distress syndrome; ROP: retinopathy of prematurity; SD: standard deviation; sec: second; SIMV: synchronised intermittent mandatory ventilation; SIPPV: synchronised intermittent positive pressure ventilation (same as AC); SpO<SUB>2</SUB>: blood oxygen saturation level; TcCO<SUB>2</SUB>: transcutaneous carbon dioxide; Ti<SUB>max</SUB>: maximal inspiratory time; TTV: targeted tidal volume; VG: volume guarantee; VT<SUB>target</SUB>: target tidal volume; VTV: volume-targeted ventilation.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2017-09-14 14:17:00 -0400" MODIFIED_BY="Anne Lawson" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:03:34 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Abd-El_x002d_Moneim-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:03:34 -0400" MODIFIED_BY="Anne Lawson">
<P>Journal publication. Cross-over study, but not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:04:05 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Abubakar-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:04:05 -0400" MODIFIED_BY="Anne Lawson">
<P>Journal publication. Order of ventilatory modes not randomised in this cross-over study which means that an effect of fatigue cannot be excluded. Additionally, study did not report outcomes specified in this Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:04:29 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Abubakar-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:04:29 -0400" MODIFIED_BY="Anne Lawson">
<P>Abstract presentation. Study investigating time to recovery after ETT suction in infants randomised to ventilation with/without VG mode. Study did not report outcomes specified in this Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 14:14:40 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Cheema-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 14:14:40 -0400" MODIFIED_BY="Anne Lawson">
<P>Journal publication. Short-term cross-over study did not address any of the outcomes of this Cochrane Review. Also, the cross-over was made from PLV to VG mode without changing P<SUB>max</SUB>, which may have interfered with the ventilator's capacity to deliver the set VT and hence affected the outcomes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 14:17:00 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Colnaghi-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 14:17:00 -0400" MODIFIED_BY="Anne Lawson">
<P>Abstract presentation. Randomised trial comparing 3 groups ventilated with Draeger Babylog 8000plus: group 1: PSV; group 2: PSV + VG; group 3: AC + VG.</P>
<P>However, outcomes were biochemical assays of inflammatory markers in serum and tracheal aspirates. Study did not report outcomes specified in this Cochrane Review. Despite randomisation, there were inception differences in study group characteristics.</P>
<P>We attempted to contact authors for further information.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:10:04 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Dotta-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:10:04 -0400" MODIFIED_BY="Anne Lawson">
<P>Abstract presentation. Randomised study, but authors did not report outcomes specified in this Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:10:39 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Keszler-2004b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:10:39 -0400" MODIFIED_BY="Anne Lawson">
<P>Abstract presentation. Abstract did not report whether interventions randomised. Study outcomes did not include those specified in this Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-03-04 07:29:48 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lista--2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-03-04 07:29:48 -0500" MODIFIED_BY="[Empty name]">
<P>Journal publication (in Italian). A non-randomised study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:10:48 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-NCT00157989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:10:48 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomised study, but later the studies were terminated.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 14:14:44 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-NCT00295230">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 14:14:44 -0400" MODIFIED_BY="Anne Lawson">
<P>Study designed to compare effects of VG with pressure supported vs synchronised intermittent mandatory ventilation in very low birth weight infants. Study started in 2006, but later participant recruitment was suspended due to suboptimal enrolment after 18 months, and study was terminated.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:11:43 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Olsen-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:11:43 -0400" MODIFIED_BY="Anne Lawson">
<P>Journal publication. Cross-over study that did not discuss outcome measurements of this Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:11:56 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Ramirez_x002d_Del-Valle-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:11:56 -0400" MODIFIED_BY="Anne Lawson">
<P>Abstract presentation. Randomised study, but authors did not report the outcomes specified in this Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:12:14 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Shah-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:12:14 -0400" MODIFIED_BY="Anne Lawson">
<P>Journal publication. Non-randomised study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:12:07 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Sinha-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:12:07 -0400" MODIFIED_BY="Anne Lawson">
<P>Abstract presentation. Outcomes did not include those specified in this Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:12:12 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Stefanescu-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:12:12 -0400" MODIFIED_BY="Anne Lawson">
<P>Journal publication. Non-randomised study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 13:18:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Unal-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 13:18:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Abstract presentation. Comparing 2 VTV modes, no comparison with PLV mode.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-09-14 06:12:44 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Wach-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-09-14 06:12:44 -0400" MODIFIED_BY="Anne Lawson">
<P>Abstract presentation. No information in the abstract whether intervention was randomised. Outcomes did not include those specified in this Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>AC: assist control; ETT: endotracheal tube; P<SUB>max</SUB>: maximum peak inflation pressure; PLV: pressure-limited ventilation; PSV: pressure support ventilation; VG: volume guarantee; VT: tidal volume; VTV: volume-targeted ventilation.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2017-09-14 14:17:05 -0400" MODIFIED_BY="Anne Lawson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2017-04-30 18:09:54 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2016">
<CHAR_METHODS MODIFIED="2017-04-30 18:09:54 -0400" MODIFIED_BY="[Empty name]">
<P>Article published in Chinese. We have not been able to obtain a translated version.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES MODIFIED="2017-04-30 18:09:42 -0400" MODIFIED_BY="[Empty name]">
<P> Translated manuscript sought.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-09-14 14:17:05 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Miracle-2016">
<CHAR_METHODS MODIFIED="2017-09-14 06:14:04 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomised parallel study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 06:14:07 -0400" MODIFIED_BY="Anne Lawson">
<P>35 preterm infants 25-32 weeks' gestation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-14 14:17:05 -0400" MODIFIED_BY="Anne Lawson">
<P>SIMV, PSV + VG</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES/>
<CHAR_NOTES MODIFIED="2017-09-14 06:14:40 -0400" MODIFIED_BY="Anne Lawson">
<P>Final published data awaited. Published as abstract only.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>PSV: pressure support ventilation; SIMV: synchronised intermittent mandatory ventilation; VG: volume guarantee.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2017-09-15 09:20:26 -0400" MODIFIED_BY="Anne Lawson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2017-09-14 13:20:59 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-ACTRN12609000986279">
<CHAR_STUDY_NAME MODIFIED="2017-09-14 06:15:54 -0400" MODIFIED_BY="Anne Lawson">
<P>A Randomised Controlled Trial of Modes of Ventilatory Support in Preterm Infants from Point of Delivery to the Neonatal Intensive Care Unit.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-09-14 06:15:56 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomisation (sealed enveloped).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 06:16:00 -0400" MODIFIED_BY="Anne Lawson">
<P>Preterm infants &lt; 32 weeks, ventilated in delivery room.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-14 13:20:59 -0400" MODIFIED_BY="Anne Lawson">
<P>VTV group: triggered VG mode.</P>
<P>PLV group: IMV.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-14 06:17:03 -0400" MODIFIED_BY="Anne Lawson">
<P>PaCO<SUB>2</SUB>, PaO<SUB>2</SUB>, cerebral blood flow, IVH grade 3-4, PVL, BPD, neurodevelopmental impairment at 1 and 3 years.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2017-09-14 06:17:02 -0400" MODIFIED_BY="Anne Lawson">
<P>29 November 2006.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-09-14 06:17:31 -0400" MODIFIED_BY="Anne Lawson">
<P>Dr Mark Tracey.</P>
<P>The <LINK REF="STD-ACTRN12609000986279" TYPE="STUDY">ACTRN12609000986279</LINK> trial of VTV from the point of delivery was registered with the Australian New Zealand Clinical Trials Registry. Recruitment commenced November 2006 and has now closed. At this stage, no outcomes have been reported.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-04-30 18:11:08 -0400" MODIFIED_BY="[Empty name]">
<P>We have attempted to contact the authors for further information.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-09-15 09:20:26 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Salvia-2006">
<CHAR_STUDY_NAME MODIFIED="2017-09-14 06:17:56 -0400" MODIFIED_BY="Anne Lawson">
<P>Effect of VG Combined with SIMV vs SIMV in the Extremely Premature Infant.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-09-14 06:17:57 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomisation (unspecified).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-09-14 06:18:08 -0400" MODIFIED_BY="Anne Lawson">
<P>60 very low birth weight infants.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-09-14 14:17:09 -0400" MODIFIED_BY="Anne Lawson">
<P>VTV group: SIMV + VG.</P>
<P>PLV group: SIMV.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-09-15 09:20:26 -0400" MODIFIED_BY="Anne Lawson">
<P>PIP, MAP, VT, CO<SUB>2</SUB>, FiO<SUB>2</SUB>/SpO<SUB>2</SUB>.</P>
<P>Duration of mechanical ventilation, oxygen therapy, duration of admission, PDA, IVH, PVL, BPD, 2-year follow-up data.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2017-09-14 06:19:19 -0400" MODIFIED_BY="Anne Lawson">
<P>Not reported.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-09-14 06:19:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Dr Salvia.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-09-14 14:09:19 -0400" MODIFIED_BY="Anne Lawson">
<P>Studied from 30 min after first surfactant dose. Study is ongoing and collecting 2-year follow-up data. Hitherto only short-term outcomes have been presented in abstract form. Longer-term follow-up is in progress (information from author), and the final published data are awaited. We have attempted to contact the authors for further information.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>BPD: bronchopulmonary dysplasia; FiO<SUB>2</SUB>: fraction of inspired oxygen; IMV: intermittent mandatory ventilation; IVH: intraventricular haemorrhage; MAP: mean airway pressure; PaCO<SUB>2</SUB>: partial pressure of carbon dioxide in arterial blood; PaO<SUB>2</SUB>: partial pressure of oxygen in arterial blood; PDA: patent ductus arteriosus; PIP: peak inflation pressure; PLV: pressure-limited ventilation; PVL: periventricular leukomalacia; SIMV: synchronised intermittent mandatory ventilation; SpO<SUB>2</SUB>: blood oxygen saturation level; VG: volume guarantee; VT: tidal volume; VTV: volume-targeted ventilation.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2017-10-11 13:45:37 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-10-11 13:45:37 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 13:49:41 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bhat-2016">
<DESCRIPTION>
<P>Random number table generation (unspecified).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:21:14 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Cheema-2007">
<DESCRIPTION>
<P>Permuted blocks within strata (&lt; 1250 g and &gt; 1250 g blocks).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 03:07:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>Random number table generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 14:46:49 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-D_x0027_Angio-2005">
<DESCRIPTION>
<P>Block randomisation (8 participants per block). Stratified by centre and BW.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-01 05:55:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Duman-2012">
<DESCRIPTION>
<P>Block randomisation with random block sizes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-04-24 02:16:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Erdemir-2014">
<DESCRIPTION>
<P>Randomisation strategy not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-04 00:57:06 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guven-2013">
<DESCRIPTION>
<P>Block randomisation with random block sizes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 02:58:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Herrera-2002">
<DESCRIPTION>
<P>Randomised, but no further information about randomisation procedure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 04:58:52 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Hummler-2006">
<DESCRIPTION>
<P>Randomised, but no further information about randomisation procedure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:01:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Jain-2016">
<DESCRIPTION>
<P>Randomisation sequence: not specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:03:45 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Keszler-2004a">
<DESCRIPTION>
<P>Random number table used to randomise participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-10-11 13:45:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lista-2004">
<DESCRIPTION>
<P>Random number sequencing, stratified by GA (25-28 weeks and 29-32 weeks) and centre.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:20:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2011">
<DESCRIPTION>
<P>Random number table used, method not specified.</P>
<P>Unequal allocation to 3 groups (PLV, VTV and high-frequency ventilation), and overall substantially more boys (n = 57) than girls (n = 27) included.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:21:24 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Nafday-2005">
<DESCRIPTION>
<P>Block randomisation, stratified by weight (500-750 g, 751-1000 g, 1001-1250 g, 1251-1500 g).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 02:58:28 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Piotrowski-1997">
<DESCRIPTION>
<P>Randomised, but no further information about randomisation procedure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 14:07:27 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Piotrowski-2007">
<DESCRIPTION>
<P>Sequential numbers. Stratified by GA (24-28 weeks and 29-33 weeks).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 02:57:54 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Polimeni-2006">
<DESCRIPTION>
<P>Randomised, but no further information about randomisation procedure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:45:30 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Singh-2006">
<DESCRIPTION>
<P>Random block randomisation. Stratified by BW.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 02:58:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sinha-1997">
<DESCRIPTION>
<P>Randomised, but no further information about randomisation procedure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 02:59:51 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>Randomised, but no further information about randomisation procedure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-10-11 13:45:12 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 13:49:44 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bhat-2016">
<DESCRIPTION>
<P>Blinding of randomisation: sequential sealed opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 13:52:28 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Cheema-2007">
<DESCRIPTION>
<P>Blinding of randomisation: sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 13:56:53 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>Blinding of randomisation: sealed opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-04 12:09:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-D_x0027_Angio-2005">
<DESCRIPTION>
<P>Blinding of randomisation: Sealed, opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 14:50:07 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Duman-2012">
<DESCRIPTION>
<P>Blinding of randomisation: sealed opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 15:03:42 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Erdemir-2014">
<DESCRIPTION>
<P>Blinding of randomisation: sealed opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 15:06:03 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Guven-2013">
<DESCRIPTION>
<P>Not specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 15:14:21 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Herrera-2002">
<DESCRIPTION>
<P>Blinding of randomisation: sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 04:58:55 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Hummler-2006">
<DESCRIPTION>
<P>Blinding of randomisation: sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:01:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Jain-2016">
<DESCRIPTION>
<P>Blinding of randomisation: not specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:03:48 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Keszler-2004a">
<DESCRIPTION>
<P>Blinding of randomisation: sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:07:42 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Lista-2004">
<DESCRIPTION>
<P>Blinding of randomisation: not specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 03:02:35 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2011">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:23:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Nafday-2005">
<DESCRIPTION>
<P>Blinding of randomisation: sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:30:38 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Piotrowski-1997">
<DESCRIPTION>
<P>Blinding of randomisation: sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:33:38 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Piotrowski-2007">
<DESCRIPTION>
<P>Blinding of randomisation: sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 03:00:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Polimeni-2006">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:45:32 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Singh-2006">
<DESCRIPTION>
<P>Blinding of randomisation: sealed, opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:49:00 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Sinha-1997">
<DESCRIPTION>
<P>Blinding of randomisation: sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 02:53:47 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2017-05-06 11:09:23 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2017-10-11 13:45:12 -0400" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1" REF_IDS="CMP-001.01 CMP-001.02 CMP-001.03 CMP-001.04 CMP-001.05 CMP-001.06 CMP-001.07 CMP-001.08 CMP-001.09 CMP-001.10 CMP-001.11 CMP-001.12 CMP-001.13 CMP-001.14 CMP-001.15 CMP-001.16 CMP-001.18 CMP-001.17 CMP-001.19 CMP-001.20 CMP-001.21 CMP-002.01 CMP-002.02 CMP-002.03 CMP-002.04 CMP-002.05 CMP-002.06 CMP-002.07 CMP-002.08 CMP-002.09 CMP-002.10 CMP-002.11 CMP-002.12 CMP-002.13 CMP-002.14 CMP-002.15 CMP-002.16 CMP-002.17 CMP-002.18 CMP-003.01 CMP-003.02 CMP-003.03 CMP-003.04 CMP-003.05 CMP-003.06">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 11:07:57 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bhat-2016">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 10:58:43 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cheema-2007">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 11:03:34 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 10:48:15 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-D_x0027_Angio-2005">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 11:02:59 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Duman-2012">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 11:06:54 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Erdemir-2014">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 11:04:17 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Guven-2013">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 10:40:23 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Herrera-2002">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-09-14 04:58:57 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Hummler-2006">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 11:08:40 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jain-2016">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 10:43:34 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Keszler-2004a">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 10:44:57 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lista-2004">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 11:02:11 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2011">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 10:45:50 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nafday-2005">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 10:39:55 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Piotrowski-1997">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 10:55:54 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Piotrowski-2007">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-09-14 05:35:08 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Polimeni-2006">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 10:52:28 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Singh-2006">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 10:39:46 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sinha-1997">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-05-06 11:01:15 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2017-10-11 13:45:12 -0400" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 11:08:00 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bhat-2016">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-07 02:52:30 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cheema-2007">
<DESCRIPTION>
<P>No (outcome measure defined end of intervention period).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 11:03:57 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 10:48:18 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-D_x0027_Angio-2005">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 11:03:05 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Duman-2012">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 11:06:56 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Erdemir-2014">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 11:04:19 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Guven-2013">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 10:40:32 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Herrera-2002">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-09-14 04:58:58 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Hummler-2006">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 11:08:42 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jain-2016">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-07 02:41:56 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Keszler-2004a">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 10:44:59 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lista-2004">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 11:02:13 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2011">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 10:45:53 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nafday-2005">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 10:40:01 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Piotrowski-1997">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 10:56:01 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Piotrowski-2007">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-09-14 05:35:08 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Polimeni-2006">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-09-14 05:45:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Singh-2006">
<DESCRIPTION>
<P>Blinding of outcome measurements to discharge: no.</P>
<P>Investigators involved in long-term follow-up were blinded to original treatment modality.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 10:35:57 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sinha-1997">
<DESCRIPTION>
<P>Was done for chest x-ray findings, but not for other outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-06 11:01:20 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2017-10-11 13:45:12 -0400" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Intervention bias (strict vs hybrid studies)</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 13:49:47 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bhat-2016">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 13:52:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Cheema-2007">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 13:56:55 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 14:46:55 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-D_x0027_Angio-2005">
<DESCRIPTION>
<P>Hybrid study: different trigger modes in VTV and PLV groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 14:50:10 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Duman-2012">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 15:04:09 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Erdemir-2014">
<DESCRIPTION>
<P>Hybrid study: different modes of flow termination. In PSV mode, inflation times varies (flow termination). In SIMV, there is a fixed inflation time.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 15:06:04 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Guven-2013">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 15:14:24 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Herrera-2002">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 04:58:59 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Hummler-2006">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:01:33 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Jain-2016">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 02:42:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Keszler-2004a">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:07:44 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lista-2004">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:20:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Liu-2011">
<DESCRIPTION>
<P>Hybrid study: different ventilators.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:23:49 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Nafday-2005">
<DESCRIPTION>
<P>Hybrid study: different modes of flow termination. In PSV mode, inflation times varies (flow termination). In SIMV, there is a fixed inflation time.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 13:16:09 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Piotrowski-1997">
<DESCRIPTION>
<P>Hybrid study; the VTV group and PLV group used different ventilator models, modes and synchronisation settings.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:33:43 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Piotrowski-2007">
<DESCRIPTION>
<P>Hybrid study: different ventilators.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:35:09 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Polimeni-2006">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:45:40 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Singh-2006">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:49:16 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Sinha-1997">
<DESCRIPTION>
<P>Hybrid study: VTV mode was pressure triggered. PLV mode was flow triggered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:51:06 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>Not applicable.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-10-11 13:45:12 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-13 13:49:52 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Bhat-2016">
<DESCRIPTION>
<P>Follow-up: complete to end of intervention. Secondary postintervention outcomes reported during period of primary admission.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-13 13:52:34 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Cheema-2007">
<DESCRIPTION>
<P>Follow-up complete to discharge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-13 13:56:59 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>Follow-up: complete to end of intervention. Secondary postintervention outcomes reported during period of primary admission.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-13 14:47:06 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-D_x0027_Angio-2005">
<DESCRIPTION>
<P>Follow-up: complete to discharge.</P>
<P>Long-term follow-up: 64 infants in each group were also assessed at 6-18 months' corrected age (neurodevelopmental outcome).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-13 14:50:16 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Duman-2012">
<DESCRIPTION>
<P>Follow-up: complete to end of intervention. Secondary postintervention outcomes reported during period of primary admission.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-13 15:04:13 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Erdemir-2014">
<DESCRIPTION>
<P>Outcomes complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-13 15:06:06 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Guven-2013">
<DESCRIPTION>
<P>Follow-up: complete to end of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-10-04 12:08:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Herrera-2002">
<DESCRIPTION>
<P>Data complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-10-04 12:10:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hummler-2006">
<DESCRIPTION>
<P>Data complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-14 05:01:36 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Jain-2016">
<DESCRIPTION>
<P>Follow-up: complete to end of intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-14 05:03:51 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Keszler-2004a">
<DESCRIPTION>
<P>Follow-up: complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-14 05:07:47 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Lista-2004">
<DESCRIPTION>
<P>Follow-up: complete to discharge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-04-22 15:33:37 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Liu-2011">
<DESCRIPTION>
<P>Completeness of follow-up not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-14 05:23:53 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Nafday-2005">
<DESCRIPTION>
<P>Follow-up: complete to discharge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-14 05:30:54 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Piotrowski-1997">
<DESCRIPTION>
<P>Follow-up: complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-14 05:33:46 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Piotrowski-2007">
<DESCRIPTION>
<P>Follow-up: complete to discharge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-10-04 12:10:28 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Polimeni-2006">
<DESCRIPTION>
<P>Data complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-14 05:45:50 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Singh-2006">
<DESCRIPTION>
<P>Follow-up: complete to discharge. 85/91 (93%) infants eligible for follow-up were assessed at a median of 22 months' corrected age.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-14 05:49:19 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Sinha-1997">
<DESCRIPTION>
<P>Follow-up: complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-09-14 13:13:31 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>Postintervention outcomes report on 25/30 (83%) participants. Stated reasons included financial dropouts and withdrawal from study due to IVH.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2017-10-11 13:45:12 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-04-29 16:53:13 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bhat-2016">
<DESCRIPTION>
<P>Trial registration submitted after completion of the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 13:52:39 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Cheema-2007">
<DESCRIPTION>
<P>Retrospectively registered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 13:57:07 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>Trial registration submitted after completion of study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 14:47:19 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-D_x0027_Angio-2005">
<DESCRIPTION>
<P>Study protocol sent to review authors. Study not registered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-04-24 02:14:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Duman-2012">
<DESCRIPTION>
<P>No trial registration.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-04-24 02:16:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Erdemir-2014">
<DESCRIPTION>
<P>No trial registration available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 15:06:09 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Guven-2013">
<DESCRIPTION>
<P>No trial registration.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-13 15:14:29 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Herrera-2002">
<DESCRIPTION>
<P>Study protocol was unavailable for review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 04:59:05 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Hummler-2006">
<DESCRIPTION>
<P>Study protocol unavailable for review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:01:38 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Jain-2016">
<DESCRIPTION>
<P>Trial registered: clinicaltrials.gov NCT01727505.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:03:56 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Keszler-2004a">
<DESCRIPTION>
<P>Study protocol unavailable for review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-10-02 18:36:16 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lista-2004">
<DESCRIPTION>
<P>Study protocol not available for review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:20:45 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Liu-2011">
<DESCRIPTION>
<P>No trial registration.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:24:00 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Nafday-2005">
<DESCRIPTION>
<P>Study protocol unavailable for review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:31:00 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Piotrowski-1997">
<DESCRIPTION>
<P>Study protocol unavailable for review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:33:51 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Piotrowski-2007">
<DESCRIPTION>
<P>Study protocol unavailable for review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:35:25 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Polimeni-2006">
<DESCRIPTION>
<P>Study protocol sent to review authors. Study retrospectively registered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:46:03 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2006">
<DESCRIPTION>
<P>Study protocol unavailable for review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:49:24 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Sinha-1997">
<DESCRIPTION>
<P>Study protocol not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-15 09:19:49 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION>
<P>Review authors requested study protocol, but received no response.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2017-10-11 13:45:12 -0400" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-04 01:04:13 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bhat-2016">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 03:10:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheema-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 13:15:38 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Chowdhury-2013">
<DESCRIPTION>
<P>Despite randomisation, there was imbalance with regard to BW, GA and antenatal steroid use. Participants in the PLV group had lower median GA/BW than participants in the VTV group (median GA/BW 26 weeks/856 g vs 28 weeks/1016 g).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-04 01:02:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-D_x0027_Angio-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-04-24 02:14:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Duman-2012">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-04 01:04:08 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Erdemir-2014">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 13:15:56 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Guven-2013">
<DESCRIPTION>
<P>Reported in paper that 90 participants were randomised. However, postrandomisation 15 participants were excluded in PLV group and 3 participants excluded in VTV group. After contact with authors, it seemed that randomisation occurred before they had considered exclusion criteria and before parents had given consent.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-09 06:01:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Herrera-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-01 05:53:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hummler-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-04 01:01:55 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jain-2016">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-03-04 05:29:24 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Keszler-2004a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 13:13:21 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Lista-2004">
<DESCRIPTION>
<P>Imbalance in numbers between the PLV and VTV groups. Postrandomisation, 7 infants excluded because placental histology identified chorioamnionitis (supplemental data), which could have influenced the primary outcome of this study. After postrandomisation exclusions, data from 30 infants in VTV group and 23 infants in PLV group were reported.</P>
<P>In post hoc subgroup of infants weighing &lt; 1000 g identified from supplemental data, 12/30 (40%) participants in VTV group were &lt; 1000 g compared with 5/23 (22%) in PLV group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 03:10:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liu-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-04 00:23:17 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nafday-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-06 10:38:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Piotrowski-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:34:03 -0400" MODIFIED_BY="Anne Lawson" RESULT="NO" STUDY_ID="STD-Piotrowski-2007">
<DESCRIPTION>
<P>Although randomised, infants in the VTV (PRVC) group had increased surfactant use and increased FiO<SUB>2</SUB> in first 6 h after admission.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-14 04:04:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Polimeni-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 05:46:07 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2006">
<DESCRIPTION>
<P>Both arms weaned using PLV mode.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-09-14 13:18:38 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Sinha-1997">
<DESCRIPTION>
<P>Both arms weaned using a PLV mode.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-07 03:10:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zhou-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-10-11 13:42:35 -0400" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-10-11 13:42:13 -0400" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2017-09-14 11:43:02 -0400" MODIFIED_BY="Anne Lawson">Volume-targeted compared to pressure-limited ventilation: main findings</TITLE>
<TABLE COLS="7" ROWS="19">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Volume-targeted ventilation compared to pressure-limited ventilation</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population:</B> neonates up to 44 weeks' postmenstrual age<BR/>
<B>Setting: </B>neonatal intensive care unit<BR/>
<B>Intervention: </B>VTV<BR/>
<B>Comparison: </B>PLV</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with PLV</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with VTV</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Death before discharge from hospital</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.75<BR/>(0.53 to 1.07)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>771<BR/>(11 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Imprecision of estimates. 95% CI &lt; 0.75.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>163 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>122 per 1000<BR/>(86 to 175)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Death or BPD</B> (36 weeks)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.73<BR/>(0.59 to 0.89)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>584<BR/>(8 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>458 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>334 per 1000<BR/>(270 to 408)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Duration of positive pressure ventilation</B> (days)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>MD of positive pressure ventilation (days); PLV group 0</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>MD 1.35 lower<BR/>(1.83 lower to 0.86 lower) in VTV group</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>736<BR/>(12 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Unblinded studies.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Pneumothorax</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.52 (0.31 to 0.87)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>825<BR/>(13 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>88 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>46 per 1000</P>
<P>(27 to 77)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>IVH grade 3-4</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.53</P>
<P>(0.37 to 0.77)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>712</P>
<P>(10 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>184 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>97 per 1000</P>
<P>(68 to 141)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>IVH grade 3-4 or PVL</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.47</P>
<P>(0.27 to 0.80)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>441<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>164 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>77 per 1000</P>
<P>(44 to 131)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>BPD</B> (supplemental oxygen at 36 weeks)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.68 (0.53 to 0.87)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>620<BR/>(9 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Possible publication bias based on funnel plot.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>346 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>235 per 1000</P>
<P>(183 to 301)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).</P>
<P>
<B>BPD:</B> bronchopulmonary dysplasia; <B>CI:</B> confidence interval; <B>IVH:</B> intraventricular haemorrhage; <B>MD:</B> mean difference; <B>PLV:</B> pressure-limited ventilation; <B>PVL:</B> periventricular leukomalacia; <B>RCT:</B> randomised controlled trial; <B>RR:</B> risk ratio; <B>VTV:</B> volume-targeted ventilation.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect.<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2017-10-11 13:42:35 -0400" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2017-09-14 11:59:50 -0400" MODIFIED_BY="Anne Lawson">Volume-targeted compared to pressure-limited ventilation: additional findings</TITLE>
<TABLE COLS="7" ROWS="36">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Volume-targeted ventilation compared to pressure-limited ventilation</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>neonates up to 44 weeks' postmenstrual age<BR/>
<B>Setting: </B>neonatal intensive care unit<BR/>
<B>Intervention: </B>VTV<BR/>
<B>Comparison: </B>PLV</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with PLV</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with VTV</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Death or BPD</B> (28 days)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.87 (0.64 to 1.18)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>149<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Imprecision of estimates, 95% CI &lt; 0.75. Few participants.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>536 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>467 per 1000</P>
<P>(343 to 633)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Failure of mode of ventilation</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.69<BR/>(0.48 to 1.00)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>445<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>242 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>167 per 1000<BR/>(116 to 242)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Addition of neuromuscular paralysis where previously not paralysed</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.32<BR/>(0.07 to 1.40)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>75<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Small numbers of participants.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>179 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>57 per 1000<BR/>(13 to 251)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Duration of positive pressure ventilation</B> (log data)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean duration of IPPV (log data) was 0</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>MD 0.08 lower<BR/>(0.16 lower to 0)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>381<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Unblinded studies. Heterogeneity of study results.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Inspired oxygen concentration %</B> (study definition)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean difference in inspired oxygen concentration %;</P>
<P>PLV group 0</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean inspired oxygen concentration % was 0.92 lower (2.08 lower to 0.24 higher) in VTV group</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>324<BR/>(7 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Unblinded studies.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Any pH &lt; 7.25</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.80<BR/>(0.52 to 1.23)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>98<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Imprecision of estimates, 95% CI &lt; 0.75. Few participants.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>380 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>304 per 1000<BR/>(198 to 467)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Hypocarbia</B>
</P>
<P>pCO<SUB>2</SUB> &lt; 35 mmHg/4.7 kPa</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.49 (0.33 to 0.72)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>98<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Small trials, but large effect and biologically plausible.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>720 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>353 per 1000</P>
<P>(238 to 518)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Respiratory acidosis</B>
</P>
<P>pH &lt; 7.25 and pCO<SUB>2</SUB> &gt; 60 mmHg/8 kPa</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.93<BR/>(0.51 to 1.70)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>98<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Imprecision of estimates, 95% CI &lt; 0.75. Few participants.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>240 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>223 per 1000<BR/>(122 to 408)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Either hypocarbia or respiratory acidosis</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.68<BR/>(0.42 to 1.10)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>37<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>No quality assessment possible.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>1889 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>1000 per 1000<BR/>(793 to 1000)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Patent ductus arteriosus</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.95<BR/>(0.80 to 1.12)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>754<BR/>(10 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Variable diagnostic practices employed.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>391 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>371 per 1000<BR/>(313 to 438)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Air leak </B>(any)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.79<BR/>(0.44 to 1.43)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>374<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Imprecision of estimates, 95% CI &lt; 0.75. Few participants.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>117 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>92 per 1000<BR/>(51 to 167)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Pulmonary interstitial emphysema</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.21<BR/>(0.63 to 2.30)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>430<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Imprecision of estimates, 95% CI &lt; 0.75.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>65 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>79 per 1000<BR/>(41 to 150)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Any IVH</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.82<BR/>(0.62 to 1.08)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>445<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Imprecision of estimates, 95% CI &lt; 0.75.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>342 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>281 per 1000<BR/>(212 to 370)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>PVL</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>OR 0.43</P>
<P>(0.19 to 0.98)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>508<BR/>(7 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>71 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>32 per 1000</P>
<P>(14 to 69)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>Any IVH or PVL</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.83<BR/>(0.58 to 1.18)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>298<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>Moderate</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>308 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>256 per 1000<BR/>(179 to 364)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<B>BPD</B> (supplemental oxygen at 28 days)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.91<BR/>(0.64 to 1.30)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>206<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>Low</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Unblinded studies. Imprecision of estimates, 95% CI &lt; 0.75.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>354 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>322 per 1000<BR/>(226 to 460)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).</P>
<P>
<B>BPD:</B> bronchopulmonary dysplasia; <B>CI:</B> confidence interval; <B>IPPV:</B> intermittent positive pressure ventilation; <B>IVH:</B> intraventricular haemorrhage; <B>MD:</B> mean difference; <B>pCO<SUB>2</SUB>:</B> partial pressure of carbon dioxide; <B>PLV:</B> pressure-limited ventilation; <B>PVL:</B> periventricular leukomalacia; <B>RCT:</B> randomised controlled trial; <B>RR:</B> risk ratio; <B>VTV:</B> volume-targeted ventilation.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect.<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2017-04-29 18:37:39 -0400" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-10-02 19:08:00 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2017-10-02 19:08:00 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Volume-targeted ventilation (VTV) versus pressure-limited ventilation (PLV) - subgroup by mode of ventilation</NAME>
<DICH_OUTCOME CHI2="6.0687125411786305" CI_END="1.0659440149452932" CI_START="0.5332858493109791" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7539581283652665" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="61" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.027734395460889502" LOG_CI_START="-0.27303994012678434" LOG_EFFECT_SIZE="-0.1226527723329474" METHOD="MH" MODIFIED="2017-09-14 14:55:54 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.8094576627954974" P_Q="0.40728194105724147" P_Z="0.10993007649456285" Q="0.686722097513934" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="397" TOTAL_2="374" WEIGHT="100.00000000000001" Z="1.598507505016126">
<NAME>Death before discharge from hospital</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.7361081903751451" CI_END="1.1466312405143697" CI_START="0.3118769945946437" DF="3" EFFECT_SIZE="0.5980032652084348" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="19" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.059423770159896055" LOG_CI_START="-0.5060166595137296" LOG_EFFECT_SIZE="-0.2232964446769168" MODIFIED="2017-09-14 12:40:12 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.8646798698840801" P_Z="0.1216205108314077" STUDIES="4" TAU2="0.0" TOTAL_1="116" TOTAL_2="104" WEIGHT="32.18564127379081" Z="1.5480074167855757">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="6.41978801003991" CI_START="0.15576838338526122" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8075206873227565" LOG_CI_START="-0.8075206873227565" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-04-09 18:54:13 -0400" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="0.9486832980505138" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.8999999999999999" WEIGHT="3.1786453597061226"/>
<DICH_DATA CI_END="13.643801456189747" CI_START="0.0732933561962918" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1349353909531412" LOG_CI_START="-1.1349353909531412" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-23 18:49:49 -0500" MODIFIED_BY="[Empty name]" ORDER="212" O_E="0.0" SE="1.3333333333333333" STUDY_ID="STD-Keszler-2004a" TOTAL_1="9" TOTAL_2="9" VAR="1.7777777777777777" WEIGHT="1.5893226798530613"/>
<DICH_DATA CI_END="1.8352567967259987" CI_START="0.22240975381420663" EFFECT_SIZE="0.6388888888888888" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.26369684112116554" LOG_CI_START="-0.6528461706205545" LOG_EFFECT_SIZE="-0.19457466474969443" MODIFIED="2010-02-23 18:49:49 -0500" MODIFIED_BY="[Empty name]" ORDER="213" O_E="0.0" SE="0.5383819020581656" STUDY_ID="STD-Lista-2004" TOTAL_1="30" TOTAL_2="23" VAR="0.2898550724637682" WEIGHT="10.795399334850982"/>
<DICH_DATA CI_END="1.2468426476730834" CI_START="0.16687271652655417" EFFECT_SIZE="0.45614035087719296" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.09581164869970143" LOG_CI_START="-0.7776146641030484" LOG_EFFECT_SIZE="-0.34090150770167343" MODIFIED="2010-02-23 18:49:49 -0500" MODIFIED_BY="[Empty name]" ORDER="214" O_E="0.0" SE="0.5130549396703126" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.263225371120108" WEIGHT="16.62227389938064"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.661510931067869" CI_END="1.2481958184142101" CI_START="0.5492287723972561" DF="6" EFFECT_SIZE="0.8279764833973396" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="42" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.09628272331562507" LOG_CI_START="-0.2602467194941893" LOG_EFFECT_SIZE="-0.08198199808928212" MODIFIED="2017-09-14 12:40:17 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.5878999513553839" P_Z="0.3673937485623069" STUDIES="7" TAU2="0.0" TOTAL_1="281" TOTAL_2="270" WEIGHT="67.8143587262092" Z="0.901366026711785">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="2.113336185472818" CI_START="0.5008783815657797" EFFECT_SIZE="1.0288461538461537" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="13" LOG_CI_END="0.32496858928238753" LOG_CI_START="-0.3002677125095291" LOG_EFFECT_SIZE="0.012350438386429243" MODIFIED="2010-03-02 03:51:54 -0500" MODIFIED_BY="[Empty name]" ORDER="371" O_E="0.0" SE="0.36726689864218076" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="104" TOTAL_2="107" VAR="0.13488497483824588" WEIGHT="20.367433774041128"/>
<DICH_DATA CI_END="1.3881009122956014" CI_START="0.12106401681052312" EFFECT_SIZE="0.40993788819875776" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.14242103964915057" LOG_CI_START="-0.9169849206291127" LOG_EFFECT_SIZE="-0.38728194048998105" MODIFIED="2015-09-20 13:07:00 -0400" MODIFIED_BY="[Empty name]" ORDER="201" O_E="0.0" SE="0.6223003052115317" STUDY_ID="STD-Duman-2012" TOTAL_1="23" TOTAL_2="22" VAR="0.3872576698663655" WEIGHT="11.372486731393018"/>
<DICH_DATA CI_END="4.206513090488437" CI_START="0.3714477921233738" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6239222447595453" LOG_CI_START="-0.43010221874343246" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2014-06-26 02:33:31 -0400" MODIFIED_BY="Kevin Wheeler" ORDER="550" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Erdemir-2014" TOTAL_1="30" TOTAL_2="30" VAR="0.38333333333333336" WEIGHT="6.357290719412245"/>
<DICH_DATA CI_END="1.6573265348249766" CI_START="0.11082515456566441" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.21940808373704027" LOG_CI_START="-0.9553616543262292" LOG_EFFECT_SIZE="-0.36797678529459443" MODIFIED="2015-09-20 13:07:33 -0400" MODIFIED_BY="[Empty name]" ORDER="202" O_E="0.0" SE="0.6900655593423543" STUDY_ID="STD-Guven-2013" TOTAL_1="42" TOTAL_2="30" VAR="0.47619047619047616" WEIGHT="9.271048965809523"/>
<DICH_DATA CI_END="1.6388281022014426" CI_START="0.1883309023649536" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.2145334025146746" LOG_CI_START="-0.7250784127212866" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2010-02-25 19:06:45 -0500" MODIFIED_BY="[Empty name]" ORDER="239" O_E="0.0" SE="0.5519326314231019" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="27" TOTAL_2="30" VAR="0.30462962962962964" WEIGHT="12.045392942044254"/>
<DICH_DATA CI_END="4.604696385222407" CI_START="0.4995503688712093" EFFECT_SIZE="1.5166666666666666" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.6632009998815035" LOG_CI_START="-0.3014207160066036" LOG_EFFECT_SIZE="0.18089014193744996" MODIFIED="2010-02-25 19:06:48 -0500" MODIFIED_BY="[Empty name]" ORDER="240" O_E="0.0" SE="0.5666235708671773" STUDY_ID="STD-Piotrowski-2007" TOTAL_1="30" TOTAL_2="26" VAR="0.32106227106227103" WEIGHT="6.811382913655977"/>
<DICH_DATA CI_END="15.116785694102392" CI_START="0.06615162907218672" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1794594562633327" LOG_CI_START="-1.1794594562633327" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-25 19:18:51 -0500" MODIFIED_BY="[Empty name]" ORDER="242" O_E="0.0" SE="1.3856406460551018" STUDY_ID="STD-Sinha-1997" TOTAL_1="25" TOTAL_2="25" VAR="1.92" WEIGHT="1.5893226798530613"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.04532347417572" CI_END="0.8918829654327892" CI_START="0.5948676446535744" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7283902243671648" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="131" I2="0.6433128917621842" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.04969213082726685" LOG_CI_START="-0.2255796520710828" LOG_EFFECT_SIZE="-0.13763589144917482" METHOD="MH" MODIFIED="2017-10-02 19:08:00 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4241762041582702" P_Q="0.6175940247113919" P_Z="0.0021590752523887547" Q="0.24926372150272838" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="298" TOTAL_2="286" WEIGHT="100.0" Z="3.067430688803702">
<NAME>Death or bronchopulmonary dysplasia (BPD) (36 weeks)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.41612110872190033" CI_END="0.938745524042951" CI_START="0.4976946188161947" DF="3" EFFECT_SIZE="0.6835265874521381" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="52" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="-0.027452120707436297" LOG_CI_START="-0.30303705491815663" LOG_EFFECT_SIZE="-0.16524458781279647" MODIFIED="2017-10-02 19:07:56 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9368924990035554" P_Z="0.018751042425338163" STUDIES="4" TAU2="0.0" TOTAL_1="116" TOTAL_2="104" WEIGHT="40.70376707435786" Z="2.3504437329335595">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="1.4174001619090495" CI_START="0.3731660501028293" EFFECT_SIZE="0.7272727272727273" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" LOG_CI_END="0.1514924780347843" LOG_CI_START="-0.4280978743673472" LOG_EFFECT_SIZE="-0.13830269816628143" MODIFIED="2017-04-09 18:57:16 -0400" MODIFIED_BY="[Empty name]" ORDER="234" O_E="0.0" SE="0.34045424201952734" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.11590909090909089" WEIGHT="8.246437374743657"/>
<DICH_DATA CI_END="1.4047291943140126" CI_START="0.1779702458039148" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.14759260840421695" LOG_CI_START="-0.7496525997321793" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2010-02-23 19:19:56 -0500" MODIFIED_BY="[Empty name]" ORDER="221" O_E="0.0" SE="0.5270462766947299" STUDY_ID="STD-Keszler-2004a" TOTAL_1="9" TOTAL_2="9" VAR="0.2777777777777778" WEIGHT="4.498056749860176"/>
<DICH_DATA CI_END="1.5800260712713923" CI_START="0.28481641492725346" EFFECT_SIZE="0.6708333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.19866425310371807" LOG_CI_START="-0.5454349844632308" LOG_EFFECT_SIZE="-0.17338536567975635" MODIFIED="2010-02-23 19:19:56 -0500" MODIFIED_BY="[Empty name]" ORDER="220" O_E="0.0" SE="0.437087575497456" STUDY_ID="STD-Lista-2004" TOTAL_1="30" TOTAL_2="23" VAR="0.1910455486542443" WEIGHT="6.789519622430454"/>
<DICH_DATA CI_END="1.0895383153266225" CI_START="0.46208889284182664" EFFECT_SIZE="0.7095516569200779" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="27" LOG_CI_END="0.0372425074985964" LOG_CI_START="-0.335274470424117" LOG_EFFECT_SIZE="-0.1490159814627603" MODIFIED="2017-10-02 19:07:56 -0400" MODIFIED_BY="[Empty name]" ORDER="224" O_E="0.0" SE="0.21881831682058203" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.047881455776192614" WEIGHT="21.16975332732358"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.196742695481772" CI_END="0.9876013182803508" CI_START="0.583600424688505" DF="3" EFFECT_SIZE="0.7591867680428447" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="79" I2="51.5874686520809" ID="CMP-001.02.02" LOG_CI_END="-0.005418339030202694" LOG_CI_START="-0.233884400740534" LOG_EFFECT_SIZE="-0.11965136988536837" MODIFIED="2017-10-02 19:08:00 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1024209716157859" P_Z="0.040079401236156845" STUDIES="4" TAU2="0.0" TOTAL_1="182" TOTAL_2="182" WEIGHT="59.29623292564213" Z="2.0529296467108287">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.1930942949046028" CI_START="0.6092272438860771" EFFECT_SIZE="0.8525641025641025" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="45" LOG_CI_END="0.07667476901687104" LOG_CI_START="-0.21522068379162262" LOG_EFFECT_SIZE="-0.06927295738737582" MODIFIED="2017-10-02 19:08:00 -0400" MODIFIED_BY="[Empty name]" ORDER="372" O_E="0.0" SE="0.1714608338855037" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="104" TOTAL_2="105" VAR="0.029398817556712295" WEIGHT="33.5740121042195"/>
<DICH_DATA CI_END="0.8739071858574172" CI_START="0.19229624713061388" EFFECT_SIZE="0.40993788819875776" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="14" LOG_CI_END="-0.05853468957429352" LOG_CI_START="-0.7160291914056686" LOG_EFFECT_SIZE="-0.38728194048998105" MODIFIED="2017-05-01 12:26:41 -0400" MODIFIED_BY="[Empty name]" ORDER="203" O_E="0.0" SE="0.3862155250260241" STUDY_ID="STD-Duman-2012" TOTAL_1="23" TOTAL_2="22" VAR="0.14916243177112742" WEIGHT="10.728698321888716"/>
<DICH_DATA CI_END="1.8856585761492402" CI_START="0.615044169861256" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.2754630606613981" LOG_CI_START="-0.21109369391859562" LOG_EFFECT_SIZE="0.032184683371401235" MODIFIED="2017-04-30 19:43:23 -0400" MODIFIED_BY="[Empty name]" ORDER="551" O_E="0.0" SE="0.2858058461350672" STUDY_ID="STD-Erdemir-2014" TOTAL_1="30" TOTAL_2="30" VAR="0.0816849816849817" WEIGHT="9.745789624697048"/>
<DICH_DATA CI_END="1.2431849614993473" CI_START="0.06566412528250914" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.09453574793580287" LOG_CI_START="-1.1826718366363544" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2017-10-02 19:07:51 -0400" MODIFIED_BY="[Empty name]" ORDER="243" O_E="0.0" SE="0.7502380574571932" STUDY_ID="STD-Sinha-1997" TOTAL_1="25" TOTAL_2="25" VAR="0.5628571428571427" WEIGHT="5.247732874836872"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.487571401169445" CI_END="1.0012242476683098" CI_START="0.47882810933214426" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6923975112090708" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="54" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="5.313588157595753E-4" LOG_CI_START="-0.31982036250641777" LOG_EFFECT_SIZE="-0.15964450184532908" METHOD="MH" MODIFIED="2017-09-14 12:41:16 -0400" MODIFIED_BY="Anne Lawson" NO="3" P_CHI2="0.6468627892709569" P_Q="0.4281885751712592" P_Z="0.05076486337845689" Q="0.6277322625962105" RANDOM="NO" SCALE="77.67" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="222" TOTAL_2="223" WEIGHT="100.0" Z="1.9534621050592242">
<NAME>Failure of mode of ventilation</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3852754769128366" CI_END="1.7237993358769705" CI_START="0.44006561071464334" DF="1" EFFECT_SIZE="0.8709677419354839" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" I2="27.81219211152459" ID="CMP-001.03.01" LOG_CI_END="0.23648670905628344" LOG_CI_START="-0.35648256840685416" LOG_EFFECT_SIZE="-0.05999792967528537" MODIFIED="2015-09-20 13:11:54 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.23920478092494268" P_Z="0.6916426184221258" STUDIES="2" TAU2="0.0" TOTAL_1="77" TOTAL_2="72" WEIGHT="26.74050527714344" Z="0.3966268937696746">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="1.5208651507974484" CI_START="0.289441547205043" EFFECT_SIZE="0.6634768740031898" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="11" LOG_CI_END="0.18209070855607973" LOG_CI_START="-0.5384391289640271" LOG_EFFECT_SIZE="-0.1781742102039737" MODIFIED="2010-02-23 20:57:57 -0500" MODIFIED_BY="[Empty name]" ORDER="226" O_E="0.0" SE="0.4232427932395292" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.17913446202919886" WEIGHT="21.209736633483793"/>
<DICH_DATA CI_END="6.0558931308155035" CI_START="0.4586900260249003" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7821782025047912" LOG_CI_START="-0.3384807032720784" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2015-09-20 13:11:54 -0400" MODIFIED_BY="[Empty name]" ORDER="178" O_E="0.0" SE="0.6582805886043833" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.43333333333333335" WEIGHT="5.530768643659648"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.4985049562498487" CI_END="0.9738488256641779" CI_START="0.40396591528235665" DF="2" EFFECT_SIZE="0.6272174520898456" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="40" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="-0.011508455108515848" LOG_CI_START="-0.3936552770410466" LOG_EFFECT_SIZE="-0.20258186607478124" MODIFIED="2017-09-14 12:41:16 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.7793831808787487" P_Z="0.03770809939224618" STUDIES="3" TAU2="0.0" TOTAL_1="145" TOTAL_2="151" WEIGHT="73.25949472285656" Z="2.078013677672761">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="4.487151628279848" CI_START="0.222858526486512" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6519707453103448" LOG_CI_START="-0.6519707453103449" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-25 19:49:01 -0500" MODIFIED_BY="[Empty name]" ORDER="244" O_E="0.0" SE="0.7659416862050704" STUDY_ID="STD-Sinha-1997" TOTAL_1="25" TOTAL_2="25" VAR="0.5866666666666666" WEIGHT="5.530768643659648"/>
<DICH_DATA CI_END="8.54735161477676" CI_START="0.016238102545216286" EFFECT_SIZE="0.37254901960784315" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.931831570019317" LOG_CI_START="-1.789464720309532" LOG_EFFECT_SIZE="-0.4288165751451074" MODIFIED="2010-03-02 03:53:56 -0500" MODIFIED_BY="[Empty name]" ORDER="373" O_E="0.0" SE="1.5985029115730547" STUDY_ID="STD-Nafday-2005" TOTAL_1="16" TOTAL_2="18" VAR="2.5552115583075334" WEIGHT="2.6117518595059455">
<FOOTNOTE>Events occuring during intervention period</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.965328703086588" CI_START="0.38013617514264497" EFFECT_SIZE="0.6057692307692307" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="36" LOG_CI_END="-0.015324780304464056" LOG_CI_START="-0.42006079938593327" LOG_EFFECT_SIZE="-0.2176927898451987" MODIFIED="2010-03-02 03:53:21 -0500" MODIFIED_BY="[Empty name]" ORDER="374" O_E="0.0" SE="0.23774394108406108" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="104" TOTAL_2="108" VAR="0.05652218152218151" WEIGHT="65.11697421969096"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3987266227484858" CI_START="0.07205200181574557" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.31746031746031744" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.14573284112984652" LOG_CI_START="-1.1423539487090475" LOG_EFFECT_SIZE="-0.49831055378960054" METHOD="MH" MODIFIED="2017-09-14 14:56:40 -0400" MODIFIED_BY="Anne Lawson" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.12940123655786065" Q="0.0" RANDOM="NO" SCALE="14.61" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="39" WEIGHT="100.0" Z="1.516467285043708">
<NAME>Addition of neuromuscular paralysis where previously not paralysed</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-03-02 03:18:19 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-23 20:57:53 -0500" MODIFIED_BY="[Empty name]" ORDER="222" O_E="0.0" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3987266227484858" CI_START="0.07205200181574557" DF="0" EFFECT_SIZE="0.31746031746031744" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.14573284112984652" LOG_CI_START="-1.1423539487090475" LOG_EFFECT_SIZE="-0.49831055378960054" MODIFIED="2017-09-14 12:41:36 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="1.0" P_Z="0.12940123655786065" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="30" WEIGHT="100.0" Z="1.516467285043708">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.3987266227484858" CI_START="0.07205200181574557" EFFECT_SIZE="0.31746031746031744" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.14573284112984652" LOG_CI_START="-1.1423539487090475" LOG_EFFECT_SIZE="-0.49831055378960054" MODIFIED="2010-02-25 19:49:58 -0500" MODIFIED_BY="[Empty name]" ORDER="245" O_E="0.0" SE="0.756628556483809" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="27" TOTAL_2="30" VAR="0.5724867724867725" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="18.433838603876428" CI_END="-0.8616461682592675" CI_START="-1.8317694120193744" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.346707790139321" ESTIMABLE="YES" I2="40.32713296249201" I2_Q="11.168658256735672" ID="CMP-001.05" MODIFIED="2017-09-14 12:42:00 -0400" MODIFIED_BY="Anne Lawson" NO="5" NOTES="&lt;p&gt;This data from paper - was absent from RevMan file?why&lt;/p&gt;" NOTES_MODIFIED="2017-09-14 12:42:00 -0400" NOTES_MODIFIED_BY="Anne Lawson" P_CHI2="0.07204479889377846" P_Q="0.2886882684222055" P_Z="5.2811811885016624E-8" Q="1.1257288028927306" RANDOM="NO" SCALE="29.5" SORT_BY="YEAR" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="384" TOTAL_2="352" UNITS="" WEIGHT="100.00000000000001" Z="5.4415741161754765">
<NAME>Duration of positive pressure ventilation (days, survivors)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="6.230740017568708" CI_END="-0.6429333985646053" CI_START="-3.5123207329441684" DF="4" EFFECT_SIZE="-2.077627065754387" ESTIMABLE="YES" I2="35.80216814180546" ID="CMP-001.05.01" MODIFIED="2017-09-14 12:41:54 -0400" MODIFIED_BY="Anne Lawson" NO="1" NOTES="&lt;p&gt;&lt;span modified=&quot;2014-06-17 21:39:00 +1000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;&lt;a link_type=&quot;STUDY&quot; href=&quot;Chowdhury 2013&quot; protected=&quot;true&quot;&gt;Chowdhury 2013&lt;/a&gt; data cannot be integrated (median r&lt;/span&gt;&lt;span modified=&quot;2014-06-17 21:40:00 +1000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;ange&lt;/span&gt;&lt;span modified=&quot;2014-06-17 21:39:00 +1000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;)&lt;/span&gt;&lt;/p&gt;" NOTES_MODIFIED="2017-09-14 12:41:54 -0400" NOTES_MODIFIED_BY="Anne Lawson" P_CHI2="0.18256661752191206" P_Z="0.0045356197976904634" STUDIES="5" TAU2="0.0" TOTAL_1="123" TOTAL_2="106" WEIGHT="11.430769477874103" Z="2.838288280842864">
<NAME>Strict studies</NAME>
<CONT_DATA CI_END="-0.8821544244998791" CI_START="-5.717845575500119" EFFECT_SIZE="-3.299999999999999" ESTIMABLE="YES" MEAN_1="8.4" MEAN_2="11.7" MODIFIED="2010-02-23 21:48:18 -0500" MODIFIED_BY="[Empty name]" ORDER="303" SD_1="4.1" SD_2="3.8" SE="1.2336173493858953" STUDY_ID="STD-Lista-2004" TOTAL_1="25" TOTAL_2="17" WEIGHT="4.024729619807946">
<FOOTNOTE>In survivors</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="2.617122688855856" CI_START="-24.817122688855854" EFFECT_SIZE="-11.1" ESTIMABLE="YES" MEAN_1="4.5" MEAN_2="15.6" MODIFIED="2010-03-02 03:17:17 -0500" MODIFIED_BY="[Empty name]" ORDER="304" SD_1="7.3" SD_2="18.4" SE="6.99866058614075" STUDY_ID="STD-Keszler-2004a" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.12504541809741412">
<FOOTNOTE>In survivors</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="4.145647537833996" CI_START="-6.745647537833994" EFFECT_SIZE="-1.299999999999999" ESTIMABLE="YES" MEAN_1="8.4" MEAN_2="9.7" MODIFIED="2010-03-02 03:17:17 -0500" MODIFIED_BY="[Empty name]" ORDER="301" SD_1="12.6" SD_2="14.0" SE="2.7784426554715127" STUDY_ID="STD-Singh-2006" TOTAL_1="52" TOTAL_2="42" WEIGHT="0.7934047049595597">
<FOOTNOTE>In survivors</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.8378330670511716" CI_START="-25.03783306705117" EFFECT_SIZE="-12.1" ESTIMABLE="YES" MEAN_1="7.9" MEAN_2="20.0" MODIFIED="2017-05-01 12:35:09 -0400" MODIFIED_BY="[Empty name]" ORDER="246" SD_1="15.3" SD_2="24.1" SE="6.601056534254275" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="18" TOTAL_2="19" WEIGHT="0.14056291098434642"/>
<CONT_DATA CI_END="0.9253591254542182" CI_START="-2.925359125454218" EFFECT_SIZE="-0.9999999999999998" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="2.8" MODIFIED="2017-04-23 03:58:38 -0400" MODIFIED_BY="[Empty name]" ORDER="243" SD_1="2.9" SD_2="3.3" SE="0.982344135219425" STUDY_ID="STD-Bhat-2016" TOTAL_1="20" TOTAL_2="20" WEIGHT="6.3470268240248355"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="11.07736978341499" CI_END="-0.7369620144771256" CI_START="-1.7677882765755173" DF="6" EFFECT_SIZE="-1.2523751455263215" ESTIMABLE="YES" I2="45.83551766067082" ID="CMP-001.05.02" MODIFIED="2017-09-14 12:42:00 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.08601456106389804" P_Z="1.9129170507722782E-6" STUDIES="7" TAU2="0.0" TOTAL_1="261" TOTAL_2="246" WEIGHT="88.5692305221259" Z="4.762412970286565">
<NAME>Hybrid studies</NAME>
<CONT_DATA CI_END="0.28010607807606025" CI_START="-12.88010607807606" EFFECT_SIZE="-6.3" ESTIMABLE="YES" MEAN_1="6.7" MEAN_2="13.0" MODIFIED="2010-03-02 03:17:17 -0500" MODIFIED_BY="[Empty name]" ORDER="246" SD_1="4.9" SD_2="15.0" SE="3.357258669026113" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="23" TOTAL_2="22" WEIGHT="0.5434105168489181">
<FOOTNOTE>In survivors</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.8369848864515173" CI_START="-4.036984886451519" EFFECT_SIZE="-1.6000000000000005" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="6.7" MODIFIED="2010-03-05 18:35:15 -0500" MODIFIED_BY="[Empty name]" ORDER="247" SD_1="2.7" SD_2="5.6" SE="1.2433824833895641" STUDY_ID="STD-Sinha-1997" TOTAL_1="25" TOTAL_2="25" WEIGHT="3.9617599516067052">
<FOOTNOTE>In all patients</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="10.284497359248487" CI_START="-3.084497359248484" EFFECT_SIZE="3.6000000000000014" ESTIMABLE="YES" MEAN_1="27.6" MEAN_2="24.0" MODIFIED="2017-05-01 12:39:08 -0400" MODIFIED_BY="[Empty name]" ORDER="375" SD_1="23.8" SD_2="22.4" SE="3.41052050546589" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="90" TOTAL_2="94" WEIGHT="0.5265702478102091">
<FOOTNOTE>In survivors</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="-0.917570222454178" CI_START="-2.482429777545822" EFFECT_SIZE="-1.7000000000000002" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="6.5" MODIFIED="2014-06-25 00:10:29 -0400" MODIFIED_BY="[Empty name]" ORDER="194" SD_1="1.1" SD_2="1.9" SE="0.3992062016024419" STUDY_ID="STD-Liu-2011" TOTAL_1="31" TOTAL_2="30" WEIGHT="38.432894023487535"/>
<CONT_DATA CI_END="1.41751249353245" CI_START="-7.15751249353245" EFFECT_SIZE="-2.87" ESTIMABLE="YES" MEAN_1="4.06" MEAN_2="6.93" MODIFIED="2015-09-20 12:56:59 -0400" MODIFIED_BY="[Empty name]" ORDER="197" SD_1="5.1" SD_2="7.23" SE="2.187546570932834" STUDY_ID="STD-Duman-2012" TOTAL_1="20" TOTAL_2="15" WEIGHT="1.2799206089372512"/>
<CONT_DATA CI_END="-0.4473246734206149" CI_START="-7.372675326579385" EFFECT_SIZE="-3.9099999999999997" ESTIMABLE="YES" MEAN_1="3.02" MEAN_2="6.93" MODIFIED="2015-09-20 13:01:25 -0400" MODIFIED_BY="[Empty name]" ORDER="198" SD_1="6.76" SD_2="7.81" SE="1.7667035485817728" STUDY_ID="STD-Guven-2013" TOTAL_1="42" TOTAL_2="30" WEIGHT="1.9623220520904345"/>
<CONT_DATA CI_END="0.11969583169159859" CI_START="-1.3796958316915984" EFFECT_SIZE="-0.6299999999999999" ESTIMABLE="YES" MEAN_1="1.05" MEAN_2="1.68" MODIFIED="2015-09-20 12:54:55 -0400" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="1.02" SD_2="1.83" SE="0.382504901929374" STUDY_ID="STD-Erdemir-2014" TOTAL_1="30" TOTAL_2="30" WEIGHT="41.862353121344846"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.333737884133438" CI_END="-0.00151362940416927" CI_START="-0.1648191581451954" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.08316639377468234" ESTIMABLE="YES" I2="52.00233009949137" I2_Q="69.10097052439953" ID="CMP-001.06" MODIFIED="2017-09-14 12:42:07 -0400" MODIFIED_BY="Anne Lawson" NO="6" P_CHI2="0.08009027361621446" P_Q="0.07202108223112047" P_Z="0.04590164708562432" Q="3.2363476036995067" RANDOM="NO" SCALE="1.2" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="198" TOTAL_2="183" UNITS="" WEIGHT="100.0" Z="1.9962966077033177">
<NAME>Duration of positive pressure ventilation (log data, survivors)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.496881066040187" CI_END="-0.03763589368853863" CI_START="-0.2430166867659922" DF="2" EFFECT_SIZE="-0.14032629022726542" ESTIMABLE="YES" I2="19.90006944256229" ID="CMP-001.06.01" MODIFIED="2017-05-15 10:41:37 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2869520322320286" P_Z="0.007399952114732428" STUDIES="3" TAU2="0.0" TOTAL_1="85" TOTAL_2="67" WEIGHT="63.22402244642751" Z="2.6782881768874436">
<NAME>Strict studies</NAME>
<CONT_DATA CI_END="0.3017248309467057" CI_START="-1.1097248309467056" EFFECT_SIZE="-0.40399999999999997" ESTIMABLE="YES" MEAN_1="0.294" MEAN_2="0.698" MODIFIED="2010-02-23 21:48:15 -0500" MODIFIED_BY="[Empty name]" ORDER="298" SD_1="0.567" SD_2="0.846" SE="0.3600703056348857" STUDY_ID="STD-Keszler-2004a" TOTAL_1="8" TOTAL_2="8" WEIGHT="1.3386621625134127"/>
<CONT_DATA CI_END="-0.05182187184772152" CI_START="-0.2741781281522783" EFFECT_SIZE="-0.16299999999999992" ESTIMABLE="YES" MEAN_1="0.88" MEAN_2="1.043" MODIFIED="2010-02-23 21:48:15 -0500" MODIFIED_BY="[Empty name]" ORDER="297" SD_1="0.208" SD_2="0.159" SE="0.056724577098986144" STUDY_ID="STD-Lista-2004" TOTAL_1="25" TOTAL_2="17" WEIGHT="53.93902219893273"/>
<CONT_DATA CI_END="0.34765923085382955" CI_START="-0.23165923085382956" EFFECT_SIZE="0.057999999999999996" ESTIMABLE="YES" MEAN_1="0.486" MEAN_2="0.428" MODIFIED="2010-02-23 21:48:15 -0500" MODIFIED_BY="[Empty name]" ORDER="294" SD_1="0.66" SD_2="0.752" SE="0.14778803750406874" STUDY_ID="STD-Singh-2006" TOTAL_1="52" TOTAL_2="42" WEIGHT="7.946338084981363"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.600509214393744" CI_END="0.14974552589398343" CI_START="-0.1195435743686814" DF="1" EFFECT_SIZE="0.015100975762651018" ESTIMABLE="YES" I2="61.545992820751074" ID="CMP-001.06.02" MODIFIED="2010-03-02 03:55:54 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1068294311804131" P_Z="0.8260124789515515" STUDIES="2" TAU2="0.0" TOTAL_1="113" TOTAL_2="116" WEIGHT="36.77597755357249" Z="0.21981854146594845">
<NAME>Hybrid studies</NAME>
<CONT_DATA CI_END="0.2458578379047675" CI_START="-0.07385783790476735" EFFECT_SIZE="0.08600000000000008" ESTIMABLE="YES" MEAN_1="1.212" MEAN_2="1.126" MODIFIED="2010-03-02 03:55:54 -0500" MODIFIED_BY="[Empty name]" ORDER="376" SD_1="0.555" SD_2="0.551" SE="0.08156162009389237" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="90" TOTAL_2="94" WEIGHT="26.089990160445684"/>
<CONT_DATA CI_END="0.09178339474742131" CI_START="-0.40778339474742137" EFFECT_SIZE="-0.15800000000000003" ESTIMABLE="YES" MEAN_1="0.702" MEAN_2="0.86" MODIFIED="2010-02-25 20:13:39 -0500" MODIFIED_BY="[Empty name]" ORDER="248" SD_1="0.367" SD_2="0.478" SE="0.12744284931645727" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="23" TOTAL_2="22" WEIGHT="10.685987393126801"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.1718212697260455" CI_END="0.24338543889240993" CI_START="-2.076175402048469" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.9163949815780295" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2017-09-14 12:42:32 -0400" MODIFIED_BY="Anne Lawson" NO="7" P_CHI2="0.7597881092344255" P_Q="0.40622773039004845" P_Z="0.1214643839354419" Q="0.6898149264354705" RANDOM="NO" SCALE="19.06" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="161" TOTAL_2="163" UNITS="" WEIGHT="100.0" Z="1.5486562178534065">
<NAME>Inspired oxygen concentration % (study definition)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.486374724628022" CI_END="0.24372984551764176" CI_START="-3.0928956742638367" DF="2" EFFECT_SIZE="-1.4245829143730975" ESTIMABLE="YES" I2="19.561601869999176" ID="CMP-001.07.01" MODIFIED="2017-09-14 12:42:23 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.28846340228383927" P_Z="0.0942041732279832" STUDIES="3" TAU2="0.0" TOTAL_1="81" TOTAL_2="75" WEIGHT="48.32775292748791" Z="1.6736257566867982">
<NAME>Parallel studies</NAME>
<CONT_DATA CI_END="4.837914021853617" CI_START="-13.437914021853612" EFFECT_SIZE="-4.299999999999997" ESTIMABLE="YES" MEAN_1="31.6" MEAN_2="35.9" MODIFIED="2017-04-23 05:14:45 -0400" MODIFIED_BY="[Empty name]" ORDER="238" SD_1="12.9" SD_2="16.2" SE="4.6622867021702" STUDY_ID="STD-Cheema-2007" TOTAL_1="21" TOTAL_2="19" WEIGHT="1.6108585641473825"/>
<CONT_DATA CI_END="-0.07270883385812188" CI_START="-3.9272911661418783" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="22.0" MEAN_2="24.0" MODIFIED="2014-06-24 21:42:16 -0400" MODIFIED_BY="[Empty name]" ORDER="191" SD_1="2.0" SD_2="6.0" SE="0.9833298883775952" STUDY_ID="STD-Singh-2006" TOTAL_1="45" TOTAL_2="41" WEIGHT="36.21236454935016"/>
<CONT_DATA CI_END="4.578388287434315" CI_START="-2.578388287434315" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="35.0" MEAN_2="34.0" MODIFIED="2014-06-24 21:29:53 -0400" MODIFIED_BY="[Empty name]" ORDER="190" SD_1="5.0" SD_2="5.0" SE="1.8257418583505538" STUDY_ID="STD-Zhou-2007" TOTAL_1="15" TOTAL_2="15" WEIGHT="10.504529813990358"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.9956316186625527" CI_END="1.172319154991147" CI_START="-2.054518336895281" DF="4" EFFECT_SIZE="-0.4410995909520671" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.02" MODIFIED="2017-09-14 12:42:32 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.9104577140711321" P_Z="0.5920669902397413" STUDIES="4" TAU2="0.0" TOTAL_1="80" TOTAL_2="88" WEIGHT="51.672247072512086" Z="0.5358431058491184">
<NAME>Cross-over studies</NAME>
<CONT_DATA CI_END="1.8866639247014758" CI_START="-1.8866639247014758" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="23.0" MEAN_2="23.0" MODIFIED="2017-04-29 14:35:35 -0400" MODIFIED_BY="[Empty name]" ORDER="229" SD_1="2.3" SD_2="2.4" SE="0.9626013230769749" STUDY_ID="STD-Herrera-2002" TOTAL_1="9" TOTAL_2="17" WEIGHT="37.78874377608155">
<FOOTNOTE>SIMV-VG 4.5 mL/kg v SIMV</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="4.9049180988772925" CI_START="-10.904918098877292" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="35.0" MEAN_2="38.0" MODIFIED="2014-06-24 21:50:10 -0400" MODIFIED_BY="[Empty name]" ORDER="185" SD_1="10.0" SD_2="12.0" SE="4.033195589934446" STUDY_ID="STD-Hummler-2006" TOTAL_1="15" TOTAL_2="15" WEIGHT="2.15256758483409"/>
<CONT_DATA CI_END="3.4051729795836128" CI_START="-7.405172979583613" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="42.0" MEAN_2="44.0" MODIFIED="2017-04-23 03:55:30 -0400" MODIFIED_BY="[Empty name]" ORDER="790" SD_1="9.3" SD_2="9.8" SE="2.757791991189087" STUDY_ID="STD-Jain-2016" TOTAL_1="24" TOTAL_2="24" WEIGHT="4.603968581160513"/>
<CONT_DATA CI_END="3.6587812072388433" CI_START="-5.658781207238843" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="40.0" MEAN_2="41.0" MODIFIED="2014-06-24 21:50:05 -0400" MODIFIED_BY="[Empty name]" ORDER="184" SD_1="7.0" SD_2="8.0" SE="2.3769728648009427" STUDY_ID="STD-Polimeni-2006" TOTAL_1="20" TOTAL_2="20" WEIGHT="6.197362722118204">
<FOOTNOTE>SIMV-VG 6.0 mL/kg v SIMV</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="11.028921352840081" CI_START="-13.028921352840081" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="32.0" MEAN_2="33.0" MODIFIED="2014-06-24 21:50:07 -0400" MODIFIED_BY="[Empty name]" ORDER="183" SD_1="16.0" SD_2="14.0" SE="6.137317546507322" STUDY_ID="STD-Polimeni-2006" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.9296044083177308">
<FOOTNOTE>SIMV-VG 4.5 mL/kg v SIMV</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.9937996833562646" CI_END="1.2320839834656419" CI_START="0.5153415436390861" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7968337730870713" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.09064031197823127" LOG_CI_START="-0.2879048460000747" LOG_EFFECT_SIZE="-0.0986322670109217" METHOD="MH" MODIFIED="2017-09-14 12:42:41 -0400" MODIFIED_BY="Anne Lawson" NO="8" P_CHI2="0.608413977816918" P_Q="1.0" P_Z="0.30708329838346426" Q="0.0" RANDOM="NO" SCALE="63.85" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="50" WEIGHT="100.0" Z="1.0213613196765463">
<NAME>Any pH &lt; 7.25</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.583089049830795" CI_START="0.054548361875977475" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6611582957074548" LOG_CI_START="-1.2632182870354172" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2010-03-01 22:52:35 -0500" MODIFIED_BY="[Empty name]" ORDER="220" O_E="0.0" SE="1.130388330520878" STUDY_ID="STD-Keszler-2004a" TOTAL_1="9" TOTAL_2="9" VAR="1.2777777777777777" WEIGHT="10.554089709762533"/>
<DICH_DATA CI_END="22.467812126325306" CI_START="0.21748564414389093" EFFECT_SIZE="2.210526315789474" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3515607836907813" LOG_CI_START="-0.6625694048006384" LOG_EFFECT_SIZE="0.34449568944507153" MODIFIED="2017-04-23 17:26:34 -0400" MODIFIED_BY="[Empty name]" ORDER="239" O_E="0.0" SE="1.183110042825089" STUDY_ID="STD-Cheema-2007" TOTAL_1="19" TOTAL_2="21" VAR="1.399749373433584" WEIGHT="5.013192612137202"/>
<DICH_DATA CI_END="1.141018344143682" CI_START="0.4929806807112714" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.05729262662359172" LOG_CI_START="-0.30717009984019156" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2017-04-10 17:25:58 -0400" MODIFIED_BY="[Empty name]" ORDER="237" O_E="0.0" SE="0.21408720964441877" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.04583333333333331" WEIGHT="84.43271767810026"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.274595676066576" CI_END="0.7153452497832631" CI_START="0.3341637362221511" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.48891966759002764" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="36" I2="12.072285151857422" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-0.14548430241310947" LOG_CI_START="-0.47604068195052374" LOG_EFFECT_SIZE="-0.3107624921818166" METHOD="MH" MODIFIED="2017-09-14 15:04:02 -0400" MODIFIED_BY="Anne Lawson" NO="9" P_CHI2="0.3206847497163494" P_Q="1.0" P_Z="2.2852253439737793E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="50" WEIGHT="100.0" Z="3.68520065033766">
<NAME>Hypocarbia partial pressure of carbon dioxide (pCO<SUB>2</SUB>) &lt; 35 mmHg/4.7 kPa</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.101887691864369" CI_START="0.42485640576422135" EFFECT_SIZE="0.6842105263157895" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.04213733200293524" LOG_CI_START="-0.37175782929491963" LOG_EFFECT_SIZE="-0.16481024864599217" MODIFIED="2010-03-01 22:52:51 -0500" MODIFIED_BY="[Empty name]" ORDER="234" O_E="0.0" SE="0.24312406656045116" STUDY_ID="STD-Keszler-2004a" TOTAL_1="9" TOTAL_2="9" VAR="0.05910931174089068" WEIGHT="26.31578947368421"/>
<DICH_DATA CI_END="1.3392327753079343" CI_START="0.12827376843696736" EFFECT_SIZE="0.4144736842105263" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.12685606935378432" LOG_CI_START="-0.891862146336166" LOG_EFFECT_SIZE="-0.3825030384911908" MODIFIED="2017-04-23 17:27:25 -0400" MODIFIED_BY="[Empty name]" ORDER="240" O_E="0.0" SE="0.5984001226327726" STUDY_ID="STD-Cheema-2007" TOTAL_1="19" TOTAL_2="21" VAR="0.3580827067669173" WEIGHT="21.052631578947366"/>
<DICH_DATA CI_END="0.7269456463636504" CI_START="0.24387699334383356" EFFECT_SIZE="0.42105263157894735" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.13849806007191892" LOG_CI_START="-0.6128291678498519" LOG_EFFECT_SIZE="-0.3756636139608854" MODIFIED="2014-06-17 07:34:31 -0400" MODIFIED_BY="[Empty name]" ORDER="180" O_E="0.0" SE="0.278624440685609" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.07763157894736843" WEIGHT="52.63157894736842"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9661642738109901" CI_END="1.7047606873203496" CI_START="0.5116572571326929" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9339449541284404" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.23166342176204718" LOG_CI_START="-0.2910208616418146" LOG_EFFECT_SIZE="-0.029678719939883694" METHOD="MH" MODIFIED="2017-09-14 12:43:27 -0400" MODIFIED_BY="Anne Lawson" NO="10" P_CHI2="0.37415621487041617" P_Q="1.0" P_Z="0.8238633322150192" Q="0.0" RANDOM="NO" SCALE="597.58" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="50" WEIGHT="100.0" Z="0.2225788072700754">
<NAME>Respiratory acidosis; pH &lt; 7.25 and pCO<SUB>2</SUB> &gt; 8 kPa</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.2400905220167475" CI_START="0.01534664667150609" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8597439961649092" LOG_CI_START="-1.8139865056042341" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2010-03-01 22:53:02 -0500" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="1.5705625319186327" STUDY_ID="STD-Keszler-2004a" TOTAL_1="9" TOTAL_2="9" VAR="2.4666666666666663" WEIGHT="11.559633027522935"/>
<DICH_DATA CI_END="107.78261587640142" CI_START="0.28065750449672583" EFFECT_SIZE="5.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0325487196840215" LOG_CI_START="-0.5518233406955336" LOG_EFFECT_SIZE="0.7403626894942439" MODIFIED="2017-04-23 17:27:58 -0400" MODIFIED_BY="[Empty name]" ORDER="241" O_E="0.0" SE="1.5180729411149698" STUDY_ID="STD-Cheema-2007" TOTAL_1="19" TOTAL_2="21" VAR="2.3045454545454547" WEIGHT="3.6697247706422016"/>
<DICH_DATA CI_END="1.5301313618884815" CI_START="0.4374928220392194" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.18472871663091092" LOG_CI_START="-0.3590290680687112" LOG_EFFECT_SIZE="-0.08715017571890014" MODIFIED="2017-04-10 17:27:49 -0400" MODIFIED_BY="[Empty name]" ORDER="238" O_E="0.0" SE="0.3194060143770026" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.102020202020202" WEIGHT="84.77064220183486"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.3287404203598936E-4" CI_END="1.1229159857792521" CI_START="0.42047119382749487" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6871345029239766" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.05034726447394636" LOG_CI_START="-0.3762637520427439" LOG_EFFECT_SIZE="-0.16295824378439877" METHOD="MH" MODIFIED="2017-09-14 12:43:39 -0400" MODIFIED_BY="Anne Lawson" NO="11" P_CHI2="0.9834007106182275" P_Q="1.0" P_Z="0.1343030816118178" Q="0.0" RANDOM="NO" SCALE="5.25" SORT_BY="YEAR" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="28" TOTAL_2="30" WEIGHT="99.99999999999999" Z="1.4973466527385104">
<NAME>Incidence of hypocarbia or respiratory acidosis</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.101887691864369" CI_START="0.42485640576422135" EFFECT_SIZE="0.6842105263157895" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.04213733200293524" LOG_CI_START="-0.37175782929491963" LOG_EFFECT_SIZE="-0.16481024864599217" MODIFIED="2010-03-01 22:53:22 -0500" MODIFIED_BY="[Empty name]" ORDER="168" O_E="0.0" SE="0.24312406656045116" STUDY_ID="STD-Keszler-2004a" TOTAL_1="9" TOTAL_2="9" VAR="0.05910931174089068" WEIGHT="55.55555555555555"/>
<DICH_DATA CI_END="1.7493677608789264" CI_START="0.2727786047189736" EFFECT_SIZE="0.6907894736842105" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.24288111864448353" LOG_CI_START="-0.5641896963941525" LOG_EFFECT_SIZE="-0.1606542888748345" MODIFIED="2017-05-15 11:14:37 -0400" MODIFIED_BY="[Empty name]" ORDER="242" O_E="0.0" SE="0.47407739181866076" STUDY_ID="STD-Cheema-2007" TOTAL_1="19" TOTAL_2="21" VAR="0.22474937343358398" WEIGHT="44.444444444444436"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.320142606245028" CI_END="1.1218040403618865" CI_START="0.8020055431330566" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9485215119749748" ESTIMABLE="YES" EVENTS_1="145" EVENTS_2="143" I2="0.0" I2_Q="35.1849381217514" ID="CMP-001.12" LOG_CI_END="0.049916999859370856" LOG_CI_START="-0.09582263004030082" LOG_EFFECT_SIZE="-0.022952815090464956" METHOD="MH" MODIFIED="2017-09-14 12:45:47 -0400" MODIFIED_BY="Anne Lawson" NO="12" P_CHI2="0.5022333936358" P_Q="0.21419436338222841" P_Z="0.5369992760430577" Q="1.5428512617614143" RANDOM="NO" SCALE="6.49" SORT_BY="YEAR" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="388" TOTAL_2="366" WEIGHT="100.0" Z="0.6173570078651631">
<NAME>Patent ductus arteriosus</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.0502669000537783" CI_END="1.0827970346835898" CI_START="0.6052216258981015" DF="2" EFFECT_SIZE="0.8095258994305526" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="44" I2="34.431967249661376" ID="CMP-001.12.01" LOG_CI_END="0.03454705775388306" LOG_CI_START="-0.2180855620757988" LOG_EFFECT_SIZE="-0.09176925216095785" MODIFIED="2017-09-14 12:43:54 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.21759209867516582" P_Z="0.15446938147833375" STUDIES="3" TAU2="0.0" TOTAL_1="107" TOTAL_2="95" WEIGHT="32.12310212784345" Z="1.4239208637816583">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="1.1021016138114148" CI_START="0.6453226292369892" EFFECT_SIZE="0.8433333333333334" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="20" LOG_CI_END="0.0422216383298421" LOG_CI_START="-0.19022310541753112" LOG_EFFECT_SIZE="-0.0740007335438445" MODIFIED="2010-02-23 18:54:46 -0500" MODIFIED_BY="[Empty name]" ORDER="256" O_E="0.0" SE="0.13653919309724555" STUDY_ID="STD-Lista-2004" TOTAL_1="30" TOTAL_2="23" VAR="0.01864295125164691" WEIGHT="15.367038465388513"/>
<DICH_DATA CI_END="1.8536079345112568" CI_START="0.5767059348735782" EFFECT_SIZE="1.0339181286549708" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="15" LOG_CI_END="0.2680178798168135" LOG_CI_START="-0.23904557924701259" LOG_EFFECT_SIZE="0.01448615028490046" MODIFIED="2010-02-23 18:54:46 -0500" MODIFIED_BY="[Empty name]" ORDER="255" O_E="0.0" SE="0.29785158585869465" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.08871556719853933" WEIGHT="10.647665872463005"/>
<DICH_DATA CI_END="1.0530372514691644" CI_START="0.10551489128812148" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="0.022443734738520807" LOG_CI_START="-0.9766862441778457" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-06-17 07:35:05 -0400" MODIFIED_BY="[Empty name]" ORDER="181" O_E="0.0" SE="0.5868938953886337" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.34444444444444444" WEIGHT="6.108397789991934"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.560352473878463" CI_END="1.245069219271764" CI_START="0.8263061808563613" DF="6" EFFECT_SIZE="1.0143019232350212" ESTIMABLE="YES" EVENTS_1="103" EVENTS_2="99" I2="0.0" ID="CMP-001.12.02" LOG_CI_END="0.09519349658205344" LOG_CI_START="-0.08285899866341333" LOG_EFFECT_SIZE="0.006167248959320059" MODIFIED="2017-09-14 12:45:47 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.7359235748023305" P_Z="0.8919987371429279" STUDIES="7" TAU2="0.0" TOTAL_1="281" TOTAL_2="271" WEIGHT="67.87689787215655" Z="0.13577552875398075">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="5.047278013902699" CI_START="0.24460073287699977" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.7030572271784014" LOG_CI_START="-0.6115422460570511" LOG_EFFECT_SIZE="0.04575749056067514" MODIFIED="2010-02-25 20:14:38 -0500" MODIFIED_BY="[Empty name]" ORDER="249" O_E="0.0" SE="0.7722022379508467" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="27" TOTAL_2="30" VAR="0.5962962962962962" WEIGHT="1.9289677231553475"/>
<DICH_DATA CI_END="2.0787452782845226" CI_START="0.21380418711580704" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.31780127576104245" LOG_CI_START="-0.6699837938724049" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2010-02-25 20:14:41 -0500" MODIFIED_BY="[Empty name]" ORDER="250" O_E="0.0" SE="0.5802298395176404" STUDY_ID="STD-Sinha-1997" TOTAL_1="25" TOTAL_2="25" VAR="0.33666666666666667" WEIGHT="4.072265193327956"/>
<DICH_DATA CI_END="1.46731015011587" CI_START="0.7695331841444923" EFFECT_SIZE="1.0626118067978534" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="43" LOG_CI_END="0.16652192178279468" LOG_CI_START="-0.11377264759325409" LOG_EFFECT_SIZE="0.026374637094770285" MODIFIED="2010-03-02 03:59:12 -0500" MODIFIED_BY="[Empty name]" ORDER="377" O_E="0.0" SE="0.16464641753198647" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="104" TOTAL_2="108" VAR="0.027108442806117225" WEIGHT="28.63391500717393"/>
<DICH_DATA CI_END="2.0648609586292093" CI_START="0.8982612474450554" EFFECT_SIZE="1.361904761904762" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="14" LOG_CI_END="0.3148908129255377" LOG_CI_START="-0.04659733613529018" LOG_EFFECT_SIZE="0.13414673839512375" MODIFIED="2010-02-25 20:14:42 -0500" MODIFIED_BY="[Empty name]" ORDER="251" O_E="0.0" SE="0.21233992815352717" STUDY_ID="STD-Piotrowski-2007" TOTAL_1="30" TOTAL_2="26" VAR="0.04508824508824508" WEIGHT="10.18066298331989"/>
<DICH_DATA CI_END="1.5078480653247903" CI_START="0.6067811860288688" EFFECT_SIZE="0.9565217391304348" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="14" LOG_CI_END="0.17835758310184496" LOG_CI_START="-0.21696789349261827" LOG_EFFECT_SIZE="-0.01930515519538663" MODIFIED="2015-09-20 13:04:47 -0400" MODIFIED_BY="[Empty name]" ORDER="200" O_E="0.0" SE="0.2322161418442572" STUDY_ID="STD-Duman-2012" TOTAL_1="23" TOTAL_2="22" VAR="0.05392433653303218" WEIGHT="9.713106609271124"/>
<DICH_DATA CI_END="2.63223959869194" CI_START="0.19382889076138543" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.42032541824502906" LOG_CI_START="-0.7125814896015051" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2015-09-20 13:05:15 -0400" MODIFIED_BY="[Empty name]" ORDER="199" O_E="0.0" SE="0.6654751256486924" STUDY_ID="STD-Guven-2013" TOTAL_1="42" TOTAL_2="30" VAR="0.44285714285714284" WEIGHT="3.1673173725884105"/>
<DICH_DATA CI_END="1.4086746752385182" CI_START="0.45432775306451406" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="15" LOG_CI_END="0.14881070704680457" LOG_CI_START="-0.3426307330629174" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2014-06-26 02:35:58 -0400" MODIFIED_BY="Kevin Wheeler" ORDER="553" O_E="0.0" SE="0.2886751345948129" STUDY_ID="STD-Erdemir-2014" TOTAL_1="30" TOTAL_2="30" VAR="0.08333333333333334" WEIGHT="10.18066298331989"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9379100084501386" CI_END="1.4294344918886037" CI_START="0.4406300975540021" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7936320681574875" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="22" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.1551642573063279" LOG_CI_START="-0.35592584137682437" LOG_EFFECT_SIZE="-0.10038079203524822" METHOD="MH" MODIFIED="2017-09-14 12:45:55 -0400" MODIFIED_BY="Anne Lawson" NO="13" P_CHI2="0.585393463299869" P_Q="0.5880363515875269" P_Z="0.44136246197781315" Q="0.29342146487028425" RANDOM="NO" SCALE="73.36" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="186" TOTAL_2="188" WEIGHT="99.99999999999999" Z="0.7698945357603623">
<NAME>Air leak (any)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.8110954868240348" CI_START="0.09292980943752158" DF="0" EFFECT_SIZE="0.5111111111111111" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-001.13.01" LOG_CI_END="0.4488755979007356" LOG_CI_START="-1.0318449534162373" LOG_EFFECT_SIZE="-0.29148467775775083" MODIFIED="2010-03-02 03:59:30 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.44032138736396276" STUDIES="2" TAU2="0.0" TOTAL_1="39" TOTAL_2="32" WEIGHT="15.272914022872156" Z="0.7716506263688089">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="2.8110954868240348" CI_START="0.09292980943752158" EFFECT_SIZE="0.5111111111111111" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.4488755979007356" LOG_CI_START="-1.0318449534162373" LOG_EFFECT_SIZE="-0.29148467775775083" MODIFIED="2010-02-25 18:58:58 -0500" MODIFIED_BY="[Empty name]" ORDER="222" O_E="0.0" SE="0.8697825815285305" STUDY_ID="STD-Lista-2004" TOTAL_1="30" TOTAL_2="23" VAR="0.7565217391304347" WEIGHT="15.272914022872156"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-25 18:58:58 -0500" MODIFIED_BY="[Empty name]" ORDER="221" O_E="0.0" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.626361036971006" CI_END="1.5847134082436387" CI_START="0.45010060120091433" DF="2" EFFECT_SIZE="0.8445593275677037" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="19" I2="0.0" ID="CMP-001.13.02" LOG_CI_END="0.1999507325018512" LOG_CI_START="-0.346690406972507" LOG_EFFECT_SIZE="-0.0733698372353279" MODIFIED="2014-06-25 00:12:33 -0400" MODIFIED_BY="[Empty name]" NO="2" NOTES="&lt;p&gt;Need to define 'air leak any'&lt;/p&gt;" NOTES_MODIFIED="2014-06-25 00:12:33 -0400" NOTES_MODIFIED_BY="[Empty name]" P_CHI2="0.44344564123938446" P_Z="0.5987976664584118" STUDIES="3" TAU2="0.0" TOTAL_1="147" TOTAL_2="156" WEIGHT="84.72708597712783" Z="0.5261303189550883">
<NAME>Hybrid Studies</NAME>
<DICH_DATA CI_END="1.659702440916843" CI_START="0.13662531549284732" EFFECT_SIZE="0.47619047619047616" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.22003023270783703" LOG_CI_START="-0.8644688221756756" LOG_EFFECT_SIZE="-0.3222192947339193" MODIFIED="2010-02-25 20:15:28 -0500" MODIFIED_BY="[Empty name]" ORDER="252" O_E="0.0" SE="0.6370401131954767" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="27" TOTAL_2="30" VAR="0.4058201058201058" WEIGHT="29.82237422360826"/>
<DICH_DATA CI_END="2.45298393935239" CI_START="0.5231945958314853" EFFECT_SIZE="1.132867132867133" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3896947047194444" LOG_CI_START="-0.28133675056430607" LOG_EFFECT_SIZE="0.054178977077569156" MODIFIED="2010-03-02 03:59:30 -0500" MODIFIED_BY="[Empty name]" ORDER="379" O_E="0.0" SE="0.3941671984929497" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="104" TOTAL_2="108" VAR="0.15536778036778037" WEIGHT="48.53392678379374"/>
<DICH_DATA CI_END="8.54735161477676" CI_START="0.016238102545216286" EFFECT_SIZE="0.37254901960784315" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.931831570019317" LOG_CI_START="-1.789464720309532" LOG_EFFECT_SIZE="-0.4288165751451074" MODIFIED="2010-03-02 04:00:20 -0500" MODIFIED_BY="[Empty name]" ORDER="378" O_E="0.0" SE="1.5985029115730547" STUDY_ID="STD-Nafday-2005" TOTAL_1="16" TOTAL_2="18" VAR="2.5552115583075334" WEIGHT="6.370784969725839">
<FOOTNOTE>Events occuring during intervention period</FOOTNOTE>
</DICH_DATA>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.572440718612591" CI_END="0.8711714703221038" CI_START="0.3105304903062148" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5201204704872795" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="36" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="-0.05989635557156633" LOG_CI_START="-0.5078957509732975" LOG_EFFECT_SIZE="-0.28389605327243195" METHOD="MH" MODIFIED="2017-10-02 18:26:51 -0400" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.8498157667988125" P_Q="0.9740150253992027" P_Z="0.012989823438868418" Q="0.001061006687112112" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="417" TOTAL_2="408" WEIGHT="99.99999999999999" Z="2.484048172735016">
<NAME>Pneumothorax</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.410699991500958" CI_END="1.4443262385873439" CI_START="0.19277041562333405" DF="3" EFFECT_SIZE="0.5276583831497127" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" I2="12.041516185075542" ID="CMP-001.14.01" LOG_CI_END="0.15966530100065648" LOG_CI_START="-0.7149596162703227" LOG_EFFECT_SIZE="-0.2776471576348331" MODIFIED="2014-06-24 21:19:47 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.33253014580358375" P_Z="0.21336350577507512" STUDIES="5" TAU2="0.0" TOTAL_1="131" TOTAL_2="119" WEIGHT="25.967457877354647" Z="1.2443698290054293">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-23 18:51:16 -0500" MODIFIED_BY="[Empty name]" ORDER="221" O_E="0.0" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.040167391222488" CI_START="0.005995662994374245" EFFECT_SIZE="0.11059907834101383" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.309665801789549" LOG_CI_START="-2.222162786063396" LOG_EFFECT_SIZE="-0.9562484921369234" MODIFIED="2010-02-23 18:51:16 -0500" MODIFIED_BY="[Empty name]" ORDER="224" O_E="0.0" SE="1.4872086452584554" STUDY_ID="STD-Lista-2004" TOTAL_1="30" TOTAL_2="23" VAR="2.21178955453149" WEIGHT="10.114919901405884"/>
<DICH_DATA CI_END="2.387596506539914" CI_START="0.08714371089438955" EFFECT_SIZE="0.45614035087719296" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3779609347733525" LOG_CI_START="-1.0597639501766993" LOG_EFFECT_SIZE="-0.34090150770167343" MODIFIED="2010-02-23 18:51:16 -0500" MODIFIED_BY="[Empty name]" ORDER="226" O_E="0.0" SE="0.8445267142726202" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.7132253711201079" WEIGHT="10.725159224084031"/>
<DICH_DATA CI_END="7.584304769707433" CI_START="0.014650137947370117" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87991577648491" LOG_CI_START="-1.8341582859242351" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-06-24 21:19:47 -0400" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="1.5942605391424158" STUDY_ID="STD-Zhou-2007" TOTAL_1="15" TOTAL_2="15" VAR="2.5416666666666665" WEIGHT="3.8455340638985507"/>
<DICH_DATA CI_END="97.99788802329087" CI_START="0.2551075385834674" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.991216716205615" LOG_CI_START="-0.5932767075335774" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2014-06-17 07:35:41 -0400" MODIFIED_BY="[Empty name]" ORDER="182" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="1.2818446879661836"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.170843061244149" CI_END="0.9434204304846895" CI_START="0.28384155291534796" DF="6" EFFECT_SIZE="0.517476492259156" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="28" I2="0.0" ID="CMP-001.14.02" LOG_CI_END="-0.02529472301220753" LOG_CI_START="-0.546924025788892" LOG_EFFECT_SIZE="-0.28610937440054973" MODIFIED="2017-09-14 12:46:01 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.9033346069631892" P_Z="0.03155140304971605" STUDIES="8" TAU2="0.0" TOTAL_1="286" TOTAL_2="289" WEIGHT="74.03254212264534" Z="2.1500481912322065">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.6824260046342328" CI_START="0.0815335776256666" EFFECT_SIZE="0.37037037037037035" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.22593597245873884" LOG_CI_START="-1.0886635007767134" LOG_EFFECT_SIZE="-0.43136376415898736" MODIFIED="2010-02-25 20:16:15 -0500" MODIFIED_BY="[Empty name]" ORDER="253" O_E="0.0" SE="0.7722022379508467" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="27" TOTAL_2="30" VAR="0.5962962962962962" WEIGHT="14.572550136878718"/>
<DICH_DATA CI_END="2.6300131119236196" CI_START="0.00775971920930058" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.41995791366918006" LOG_CI_START="-2.110153993697694" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2010-02-25 20:16:20 -0500" MODIFIED_BY="[Empty name]" ORDER="255" O_E="0.0" SE="1.4862002586432317" STUDY_ID="STD-Sinha-1997" TOTAL_1="25" TOTAL_2="25" VAR="2.208791208791209" WEIGHT="8.972912815763285"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-03-02 04:00:28 -0500" MODIFIED_BY="[Empty name]" ORDER="380" O_E="0.0" SE="0.0" STUDY_ID="STD-Nafday-2005" TOTAL_1="16" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.8767740688038792" CI_START="0.2553796691862155" EFFECT_SIZE="0.6923076923076923" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.27341199421029383" LOG_CI_START="-0.5928136799453176" LOG_EFFECT_SIZE="-0.1597008428675119" MODIFIED="2010-03-02 04:00:29 -0500" MODIFIED_BY="[Empty name]" ORDER="381" O_E="0.0" SE="0.5088252488852474" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="104" TOTAL_2="108" VAR="0.2589031339031339" WEIGHT="22.637860904459394"/>
<DICH_DATA CI_END="2.6406389086017494" CI_START="0.15999915725839203" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4217090181234982" LOG_CI_START="-0.7958823048377871" LOG_EFFECT_SIZE="-0.18708664335714442" MODIFIED="2010-02-25 20:16:17 -0500" MODIFIED_BY="[Empty name]" ORDER="254" O_E="0.0" SE="0.7152191702817127" STUDY_ID="STD-Piotrowski-2007" TOTAL_1="30" TOTAL_2="26" VAR="0.5115384615384615" WEIGHT="10.987240182567287"/>
<DICH_DATA CI_END="5.060418121213466" CI_START="0.04626714785523958" EFFECT_SIZE="0.4838709677419355" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7041864022614691" LOG_CI_START="-1.334727271818652" LOG_EFFECT_SIZE="-0.3152704347785914" MODIFIED="2014-06-25 00:12:54 -0400" MODIFIED_BY="[Empty name]" ORDER="196" O_E="0.0" SE="1.1976679849401242" STUDY_ID="STD-Liu-2011" TOTAL_1="31" TOTAL_2="30" VAR="1.4344086021505376" WEIGHT="5.211434141239566"/>
<DICH_DATA CI_END="6.211054714026899" CI_START="0.14730732211436595" EFFECT_SIZE="0.9565217391304348" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7931653550216421" LOG_CI_START="-0.8317756654124153" LOG_EFFECT_SIZE="-0.01930515519538663" MODIFIED="2015-09-20 13:13:25 -0400" MODIFIED_BY="[Empty name]" ORDER="204" O_E="0.0" SE="0.9544983989907418" STUDY_ID="STD-Duman-2012" TOTAL_1="23" TOTAL_2="22" VAR="0.9110671936758894" WEIGHT="5.241320501906173"/>
<DICH_DATA CI_END="3.9981665126016623" CI_START="0.010004585820506876" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6018608773254143" LOG_CI_START="-1.9998008859974516" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2014-06-26 02:36:40 -0400" MODIFIED_BY="Kevin Wheeler" ORDER="554" O_E="0.0" SE="1.5282289982092807" STUDY_ID="STD-Erdemir-2014" TOTAL_1="30" TOTAL_2="30" VAR="2.335483870967742" WEIGHT="6.409223439830917"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1012900501139367" CI_END="2.3040098353052425" CI_START="0.63187251063395" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2065821477046796" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.36248432866162483" LOG_CI_START="-0.19937053803634777" LOG_EFFECT_SIZE="0.08155689531263857" METHOD="MH" MODIFIED="2017-09-14 12:46:09 -0400" MODIFIED_BY="Anne Lawson" NO="15" P_CHI2="0.8940674790444508" P_Q="0.6136104650184016" P_Z="0.56935404600959" Q="0.2549508180437446" RANDOM="NO" SCALE="87.06" SORT_BY="YEAR" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="216" TOTAL_2="214" WEIGHT="100.0" Z="0.569003089509955">
<NAME>Pulmonary interstitial emphysema</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.0403878281558" CI_START="0.11661360153566529" DF="0" EFFECT_SIZE="0.7666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-001.15.01" LOG_CI_END="0.7024639541336034" LOG_CI_START="-0.9332507915377425" LOG_EFFECT_SIZE="-0.11539341870206953" MODIFIED="2010-03-02 04:00:53 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7821364715192507" STUDIES="2" TAU2="0.0" TOTAL_1="39" TOTAL_2="32" WEIGHT="15.204839000348525" Z="0.27653592450336617">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="5.0403878281558" CI_START="0.11661360153566529" EFFECT_SIZE="0.7666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7024639541336034" LOG_CI_START="-0.9332507915377425" LOG_EFFECT_SIZE="-0.11539341870206953" MODIFIED="2010-02-23 18:51:46 -0500" MODIFIED_BY="[Empty name]" ORDER="232" O_E="0.0" SE="0.9608269385259249" STUDY_ID="STD-Lista-2004" TOTAL_1="30" TOTAL_2="23" VAR="0.9231884057971015" WEIGHT="15.204839000348525"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-23 18:51:46 -0500" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8387425091595859" CI_END="2.566788858367464" CI_START="0.6437689820527465" DF="3" EFFECT_SIZE="1.2854645271245542" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" I2="0.0" ID="CMP-001.15.02" LOG_CI_END="0.40939014548590075" LOG_CI_START="-0.19126995223545284" LOG_EFFECT_SIZE="0.10906009662522395" MODIFIED="2017-09-14 12:46:09 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.8401797080241384" P_Z="0.4766320829253923" STUDIES="4" TAU2="0.0" TOTAL_1="177" TOTAL_2="182" WEIGHT="84.79516099965147" Z="0.7117298530293177">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="16.911066483262303" CI_START="0.07300355080837032" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.228170996905305" LOG_CI_START="-1.1366560157839547" LOG_EFFECT_SIZE="0.04575749056067514" MODIFIED="2010-02-25 20:17:04 -0500" MODIFIED_BY="[Empty name]" ORDER="257" O_E="0.0" SE="1.3891110933361772" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="27" TOTAL_2="30" VAR="1.9296296296296296" WEIGHT="6.362024739619514"/>
<DICH_DATA CI_END="4.914374669793243" CI_START="0.5617622270724724" EFFECT_SIZE="1.6615384615384616" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.6914682638292159" LOG_CI_START="-0.2504474661410276" LOG_EFFECT_SIZE="0.22051039884409415" MODIFIED="2010-03-02 04:00:53 -0500" MODIFIED_BY="[Empty name]" ORDER="383" O_E="0.0" SE="0.5532859623425812" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="104" TOTAL_2="108" VAR="0.30612535612535613" WEIGHT="32.94381783408847"/>
<DICH_DATA CI_END="8.54735161477676" CI_START="0.016238102545216286" EFFECT_SIZE="0.37254901960784315" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.931831570019317" LOG_CI_START="-1.789464720309532" LOG_EFFECT_SIZE="-0.4288165751451074" MODIFIED="2010-03-02 04:01:06 -0500" MODIFIED_BY="[Empty name]" ORDER="382" O_E="0.0" SE="1.5985029115730547" STUDY_ID="STD-Nafday-2005" TOTAL_1="16" TOTAL_2="18" VAR="2.5552115583075334" WEIGHT="9.513583291190292">
<FOOTNOTE>Events occuring during intervention period</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="3.3662521537547194" CI_START="0.4373343738185834" EFFECT_SIZE="1.2133333333333334" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5271466442846959" LOG_CI_START="-0.3591863864259088" LOG_EFFECT_SIZE="0.08398012892939356" MODIFIED="2010-02-25 20:17:02 -0500" MODIFIED_BY="[Empty name]" ORDER="256" O_E="0.0" SE="0.5206364096586706" STUDY_ID="STD-Piotrowski-2007" TOTAL_1="30" TOTAL_2="26" VAR="0.2710622710622711" WEIGHT="35.9757351347532"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.266284360380036" CI_END="1.1502254755081731" CI_START="0.7019314146324515" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8985429289520541" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="86" I2="39.51333172174918" I2_Q="28.036527330579762" ID="CMP-001.16" LOG_CI_END="0.0607829822411007" LOG_CI_START="-0.15370532049386693" LOG_EFFECT_SIZE="-0.04646116912638309" METHOD="MH" MODIFIED="2017-09-14 12:46:49 -0400" MODIFIED_BY="Anne Lawson" NO="16" P_CHI2="0.1421581252706352" P_Q="0.23847390261591084" P_Z="0.39581938529137817" Q="1.3895938632557605" RANDOM="NO" SCALE="152.59" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="253" TOTAL_2="248" WEIGHT="99.99999999999999" Z="0.8491112755911554">
<NAME>Any intraventricular haemorrhage (IVH)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6372199879800329" CI_END="1.6724285015818385" CI_START="0.7372771734787877" DF="1" EFFECT_SIZE="1.1104248549504023" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="23" I2="0.0" ID="CMP-001.16.01" LOG_CI_END="0.22334756020236873" LOG_CI_START="-0.13236921189327303" LOG_EFFECT_SIZE="0.045489174154547826" MODIFIED="2017-09-14 12:46:43 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.42471951580508416" P_Z="0.616172928303993" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="60" WEIGHT="28.079093194647424" Z="0.5012816376586948">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="7.140168426766256" CI_START="0.015561413186640009" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8537084563073322" LOG_CI_START="-1.8079509657466573" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2010-02-23 18:53:23 -0500" MODIFIED_BY="[Empty name]" ORDER="242" O_E="0.0" SE="1.563471919941143" STUDY_ID="STD-Keszler-2004a" TOTAL_1="8" TOTAL_2="8" VAR="2.444444444444444" WEIGHT="1.7184846480721894"/>
<DICH_DATA CI_END="1.7547345307351085" CI_START="0.7682742095993482" EFFECT_SIZE="1.161084529505582" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="22" LOG_CI_END="0.2442114224784697" LOG_CI_START="-0.11448374551382831" LOG_EFFECT_SIZE="0.06486383848232072" MODIFIED="2017-04-30 19:58:21 -0400" MODIFIED_BY="[Empty name]" ORDER="240" O_E="0.0" SE="0.21069931724839341" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.04439420228893913" WEIGHT="26.360608546575236"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.357619664749921" CI_END="1.1104143406558495" CI_START="0.599383051957445" DF="3" EFFECT_SIZE="0.8158207747046021" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="63" I2="52.8125279869505" ID="CMP-001.16.02" LOG_CI_END="0.045485061925157735" LOG_CI_START="-0.22229554124593118" LOG_EFFECT_SIZE="-0.0884052396603867" MODIFIED="2017-09-14 12:46:49 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.0954500788766568" P_Z="0.1956214755896681" STUDIES="4" TAU2="0.0" TOTAL_1="188" TOTAL_2="188" WEIGHT="71.92090680535256" Z="1.2941272349609618">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.2367930912144782" CI_START="0.48470076812028384" EFFECT_SIZE="0.7742574257425743" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="30" LOG_CI_END="0.09229705059122166" LOG_CI_START="-0.3145262920368108" LOG_EFFECT_SIZE="-0.11111462072279456" MODIFIED="2010-03-02 04:03:01 -0500" MODIFIED_BY="[Empty name]" ORDER="384" O_E="0.0" SE="0.23897004526773055" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="101" TOTAL_2="102" VAR="0.057106682535261195" WEIGHT="34.2003841291214"/>
<DICH_DATA CI_END="1.9002975439776397" CI_START="0.29600627637637933" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.2788216070530783" LOG_CI_START="-0.5286990802696782" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2014-06-26 02:34:46 -0400" MODIFIED_BY="Kevin Wheeler" ORDER="552" O_E="0.0" SE="0.4743416490252569" STUDY_ID="STD-Erdemir-2014" TOTAL_1="30" TOTAL_2="30" VAR="0.22499999999999998" WEIGHT="9.16525145638501"/>
<DICH_DATA CI_END="0.9804743478777104" CI_START="0.2014645917306221" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.008563764281657118" LOG_CI_START="-0.6958012719410679" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2010-03-01 22:26:32 -0500" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="0.4036867138796656" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="27" TOTAL_2="30" VAR="0.16296296296296298" WEIGHT="16.280380876473373"/>
<DICH_DATA CI_END="2.6267016489395285" CI_START="0.8264018534375561" EFFECT_SIZE="1.4733333333333334" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="10" LOG_CI_END="0.4194107467192206" LOG_CI_START="-0.08280871746036163" LOG_EFFECT_SIZE="0.16830101462942948" MODIFIED="2017-05-09 11:47:27 -0400" MODIFIED_BY="[Empty name]" ORDER="259" O_E="0.0" SE="0.2950061992855284" STUDY_ID="STD-Piotrowski-2007" TOTAL_1="30" TOTAL_2="26" VAR="0.08702865761689291" WEIGHT="12.27489034337278"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.053858530214429" CI_END="0.9806997282507093" CI_START="0.21056878585269956" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.45442793825184674" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="-0.008463945041799682" LOG_CI_START="-0.6766060070187299" LOG_EFFECT_SIZE="-0.34253497603026484" METHOD="MH" MODIFIED="2017-09-14 12:47:09 -0400" MODIFIED_BY="Anne Lawson" NO="17" P_CHI2="0.8416436687398183" P_Q="0.7029731298872046" P_Z="0.044471298813366596" Q="0.14539756274810345" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="267" TOTAL_2="241" WEIGHT="100.0" Z="2.0096211709173626">
<NAME>Periventricular leukomalacia (PVL)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.4547686911053648" CI_END="1.6545277775588434" CI_START="0.17296700712293575" DF="2" EFFECT_SIZE="0.5349567439392792" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-001.17.01" LOG_CI_END="0.2186740628462851" LOG_CI_START="-0.7620367291887351" LOG_EFFECT_SIZE="-0.27168133317122506" MODIFIED="2017-05-15 15:04:57 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.483171229251512" P_Z="0.27751539993851215" STUDIES="4" TAU2="0.0" TOTAL_1="115" TOTAL_2="103" WEIGHT="42.04692293569991" Z="1.085917749885256">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="69.5152908317231" CI_START="0.12946791838627933" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.84208034406391" LOG_CI_START="-0.8878378346245852" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2014-06-17 07:36:53 -0400" MODIFIED_BY="[Empty name]" ORDER="184" O_E="0.0" SE="1.6035674514745464" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="2.5714285714285716" WEIGHT="2.6300667388453327"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-05-15 15:04:57 -0400" MODIFIED_BY="[Empty name]" ORDER="219" O_E="0.0" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.9722667916829613" CI_START="0.03699259192562627" EFFECT_SIZE="0.38333333333333336" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5990384095777865" LOG_CI_START="-1.431885238309888" LOG_EFFECT_SIZE="-0.41642341436605074" MODIFIED="2010-02-25 18:59:04 -0500" MODIFIED_BY="[Empty name]" ORDER="227" O_E="0.0" SE="1.1929746040034135" STUDY_ID="STD-Lista-2004" TOTAL_1="30" TOTAL_2="23" VAR="1.4231884057971014" WEIGHT="11.909736175903394"/>
<DICH_DATA CI_END="1.8005099458924463" CI_START="0.0739573657511528" EFFECT_SIZE="0.3649122807017544" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.25539552472661925" LOG_CI_START="-1.131018566146079" LOG_EFFECT_SIZE="-0.43781152070972984" MODIFIED="2010-02-25 18:59:04 -0500" MODIFIED_BY="[Empty name]" ORDER="229" O_E="0.0" SE="0.8143864998390554" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.6632253711201078" WEIGHT="27.507120020951188"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5568380444401602" CI_END="1.1384721177681962" CI_START="0.13774358801372466" DF="2" EFFECT_SIZE="0.396001558525942" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" I2="0.0" ID="CMP-001.17.02" LOG_CI_END="0.05632239880913629" LOG_CI_START="-0.8609286084839473" LOG_EFFECT_SIZE="-0.40230310483740545" MODIFIED="2017-09-14 12:47:09 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.7569795839701083" P_Z="0.08556580457237686" STUDIES="3" TAU2="0.0" TOTAL_1="152" TOTAL_2="138" WEIGHT="57.95307706430009" Z="1.7192667875654062">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="2.628204886891794" CI_START="0.09294781553899312" EFFECT_SIZE="0.4942528735632184" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4196592184897508" LOG_CI_START="-1.0317608125678148" LOG_EFFECT_SIZE="-0.306050797039032" MODIFIED="2010-03-02 04:03:34 -0500" MODIFIED_BY="[Empty name]" ORDER="386" O_E="0.0" SE="0.8525713108882403" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="87" TOTAL_2="86" VAR="0.7268778401496926" WEIGHT="21.162155494061867"/>
<DICH_DATA CI_END="2.353656634664371" CI_START="0.09718217007039986" EFFECT_SIZE="0.4782608695652174" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3717431056835472" LOG_CI_START="-1.0124134074022828" LOG_EFFECT_SIZE="-0.3203351508593678" MODIFIED="2015-09-20 13:16:03 -0400" MODIFIED_BY="[Empty name]" ORDER="207" O_E="0.0" SE="0.8130603874718589" STUDY_ID="STD-Duman-2012" TOTAL_1="23" TOTAL_2="22" VAR="0.6610671936758894" WEIGHT="21.50810133100183"/>
<DICH_DATA CI_END="2.899070430341076" CI_START="0.007171131750051145" EFFECT_SIZE="0.14418604651162792" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.462258766281847" LOG_CI_START="-2.144412298444512" LOG_EFFECT_SIZE="-0.8410767660813326" MODIFIED="2015-09-20 13:16:32 -0400" MODIFIED_BY="[Empty name]" ORDER="208" O_E="0.0" SE="1.5311714866501343" STUDY_ID="STD-Guven-2013" TOTAL_1="42" TOTAL_2="30" VAR="2.3444861215303825" WEIGHT="15.282820239236392"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="16.767803913002936" CI_END="-0.039440060421885505" CI_START="-0.13792779708452554" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RD" EFFECT_SIZE="-0.08868392875320552" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="63" I2="46.32570820427613" I2_Q="0.10869057380176193" ID="CMP-001.18" LOG_CI_END="NaN" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" METHOD="MH" MODIFIED="2017-09-14 12:47:33 -0400" MODIFIED_BY="Anne Lawson" NO="18" P_CHI2="0.052478801667668606" P_Q="0.3170476210076477" P_Z="4.1599203250075297E-4" Q="1.0010880883875295" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="369" TOTAL_2="343" WEIGHT="100.00000000000003" Z="3.5297248622778876">
<NAME>IVH grade 3-4</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.1059516239075133" CI_END="0.02116845943974316" CI_START="-0.1291702475488178" DF="3" EFFECT_SIZE="-0.05400089405453733" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="11" I2="0.0" ID="CMP-001.18.01" LOG_CI_END="-1.6743107471371164" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" MODIFIED="2017-09-14 12:47:27 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.5507097034633668" P_Z="0.15912572151905785" STUDIES="4" TAU2="0.0" TOTAL_1="115" TOTAL_2="103" WEIGHT="30.612461364176802" Z="1.4080180626790875">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="0.022215473397647595" CI_START="-0.32221547339764756" EFFECT_SIZE="-0.15" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-17 07:36:19 -0400" MODIFIED_BY="[Empty name]" ORDER="183" O_E="0.0" SE="0.08786665201812954" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.007720548536875068" WEIGHT="5.646854502230328"/>
<DICH_DATA CI_END="0.16079207124162875" CI_START="-0.41079207124162875" EFFECT_SIZE="-0.125" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-23 18:53:57 -0500" MODIFIED_BY="[Empty name]" ORDER="246" O_E="0.0" SE="0.14581496062984836" STUDY_ID="STD-Keszler-2004a" TOTAL_1="8" TOTAL_2="8" VAR="0.021262002743484224" WEIGHT="2.258741800892131"/>
<DICH_DATA CI_END="0.07823497161004808" CI_START="-0.1854813484216423" EFFECT_SIZE="-0.0536231884057971" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-23 18:53:57 -0500" MODIFIED_BY="[Empty name]" ORDER="245" O_E="0.0" SE="0.06727580764540855" STUDY_ID="STD-Lista-2004" TOTAL_1="30" TOTAL_2="23" VAR="0.0045260342943420125" WEIGHT="7.351565295356464"/>
<DICH_DATA CI_END="0.10025519977188027" CI_START="-0.11712429558834453" EFFECT_SIZE="-0.008434547908232129" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-28 02:06:09 -0500" MODIFIED_BY="[Empty name]" ORDER="248" O_E="0.0" SE="0.05545497189613853" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.003075253908001514" WEIGHT="15.35529976569788"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.534577303483983" CI_END="-0.04124116860344282" CI_START="-0.16672967844775757" DF="5" EFFECT_SIZE="-0.1039854235256002" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="52" I2="65.59927478041288" ID="CMP-001.18.02" LOG_CI_END="NaN" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" MODIFIED="2017-09-14 12:47:33 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.01254764571662803" P_Z="0.001161259213756522" STUDIES="6" TAU2="0.0" TOTAL_1="254" TOTAL_2="240" WEIGHT="69.38753863582322" Z="3.2482286271495466">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="0.043313381873246556" CI_START="-0.12019165793614696" EFFECT_SIZE="-0.0384391380314502" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-03-02 04:03:11 -0500" MODIFIED_BY="[Empty name]" ORDER="385" O_E="0.0" SE="0.04171123579287691" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="101" TOTAL_2="102" VAR="0.0017398271913689756" WEIGHT="28.657091173387602"/>
<DICH_DATA CI_END="0.050631472030560815" CI_START="-0.42612554317680584" EFFECT_SIZE="-0.18774703557312253" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-09-20 13:14:44 -0400" MODIFIED_BY="[Empty name]" ORDER="205" O_E="0.0" SE="0.12162392242101518" STUDY_ID="STD-Duman-2012" TOTAL_1="23" TOTAL_2="22" VAR="0.014792378505073119" WEIGHT="6.34957417361899"/>
<DICH_DATA CI_END="-0.13979182495102696" CI_START="-0.5363986512394493" EFFECT_SIZE="-0.3380952380952381" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-09-20 13:15:14 -0400" MODIFIED_BY="[Empty name]" ORDER="206" O_E="0.0" SE="0.10117706994026582" STUDY_ID="STD-Guven-2013" TOTAL_1="42" TOTAL_2="30" VAR="0.010236799481697442" WEIGHT="9.881995378903072"/>
<DICH_DATA CI_END="0.07438422335512387" CI_START="-0.14320142765619914" EFFECT_SIZE="-0.034408602150537634" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-03-03 23:20:36 -0500" MODIFIED_BY="[Empty name]" ORDER="213" O_E="0.0" SE="0.05550756358984422" STUDY_ID="STD-Liu-2011" TOTAL_1="31" TOTAL_2="30" VAR="0.0030810896156805998" WEIGHT="8.609138831269188"/>
<DICH_DATA CI_END="-0.04630041854701156" CI_START="-0.4648106925640995" EFFECT_SIZE="-0.25555555555555554" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-28 02:06:01 -0500" MODIFIED_BY="[Empty name]" ORDER="261" O_E="0.0" SE="0.1067647868323713" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="27" TOTAL_2="30" VAR="0.011398719707361683" WEIGHT="8.024477450537834"/>
<DICH_DATA CI_END="0.339932458220807" CI_START="-0.1450606633490121" EFFECT_SIZE="0.09743589743589742" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2017-05-11 14:13:10 -0400" MODIFIED_BY="[Empty name]" ORDER="263" O_E="0.0" SE="0.12372500857040815" STUDY_ID="STD-Piotrowski-2007" TOTAL_1="30" TOTAL_2="26" VAR="0.015307877745747569" WEIGHT="7.865261628106528"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.38094331825906025" CI_END="1.1790229340020038" CI_START="0.5782053226340275" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8256617563794185" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="45" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="0.07152225294381434" LOG_CI_START="-0.237917914775448" LOG_EFFECT_SIZE="-0.08319783091581681" METHOD="MH" MODIFIED="2017-09-14 12:47:53 -0400" MODIFIED_BY="Anne Lawson" NO="19" P_CHI2="0.8265692394338915" P_Q="0.9522000221908423" P_Z="0.29191316449226956" Q="0.0035933215017766302" RANDOM="NO" SCALE="310.38" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="152" TOTAL_2="146" WEIGHT="100.0" Z="1.0539339697798606">
<NAME>Any IVH or PVL</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.3711717162448779" CI_END="1.3461528201549593" CI_START="0.5174479469256692" DF="1" EFFECT_SIZE="0.8346041055718474" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="22" I2="0.0" ID="CMP-001.19.01" LOG_CI_END="0.12909436537284497" LOG_CI_START="-0.2861333318613095" LOG_EFFECT_SIZE="-0.07851948324423226" MODIFIED="2017-09-14 12:47:41 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.5423665558174509" P_Z="0.45853722359307436" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="60" WEIGHT="50.3544864342574" Z="0.7412576775031802">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="7.140168426766256" CI_START="0.015561413186640009" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8537084563073322" LOG_CI_START="-1.8079509657466573" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2010-02-25 20:19:18 -0500" MODIFIED_BY="[Empty name]" ORDER="267" O_E="0.0" SE="1.563471919941143" STUDY_ID="STD-Keszler-2004a" TOTAL_1="8" TOTAL_2="8" VAR="2.444444444444444" WEIGHT="3.2191431210170425"/>
<DICH_DATA CI_END="1.408971446044227" CI_START="0.5357672784717964" EFFECT_SIZE="0.8688387635756056" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="21" LOG_CI_END="0.14890219186657128" LOG_CI_START="-0.271023814081832" LOG_EFFECT_SIZE="-0.061060811107630335" MODIFIED="2010-02-28 14:06:01 -0500" MODIFIED_BY="[Empty name]" ORDER="265" O_E="0.0" SE="0.2466666145613459" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.06084441873915558" WEIGHT="47.13534331324036"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.638705525737866E-31" CI_END="1.3866522112706066" CI_START="0.48088627116686805" DF="0" EFFECT_SIZE="0.8165917041479261" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="23" I2="100.0" ID="CMP-001.19.02" LOG_CI_END="0.14196754855265842" LOG_CI_START="-0.31795762143228773" LOG_EFFECT_SIZE="-0.08799503643981467" MODIFIED="2017-09-14 12:47:53 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.0" P_Z="0.4532673777247458" STUDIES="1" TAU2="0.0" TOTAL_1="87" TOTAL_2="86" WEIGHT="49.64551356574259" Z="0.7499789683003062">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.3866522112706063" CI_START="0.480886271166868" EFFECT_SIZE="0.816591704147926" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="23" LOG_CI_END="0.14196754855265833" LOG_CI_START="-0.3179576214322878" LOG_EFFECT_SIZE="-0.08799503643981473" MODIFIED="2010-03-02 04:03:58 -0500" MODIFIED_BY="[Empty name]" ORDER="387" O_E="0.0" SE="0.2701623215154664" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="87" TOTAL_2="86" VAR="0.07298767996662622" WEIGHT="49.64551356574259"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.154722105800028" CI_END="0.8009780801641304" CI_START="0.2744525471079896" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.46886082612936764" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="35" I2="0.0" I2_Q="0.0" ID="CMP-001.20" LOG_CI_END="-0.09637936880217977" LOG_CI_START="-0.5615327343128215" LOG_EFFECT_SIZE="-0.3289560515575006" METHOD="MH" MODIFIED="2017-09-14 12:48:03 -0400" MODIFIED_BY="Anne Lawson" NO="20" P_CHI2="0.8273486073514869" P_Q="0.743132099597212" P_Z="0.0055684012951026955" Q="0.10739287098785852" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="227" TOTAL_2="214" WEIGHT="100.0" Z="2.7721696169666954">
<NAME>IVH grade 3-4 or PVL</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.587809753935497" CI_END="1.0329303210784062" CI_START="0.25061184700151756" DF="3" EFFECT_SIZE="0.508787357929941" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="18" I2="0.0" ID="CMP-001.20.01" LOG_CI_END="0.014071026077411444" LOG_CI_START="-0.6009984027521873" LOG_EFFECT_SIZE="-0.293463688337388" MODIFIED="2017-04-10 17:39:29 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8992172987122218" P_Z="0.06144393705529181" STUDIES="4" TAU2="0.0" TOTAL_1="115" TOTAL_2="103" WEIGHT="52.58748053121531" Z="1.8702872649875015">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="2.938902847851195" CI_START="0.03780700379134716" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.46818522971347326" LOG_CI_START="-1.4224277391527982" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2017-04-10 17:39:29 -0400" MODIFIED_BY="[Empty name]" ORDER="239" O_E="0.0" SE="1.1105554165971787" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="1.2333333333333332" WEIGHT="8.095771542786395"/>
<DICH_DATA CI_END="7.140168426766256" CI_START="0.015561413186640009" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8537084563073322" LOG_CI_START="-1.8079509657466573" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2010-02-25 18:59:08 -0500" MODIFIED_BY="[Empty name]" ORDER="232" O_E="0.0" SE="1.563471919941143" STUDY_ID="STD-Keszler-2004a" TOTAL_1="8" TOTAL_2="8" VAR="2.444444444444444" WEIGHT="4.047885771393197"/>
<DICH_DATA CI_END="1.9141278130076758" CI_START="0.07676835551203351" EFFECT_SIZE="0.38333333333333336" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.2819709337703232" LOG_CI_START="-1.1148177625024247" LOG_EFFECT_SIZE="-0.41642341436605074" MODIFIED="2010-02-28 14:09:26 -0500" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="0.8204805944061697" STUDY_ID="STD-Lista-2004" TOTAL_1="30" TOTAL_2="23" VAR="0.6731884057971015" WEIGHT="12.220032517413427"/>
<DICH_DATA CI_END="1.554678655054301" CI_START="0.26230853384589564" EFFECT_SIZE="0.6385964912280702" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.19164063596173417" LOG_CI_START="-0.581187580008605" LOG_EFFECT_SIZE="-0.19477347202343542" MODIFIED="2010-02-25 18:59:08 -0500" MODIFIED_BY="[Empty name]" ORDER="231" O_E="0.0" SE="0.4539631196223442" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.2060825139772508" WEIGHT="28.223790699622295"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.5899357212570844" CI_END="0.9623689483175704" CI_START="0.18731394934125628" DF="1" EFFECT_SIZE="0.4245764105938476" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="17" I2="37.104375564985176" ID="CMP-001.20.02" LOG_CI_END="-0.01665839833642929" LOG_CI_START="-0.7274298793447153" LOG_EFFECT_SIZE="-0.3720441388405723" MODIFIED="2017-04-30 19:52:34 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2073353664147516" P_Z="0.04018564261337521" STUDIES="2" TAU2="0.0" TOTAL_1="112" TOTAL_2="111" WEIGHT="47.41251946878468" Z="2.0518355963081767">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.394677557135425" CI_START="0.2384065443619464" EFFECT_SIZE="0.5766283524904214" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="12" LOG_CI_END="0.14447381238144427" LOG_CI_START="-0.6226818271982819" LOG_EFFECT_SIZE="-0.2391040074084188" MODIFIED="2010-03-02 04:04:05 -0500" MODIFIED_BY="[Empty name]" ORDER="388" O_E="0.0" SE="0.45063102017079204" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="87" TOTAL_2="86" VAR="0.20306831634016878" WEIGHT="32.57027164034295"/>
<DICH_DATA CI_END="1.5615372845499014" CI_START="0.005292517118667142" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19355235826264292" LOG_CI_START="-2.276337728579093" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2017-04-30 19:52:34 -0400" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="1.4508256631639465" STUDY_ID="STD-Sinha-1997" TOTAL_1="25" TOTAL_2="25" VAR="2.104895104895105" WEIGHT="14.842247828441725"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.081445315939083" CI_END="0.8685984298768253" CI_START="0.5322332127938157" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6799242111890167" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="102" I2="20.64629872711061" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="-0.06118096002611181" LOG_CI_START="-0.2738980277872213" LOG_EFFECT_SIZE="-0.16753949390666656" METHOD="MH" MODIFIED="2017-09-14 12:48:25 -0400" MODIFIED_BY="Anne Lawson" NO="21" P_CHI2="0.2593561018287446" P_Q="0.5216055351115749" P_Z="0.0020191546135528106" Q="0.41071756962835015" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="325" TOTAL_2="295" WEIGHT="100.0" Z="3.087400343576658">
<NAME>BPD (supplemental oxygen in survivors at 36 weeks only)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.2720265103117123" CI_END="1.0711380478664596" CI_START="0.5213773551856372" DF="3" EFFECT_SIZE="0.7473065786110284" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="40" I2="0.0" ID="CMP-001.21.01" LOG_CI_END="0.02984544614753114" LOG_CI_START="-0.28284783533011437" LOG_EFFECT_SIZE="-0.12650119459129158" MODIFIED="2017-09-14 12:48:19 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.7357862325729669" P_Z="0.11277992163851353" STUDIES="4" TAU2="0.0" TOTAL_1="115" TOTAL_2="103" WEIGHT="39.029485611527406" Z="1.5858209951207394">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="1.281706218654799" CI_START="0.4816602508361394" EFFECT_SIZE="0.7857142857142857" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="14" LOG_CI_END="0.10778849145562114" LOG_CI_START="-0.3172591924956471" LOG_EFFECT_SIZE="-0.104735350520013" MODIFIED="2017-04-10 17:45:42 -0400" MODIFIED_BY="[Empty name]" ORDER="241" O_E="0.0" SE="0.2496751135729437" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.06233766233766233" WEIGHT="13.227733910873475"/>
<DICH_DATA CI_END="1.489578328637641" CI_START="0.10741294829815026" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.1730633452823052" LOG_CI_START="-0.9689433626263804" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2010-02-25 18:59:17 -0500" MODIFIED_BY="[Empty name]" ORDER="235" O_E="0.0" SE="0.6708203932499369" STUDY_ID="STD-Keszler-2004a" TOTAL_1="8" TOTAL_2="8" VAR="0.44999999999999996" WEIGHT="4.724190682454813"/>
<DICH_DATA CI_END="2.3199086424580555" CI_START="0.14251638790814056" EFFECT_SIZE="0.575" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.3654708827971262" LOG_CI_START="-0.8461351934178653" LOG_EFFECT_SIZE="-0.24033215531036956" MODIFIED="2010-02-25 18:59:17 -0500" MODIFIED_BY="[Empty name]" ORDER="234" O_E="0.0" SE="0.7117034067154904" STUDY_ID="STD-Lista-2004" TOTAL_1="30" TOTAL_2="23" VAR="0.5065217391304347" WEIGHT="4.27851231618549"/>
<DICH_DATA CI_END="1.5181193695014223" CI_START="0.48561621211439454" EFFECT_SIZE="0.8586171310629515" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="17" LOG_CI_END="0.1813059214129375" LOG_CI_START="-0.31370682293302027" LOG_EFFECT_SIZE="-0.06620045076004141" MODIFIED="2010-02-25 18:59:17 -0500" MODIFIED_BY="[Empty name]" ORDER="238" O_E="0.0" SE="0.2907729363814189" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.08454890053187267" WEIGHT="16.799048702013625"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.747454082626415" CI_END="0.8871513193795266" CI_START="0.45708305613206884" DF="4" EFFECT_SIZE="0.6367902608501413" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="62" I2="54.27240929512826" ID="CMP-001.21.02" LOG_CI_END="-0.052002297229603214" LOG_CI_START="-0.3400048775177869" LOG_EFFECT_SIZE="-0.19600358737369508" MODIFIED="2017-09-14 12:48:25 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.06773144760499206" P_Z="0.0076360217745166685" STUDIES="5" TAU2="0.0" TOTAL_1="210" TOTAL_2="192" WEIGHT="60.9705143884726" Z="2.6677536826836104">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.2746633657517594" CI_START="0.5465650093191216" EFFECT_SIZE="0.8346774193548387" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="32" LOG_CI_END="0.10539550422096985" LOG_CI_START="-0.2623581749595669" LOG_EFFECT_SIZE="-0.0784813353692985" MODIFIED="2010-03-02 04:04:16 -0500" MODIFIED_BY="[Empty name]" ORDER="389" O_E="0.0" SE="0.21602033156071843" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="93" TOTAL_2="92" VAR="0.046664783647602716" WEIGHT="30.398251829157882"/>
<DICH_DATA CI_END="1.2619539271465314" CI_START="0.11143433763701216" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.10104349947920775" LOG_CI_START="-0.95298096402377" LOG_EFFECT_SIZE="-0.42596873227228116" MODIFIED="2015-09-20 13:17:59 -0400" MODIFIED_BY="[Empty name]" ORDER="209" O_E="0.0" SE="0.6191391873668903" STUDY_ID="STD-Duman-2012" TOTAL_1="20" TOTAL_2="15" VAR="0.38333333333333336" WEIGHT="6.478890078795171"/>
<DICH_DATA CI_END="2.1662990840010576" CI_START="0.4616167764577755" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.33571841607710695" LOG_CI_START="-0.3357184160771069" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-26 03:47:40 -0400" MODIFIED_BY="Kevin Wheeler" ORDER="555" O_E="0.0" SE="0.39440531887330776" STUDY_ID="STD-Erdemir-2014" TOTAL_1="30" TOTAL_2="30" VAR="0.15555555555555556" WEIGHT="8.503543228418662"/>
<DICH_DATA CI_END="0.6826539676873069" CI_START="0.036907810520545" EFFECT_SIZE="0.15873015873015872" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.16579938124588642" LOG_CI_START="-1.4328817176612771" LOG_EFFECT_SIZE="-0.7993405494535817" MODIFIED="2015-09-20 13:18:29 -0400" MODIFIED_BY="[Empty name]" ORDER="210" O_E="0.0" SE="0.7442904365691219" STUDY_ID="STD-Guven-2013" TOTAL_1="42" TOTAL_2="30" VAR="0.553968253968254" WEIGHT="9.920800433155106"/>
<DICH_DATA CI_END="1.2857880100985914" CI_START="0.021603699489815463" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10916937167255707" LOG_CI_START="-1.6654718724398443" LOG_EFFECT_SIZE="-0.7781512503836436" MODIFIED="2010-02-25 20:24:55 -0500" MODIFIED_BY="[Empty name]" ORDER="271" O_E="0.0" SE="1.0424330514074593" STUDY_ID="STD-Sinha-1997" TOTAL_1="25" TOTAL_2="25" VAR="1.0866666666666667" WEIGHT="5.669028818945775"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2017-09-14 15:12:15 -0400" MODIFIED_BY="Anne Lawson" NO="2">
<NAME>Volume-targeted ventilation (VTV) versus pressure-limited ventilation (PLV) - infants weighing less than 1000 g</NAME>
<DICH_OUTCOME CHI2="3.6454391755316036" CI_END="1.2134992376552813" CI_START="0.41947195106178065" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7134626078718102" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="26" I2="0.0" I2_Q="15.8209971258871" ID="CMP-002.01" LOG_CI_END="0.08403950783547838" LOG_CI_START="-0.3772970739445885" LOG_EFFECT_SIZE="-0.14662878305455507" METHOD="MH" MODIFIED="2017-09-14 12:49:29 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.4561112113655985" P_Q="0.275744586673498" P_Z="0.21280509729246355" Q="1.1879446962509987" RANDOM="NO" SCALE="91.43" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="124" TOTAL_2="122" WEIGHT="100.0" Z="1.2458892064227025">
<NAME>Death in hospital</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.4412125139122676" CI_END="1.391196940418789" CI_START="0.45628760468557505" DF="3" EFFECT_SIZE="0.7967345352057923" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="22" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.14338861387627047" LOG_CI_START="-0.3407613289257276" LOG_EFFECT_SIZE="-0.09868635752472855" MODIFIED="2017-09-14 12:49:14 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.486009260069061" P_Z="0.42428130657486063" STUDIES="4" TAU2="0.0" TOTAL_1="114" TOTAL_2="112" WEIGHT="84.76922126336169" Z="0.7990157156458229">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="2.1896936604408523" CI_START="0.07928557051042376" EFFECT_SIZE="0.4166666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.3403833610108973" LOG_CI_START="-1.1008058444341093" LOG_EFFECT_SIZE="-0.38021124171160603" MODIFIED="2010-02-23 20:59:16 -0500" MODIFIED_BY="[Empty name]" ORDER="237" O_E="0.0" SE="0.8465616732800195" STUDY_ID="STD-Lista-2004" TOTAL_1="12" TOTAL_2="5" VAR="0.7166666666666666" WEIGHT="10.751137931744692"/>
<DICH_DATA CI_END="17.89378654152825" CI_START="0.22354128293174408" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2527022522545526" LOG_CI_START="-0.6506422609265902" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2010-02-23 20:59:16 -0500" MODIFIED_BY="[Empty name]" ORDER="238" O_E="0.0" SE="1.118033988749895" STUDY_ID="STD-Keszler-2004a" TOTAL_1="2" TOTAL_2="4" VAR="1.25" WEIGHT="2.538463122773052"/>
<DICH_DATA CI_END="2.2503375336507045" CI_START="0.48272420739427796" EFFECT_SIZE="1.0422535211267605" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.35224766389260065" LOG_CI_START="-0.3163009218687988" LOG_EFFECT_SIZE="0.01797337101190088" MODIFIED="2010-02-23 20:59:16 -0500" MODIFIED_BY="[Empty name]" ORDER="241" O_E="0.0" SE="0.3927087486451184" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="71" TOTAL_2="74" VAR="0.15422016126241478" WEIGHT="41.01806273556731"/>
<DICH_DATA CI_END="1.478624718668164" CI_START="0.1690760318312422" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.16985796216952734" LOG_CI_START="-0.7719179534974896" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2010-02-23 20:59:16 -0500" MODIFIED_BY="[Empty name]" ORDER="239" O_E="0.0" SE="0.553203834728774" STUDY_ID="STD-Singh-2006" TOTAL_1="29" TOTAL_2="29" VAR="0.30603448275862066" WEIGHT="30.461557473276624"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.862782027825117" CI_START="0.03355196639564513" DF="0" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.27016203919518383" LOG_CI_START="-1.4742820218511086" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2017-09-14 12:49:29 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="1.0" P_Z="0.1760924462313082" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="15.230778736638312" Z="1.3528847681450413">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.8627820278251161" CI_START="0.03355196639564513" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2701620391951836" LOG_CI_START="-1.4742820218511086" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2010-02-25 20:40:04 -0500" MODIFIED_BY="[Empty name]" ORDER="272" O_E="0.0" SE="1.0246950765959597" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="10" TOTAL_2="10" VAR="1.0499999999999998" WEIGHT="15.230778736638312"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9439377132562609" CI_END="1.0106793570478914" CI_START="0.6198059933210119" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7914702286404145" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="67" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.004613395401241873" LOG_CI_START="-0.20774422859099315" LOG_EFFECT_SIZE="-0.10156541659487564" METHOD="MH" MODIFIED="2017-09-14 12:50:06 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.8148137431746698" P_Q="0.7489598919348137" P_Z="0.06081956678058905" Q="0.10240714857831706" RANDOM="NO" SCALE="5.19" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="114" TOTAL_2="110" WEIGHT="100.0" Z="1.8748049150148896">
<NAME>Death or bronchopulmonary dysplasia (BPD) (36 weeks)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.028862070415278" CI_END="1.0961511515043492" CI_START="0.5172961619787286" DF="2" EFFECT_SIZE="0.7530171204041537" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="26" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="0.03987044442035938" LOG_CI_START="-0.2862607437785126" LOG_EFFECT_SIZE="-0.12319514967907663" MODIFIED="2017-09-14 12:50:00 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.5978407252559685" P_Z="0.13867536598266836" STUDIES="3" TAU2="0.0" TOTAL_1="43" TOTAL_2="38" WEIGHT="39.153816065614336" Z="1.4807418926997706">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="1.7938216794284925" CI_START="0.5574690123706152" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.2537792684241523" LOG_CI_START="-0.2537792684241523" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-23 20:59:19 -0500" MODIFIED_BY="[Empty name]" ORDER="244" O_E="0.0" SE="0.29814239699997197" STUDY_ID="STD-Keszler-2004a" TOTAL_1="2" TOTAL_2="4" VAR="0.0888888888888889" WEIGHT="5.043952167868926"/>
<DICH_DATA CI_END="3.1790701235361594" CI_START="0.21844263179448098" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.5023001076344724" LOG_CI_START="-0.6606625997297221" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2010-02-23 20:59:19 -0500" MODIFIED_BY="[Empty name]" ORDER="245" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Lista-2004" TOTAL_1="12" TOTAL_2="5" VAR="0.4666666666666666" WEIGHT="4.21977697704067"/>
<DICH_DATA CI_END="1.096640238548036" CI_START="0.4468192783521836" EFFECT_SIZE="0.7" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="20" LOG_CI_END="0.040064177220232165" LOG_CI_START="-0.3498680971917186" LOG_EFFECT_SIZE="-0.1549019599857432" MODIFIED="2010-02-23 20:59:19 -0500" MODIFIED_BY="[Empty name]" ORDER="242" O_E="0.0" SE="0.229048148185468" STUDY_ID="STD-Singh-2006" TOTAL_1="29" TOTAL_2="29" VAR="0.05246305418719212" WEIGHT="29.890086920704743"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.207854484268793E-31" CI_END="1.1244586122876448" CI_START="0.5924681202945528" DF="0" EFFECT_SIZE="0.816214359326692" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="41" I2="100.0" ID="CMP-002.02.02" LOG_CI_END="0.05094347507989339" LOG_CI_START="-0.227335013339203" LOG_EFFECT_SIZE="-0.0881957691296548" MODIFIED="2017-09-14 12:50:06 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.0" P_Z="0.21410511707283897" STUDIES="1" TAU2="0.0" TOTAL_1="71" TOTAL_2="72" WEIGHT="60.84618393438567" Z="1.2423564039387724">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.1244586122876445" CI_START="0.5924681202945528" EFFECT_SIZE="0.8162143593266918" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="41" LOG_CI_END="0.0509434750798933" LOG_CI_START="-0.227335013339203" LOG_EFFECT_SIZE="-0.08819576912965485" MODIFIED="2010-03-02 04:05:46 -0500" MODIFIED_BY="[Empty name]" ORDER="390" O_E="0.0" SE="0.1634621615981109" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="71" TOTAL_2="72" VAR="0.026719878274326918" WEIGHT="60.84618393438567"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="13.485399512867305" CI_END="2.802580840519309" CI_START="-4.433445457812206" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8154323086464482" ESTIMABLE="YES" I2="77.75371803306604" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2017-09-14 12:50:28 -0400" MODIFIED_BY="Anne Lawson" NO="3" P_CHI2="0.0036962821349676434" P_Q="0.6532664060584459" P_Z="0.6586779966029634" Q="0.20180678672509145" RANDOM="NO" SCALE="59.43" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="103" TOTAL_2="95" UNITS="" WEIGHT="100.0" Z="0.4417391233489313">
<NAME>Duration of positive pressure ventilation (days, survivors)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.2465034796134262" CI_END="3.887544681304547" CI_START="-4.531867324071747" DF="1" EFFECT_SIZE="-0.32216132138359993" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.01" MODIFIED="2017-09-14 12:50:22 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.6195479485688308" P_Z="0.8807704838600031" STUDIES="3" TAU2="0.0" TOTAL_1="36" TOTAL_2="27" WEIGHT="73.86466772388849" Z="0.1499925616469386">
<NAME>Strict studies</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="5.7" MEAN_2="37.3" MODIFIED="2010-02-23 21:48:08 -0500" MODIFIED_BY="[Empty name]" ORDER="293" SD_1="0.0" SD_2="6.7" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="1" TOTAL_2="3" WEIGHT="0.0"/>
<CONT_DATA CI_END="4.887278899513372" CI_START="-4.4872788995133694" EFFECT_SIZE="0.20000000000000107" ESTIMABLE="YES" MEAN_1="9.9" MEAN_2="9.7" MODIFIED="2010-02-23 21:48:08 -0500" MODIFIED_BY="[Empty name]" ORDER="292" SD_1="5.4" SD_2="2.9" SE="2.3915127708907042" STUDY_ID="STD-Lista-2004" TOTAL_1="10" TOTAL_2="3" WEIGHT="59.5797519823084"/>
<CONT_DATA CI_END="7.072630582473179" CI_START="-12.072630582473176" EFFECT_SIZE="-2.4999999999999982" ESTIMABLE="YES" MEAN_1="13.9" MEAN_2="16.4" MODIFIED="2010-02-23 21:48:08 -0500" MODIFIED_BY="[Empty name]" ORDER="289" SD_1="16.5" SD_2="16.5" SE="4.884084941346303" STUDY_ID="STD-Singh-2006" TOTAL_1="25" TOTAL_2="21" WEIGHT="14.284915741580093"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="13.037089246528785" CI_END="4.867579477080339" CI_START="-9.286646454846585" DF="1" EFFECT_SIZE="-2.2095334888831233" ESTIMABLE="YES" I2="92.32957617233266" ID="CMP-002.03.02" MODIFIED="2017-09-14 12:50:28 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="3.0538583086836546E-4" P_Z="0.5405926463137298" STUDIES="2" TAU2="0.0" TOTAL_1="67" TOTAL_2="68" WEIGHT="26.135332276111505" Z="0.6119170460714125">
<NAME>Hybrid studies</NAME>
<CONT_DATA CI_END="13.977646419956338" CI_START="-2.5776464199563325" EFFECT_SIZE="5.700000000000003" ESTIMABLE="YES" MEAN_1="37.1" MEAN_2="31.4" MODIFIED="2010-03-02 04:05:52 -0500" MODIFIED_BY="[Empty name]" ORDER="391" SD_1="23.6" SD_2="23.0" SE="4.223366595125907" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="59" TOTAL_2="63" WEIGHT="19.10409806247232"/>
<CONT_DATA CI_END="-10.055602644601535" CI_START="-37.34439735539846" EFFECT_SIZE="-23.7" ESTIMABLE="YES" MEAN_1="10.2" MEAN_2="33.9" MODIFIED="2010-02-25 20:40:58 -0500" MODIFIED_BY="[Empty name]" ORDER="273" SD_1="5.7" SD_2="14.9" SE="6.961555142351456" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="8" TOTAL_2="5" WEIGHT="7.031234213639184"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="18.149310562538364" CI_END="0.09908583624242985" CI_START="-0.11681114323517457" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.008862653496372363" ESTIMABLE="YES" I2="83.47044649623088" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2017-09-14 12:50:50 -0400" MODIFIED_BY="Anne Lawson" NO="4" P_CHI2="4.0973739832772527E-4" P_Q="0.6704758717575563" P_Z="0.8721607096774966" Q="0.18104599489085552" RANDOM="NO" SCALE="1.09" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="103" TOTAL_2="95" UNITS="" WEIGHT="100.00000000000001" Z="0.16091454083682266">
<NAME>Duration of positive pressure ventilation (log data, survivors)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.022233596595491872" CI_END="0.14358060251835902" CI_START="-0.22658152787030172" DF="1" EFFECT_SIZE="-0.04150046267597134" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.01" MODIFIED="2017-09-14 12:50:43 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.8814673648828514" P_Z="0.6603138280987382" STUDIES="3" TAU2="0.0" TOTAL_1="36" TOTAL_2="27" WEIGHT="34.01803007147612" Z="0.43947992249368295">
<NAME>Strict studies</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.753" MEAN_2="1.567" MODIFIED="2010-02-25 20:41:18 -0500" MODIFIED_BY="[Empty name]" ORDER="278" SD_1="0.0" SD_2="0.075" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="1" TOTAL_2="3" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.16885258677105422" CI_START="-0.23885258677105428" EFFECT_SIZE="-0.03500000000000003" ESTIMABLE="YES" MEAN_1="0.938" MEAN_2="0.973" MODIFIED="2010-02-25 20:41:18 -0500" MODIFIED_BY="[Empty name]" ORDER="277" SD_1="0.242" SD_2="0.122" SE="0.10400833299949255" STUDY_ID="STD-Lista-2004" TOTAL_1="10" TOTAL_2="3" WEIGHT="28.041464266349088"/>
<CONT_DATA CI_END="0.36956100979107287" CI_START="-0.513561009791073" EFFECT_SIZE="-0.07200000000000006" ESTIMABLE="YES" MEAN_1="0.693" MEAN_2="0.765" MODIFIED="2010-02-25 20:41:18 -0500" MODIFIED_BY="[Empty name]" ORDER="274" SD_1="0.708" SD_2="0.803" SE="0.22529036924864426" STUDY_ID="STD-Singh-2006" TOTAL_1="25" TOTAL_2="21" WEIGHT="5.9765658051270325"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="17.946030971052018" CI_END="0.14085783514763967" CI_START="-0.12492928259840887" DF="1" EFFECT_SIZE="0.007964276274615394" ESTIMABLE="YES" I2="94.42773724388944" ID="CMP-002.04.02" MODIFIED="2017-09-14 12:50:50 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="2.2726065290745723E-5" P_Z="0.9064954371893792" STUDIES="2" TAU2="0.0" TOTAL_1="67" TOTAL_2="68" WEIGHT="65.9819699285239" Z="0.11746012969738884">
<NAME>Hybrid studies</NAME>
<CONT_DATA CI_END="-0.2637694745164467" CI_START="-0.8502305254835532" EFFECT_SIZE="-0.5569999999999999" ESTIMABLE="YES" MEAN_1="0.931" MEAN_2="1.488" MODIFIED="2010-02-25 20:41:51 -0500" MODIFIED_BY="[Empty name]" ORDER="279" SD_1="0.312" SD_2="0.226" SE="0.1496101600827965" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="8" TOTAL_2="5" WEIGHT="13.552355458985314"/>
<CONT_DATA CI_END="0.3030830395054915" CI_START="0.004916960494508793" EFFECT_SIZE="0.15400000000000014" ESTIMABLE="YES" MEAN_1="1.475" MEAN_2="1.321" MODIFIED="2010-03-02 04:06:16 -0500" MODIFIED_BY="[Empty name]" ORDER="392" SD_1="0.344" SD_2="0.488" SE="0.07606417295493148" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="59" TOTAL_2="63" WEIGHT="52.42961446953858"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.3807089845722721" CI_END="1.088443511749387" CI_START="0.45831574552576326" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7062937062937062" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.03680589486345238" LOG_CI_START="-0.33883522222829093" LOG_EFFECT_SIZE="-0.15101466368241925" METHOD="MH" MODIFIED="2017-09-14 12:50:58 -0400" MODIFIED_BY="Anne Lawson" NO="5" P_CHI2="0.5372243664010716" P_Q="1.0" P_Z="0.11505267535645437" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="22" TOTAL_2="24" WEIGHT="100.0" Z="1.5758834083260502">
<NAME>Any pH &lt; 7.25</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.141018344143682" CI_START="0.4929806807112714" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.05729262662359172" LOG_CI_START="-0.30717009984019156" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2017-04-09 19:01:35 -0400" MODIFIED_BY="[Empty name]" ORDER="235" O_E="0.0" SE="0.21408720964441877" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.04583333333333331" WEIGHT="89.5104895104895"/>
<DICH_DATA CI_END="4.851113688172902" CI_START="0.02290424802494361" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6858414526445321" LOG_CI_START="-1.640083962083857" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2010-03-02 00:23:12 -0500" MODIFIED_BY="[Empty name]" ORDER="181" O_E="0.0" SE="1.3662601021279464" STUDY_ID="STD-Keszler-2004a" TOTAL_1="2" TOTAL_2="4" VAR="1.8666666666666665" WEIGHT="10.489510489510488"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.3648544983834014" CI_START="0.014501337327735878" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.18518518518518517" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.3738044252035941" LOG_CI_START="-1.8385919448495311" LOG_EFFECT_SIZE="-0.7323937598229685" METHOD="MH" MODIFIED="2017-09-14 15:10:31 -0400" MODIFIED_BY="Anne Lawson" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.1944053584048575" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2" TOTAL_2="4" WEIGHT="100.0" Z="1.2976566145065838">
<NAME>Hypocarbia partial pressure of carbon dioxide (pCO<SUB>2</SUB>) &lt; 35 mmHg/4.7 kPa</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.3648544983834014" CI_START="0.014501337327735878" EFFECT_SIZE="0.18518518518518517" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3738044252035941" LOG_CI_START="-1.8385919448495311" LOG_EFFECT_SIZE="-0.7323937598229685" MODIFIED="2010-03-02 00:23:41 -0500" MODIFIED_BY="[Empty name]" ORDER="182" O_E="0.0" SE="1.2995725793078619" STUDY_ID="STD-Keszler-2004a" TOTAL_1="2" TOTAL_2="4" VAR="1.688888888888889" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.06866238292997061" CI_END="1.4725852835968565" CI_START="0.4279150152061789" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7938144329896907" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" I2="0.0" I2_Q="100.0" ID="CMP-002.07" LOG_CI_END="0.16808045600445146" LOG_CI_START="-0.36864247419197743" LOG_EFFECT_SIZE="-0.100281009093763" METHOD="MH" MODIFIED="2017-09-14 15:12:15 -0400" MODIFIED_BY="Anne Lawson" NO="7" P_CHI2="0.7932944019954133" P_Q="0.0" P_Z="0.4639262171874581" Q="7.75041527727816E-33" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="22" TOTAL_2="24" WEIGHT="99.99999999999999" Z="0.7323971274533665">
<NAME>Respiratory acidosis pH &lt; 7.25 and pCO<SUB>2</SUB> &gt; 60 mmHg/8 kPa</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.72717937879812" CI_START="0.03172985336133252" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.987986924768654" LOG_CI_START="-1.4985319349752662" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2010-03-02 00:24:03 -0500" MODIFIED_BY="[Empty name]" ORDER="183" O_E="0.0" SE="1.4605934866804429" STUDY_ID="STD-Keszler-2004a" TOTAL_1="2" TOTAL_2="4" VAR="2.133333333333333" WEIGHT="9.278350515463917"/>
<DICH_DATA CI_END="1.5301313618884815" CI_START="0.4374928220392194" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.18472871663091092" LOG_CI_START="-0.3590290680687112" LOG_EFFECT_SIZE="-0.08715017571890014" MODIFIED="2017-04-09 19:03:44 -0400" MODIFIED_BY="[Empty name]" ORDER="236" O_E="0.0" SE="0.3194060143770026" STUDY_ID="STD-Chowdhury-2013" TOTAL_1="20" TOTAL_2="20" VAR="0.102020202020202" WEIGHT="90.72164948453607"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.3648544983834014" CI_START="0.014501337327735878" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.18518518518518517" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="0.3738044252035941" LOG_CI_START="-1.8385919448495311" LOG_EFFECT_SIZE="-0.7323937598229685" METHOD="MH" MODIFIED="2017-05-15 16:11:45 -0400" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.1944053584048575" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="YEAR" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2" TOTAL_2="4" WEIGHT="100.0" Z="1.2976566145065838">
<NAME>Hypocarbia or respiratory acidosis</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.3648544983834014" CI_START="0.014501337327735878" EFFECT_SIZE="0.18518518518518517" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3738044252035941" LOG_CI_START="-1.8385919448495311" LOG_EFFECT_SIZE="-0.7323937598229685" MODIFIED="2010-03-02 00:24:24 -0500" MODIFIED_BY="[Empty name]" ORDER="184" O_E="0.0" SE="1.2995725793078619" STUDY_ID="STD-Keszler-2004a" TOTAL_1="2" TOTAL_2="4" VAR="1.688888888888889" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.4412445761908869" CI_END="1.391065711149646" CI_START="0.8500571993396033" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0874214557921973" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="55" I2="0.0" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="0.1433476456754695" LOG_CI_START="-0.07055185014245226" LOG_EFFECT_SIZE="0.03639789776650862" METHOD="MH" MODIFIED="2017-09-14 12:51:55 -0400" MODIFIED_BY="Anne Lawson" NO="9" P_CHI2="0.9315965501321678" P_Q="0.9536014606248272" P_Z="0.5047537015994181" Q="0.0033854713684740474" RANDOM="NO" SCALE="10.0" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="122" TOTAL_2="119" WEIGHT="100.0" Z="0.6670288629016077">
<NAME>Patent ductus arteriosus</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.5079062615957346" CI_END="1.5690534593250494" CI_START="0.7675745793256835" DF="1" EFFECT_SIZE="1.0974358974358973" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="18" I2="0.0" ID="CMP-002.09.01" LOG_CI_END="0.19563774071527015" LOG_CI_START="-0.11487941674192463" LOG_EFFECT_SIZE="0.040379161986672775" MODIFIED="2017-09-14 12:51:48 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.4760466847512005" P_Z="0.61023274624346" STUDIES="2" TAU2="0.0" TOTAL_1="41" TOTAL_2="34" WEIGHT="36.28646809161473" Z="0.5097412578929541">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="1.3029358902326098" CI_START="0.7674974705175037" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.1149230471759882" LOG_CI_START="-0.11492304717598824" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-23 21:43:19 -0500" MODIFIED_BY="[Empty name]" ORDER="266" O_E="0.0" SE="0.1350127335788675" STUDY_ID="STD-Lista-2004" TOTAL_1="12" TOTAL_2="5" VAR="0.018228438228438254" WEIGHT="13.305038300258735"/>
<DICH_DATA CI_END="1.9709442333565077" CI_START="0.6754939709675403" EFFECT_SIZE="1.1538461538461537" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.2946743363605327" LOG_CI_START="-0.1703785228628439" LOG_EFFECT_SIZE="0.062147906748844434" MODIFIED="2010-02-23 21:43:19 -0500" MODIFIED_BY="[Empty name]" ORDER="265" O_E="0.0" SE="0.27317435155659153" STUDY_ID="STD-Singh-2006" TOTAL_1="29" TOTAL_2="29" VAR="0.07462422634836427" WEIGHT="22.981429791355996"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.008390628102955492" CI_END="1.5033456773138718" CI_START="0.7783398066651572" DF="1" EFFECT_SIZE="1.0817179779551502" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="37" I2="0.0" ID="CMP-002.09.02" LOG_CI_END="0.17705885316758185" LOG_CI_START="-0.10883075784245665" LOG_EFFECT_SIZE="0.03411404766256261" MODIFIED="2017-09-14 12:51:55 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.9270155564971937" P_Z="0.6399640223573722" STUDIES="2" TAU2="0.0" TOTAL_1="81" TOTAL_2="85" WEIGHT="63.71353190838528" Z="0.46774910462316727">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="5.772152615091743" CI_START="0.17324559253430377" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7613378052724571" LOG_CI_START="-0.7613378052724571" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-25 20:44:55 -0500" MODIFIED_BY="[Empty name]" ORDER="283" O_E="0.0" SE="0.8944271909999159" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="10" TOTAL_2="10" VAR="0.8" WEIGHT="3.535604583285538"/>
<DICH_DATA CI_END="1.5164222145583852" CI_START="0.7784928071147184" EFFECT_SIZE="1.0865191146881288" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="35" LOG_CI_END="0.18082013792101426" LOG_CI_START="-0.10874539574174151" LOG_EFFECT_SIZE="0.036037371089636394" MODIFIED="2010-03-02 04:07:29 -0500" MODIFIED_BY="[Empty name]" ORDER="393" O_E="0.0" SE="0.1700922278460115" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="71" TOTAL_2="75" VAR="0.028931365973619484" WEIGHT="60.17792732509974"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.7344223407585757" CI_END="2.2334672223825796" CI_START="0.5474922938466906" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1058056306664545" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-002.10" LOG_CI_END="0.3489795832941658" LOG_CI_START="-0.26162198929772923" LOG_EFFECT_SIZE="0.04367879699821829" METHOD="MH" MODIFIED="2017-09-14 12:52:08 -0400" MODIFIED_BY="Anne Lawson" NO="10" P_CHI2="0.42012191585463166" P_Q="0.7882267254528208" P_Z="0.7791642839826147" Q="0.07215349370925953" RANDOM="NO" SCALE="126.6" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="95" TOTAL_2="94" WEIGHT="99.99999999999999" Z="0.28040828208532015">
<NAME>Air leak (any)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.0130919159516418E-32" CI_END="7.23962893221806" CI_START="0.09592265721714027" DF="0" EFFECT_SIZE="0.8333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="100.0" ID="CMP-002.10.01" LOG_CI_END="0.8597163069678672" LOG_CI_START="-1.018078799063117" LOG_EFFECT_SIZE="-0.07918124604762487" MODIFIED="2017-09-14 12:52:02 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.0" P_Z="0.8687140411996004" STUDIES="2" TAU2="0.0" TOTAL_1="14" TOTAL_2="9" WEIGHT="11.146810879592811" Z="0.1652921450331957">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-03-01 22:46:10 -0500" MODIFIED_BY="[Empty name]" ORDER="180" O_E="0.0" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="2" TOTAL_2="4" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.2396289322180625" CI_START="0.09592265721714027" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.8597163069678673" LOG_CI_START="-1.018078799063117" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2010-02-23 21:43:12 -0500" MODIFIED_BY="[Empty name]" ORDER="257" O_E="0.0" SE="1.1030261405182866" STUDY_ID="STD-Lista-2004" TOTAL_1="12" TOTAL_2="5" VAR="1.2166666666666668" WEIGHT="11.146810879592811"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.6333623886614657" CI_END="2.3987192388097656" CI_START="0.541777555711223" DF="1" EFFECT_SIZE="1.1399878271454655" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" I2="38.776599305712175" ID="CMP-002.10.02" LOG_CI_END="0.37997941838413835" LOG_CI_START="-0.26617899050378696" LOG_EFFECT_SIZE="0.056900213940175616" MODIFIED="2017-09-14 12:52:08 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.2012386747476571" P_Z="0.7299546559105565" STUDIES="2" TAU2="0.0" TOTAL_1="81" TOTAL_2="85" WEIGHT="88.85318912040718" Z="0.3451858507182608">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="3.704864004538551" CI_START="0.010796617622400985" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5687722708409982" LOG_CI_START="-1.9667122795130358" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2010-02-25 20:42:58 -0500" MODIFIED_BY="[Empty name]" ORDER="280" O_E="0.0" SE="1.4893561757289013" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="10" TOTAL_2="10" VAR="2.2181818181818183" WEIGHT="19.7391442659456"/>
<DICH_DATA CI_END="3.137749436154965" CI_START="0.6322153590006792" EFFECT_SIZE="1.408450704225352" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.4966182602069477" LOG_CI_START="-0.19913495764509842" LOG_EFFECT_SIZE="0.14874165128092467" MODIFIED="2010-03-02 04:07:43 -0500" MODIFIED_BY="[Empty name]" ORDER="394" O_E="0.0" SE="0.40868888420026495" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="71" TOTAL_2="75" VAR="0.16702660406885755" WEIGHT="69.11404485446158"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1875403094409482" CI_END="1.374807064083879" CI_START="0.28551305531842464" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.626518447725158" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-002.11" LOG_CI_END="0.1382417549786926" LOG_CI_START="-0.5443740284930193" LOG_EFFECT_SIZE="-0.20306613675716334" METHOD="MH" MODIFIED="2017-09-14 12:52:21 -0400" MODIFIED_BY="Anne Lawson" NO="11" P_CHI2="0.7559942439521314" P_Q="0.6068304905588784" P_Z="0.24357026802749737" Q="0.264816282577961" RANDOM="NO" SCALE="176.54" SORT_BY="YEAR" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="124" TOTAL_2="123" WEIGHT="100.00000000000001" Z="1.1661093228742168">
<NAME>Pneumothorax</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6754817331804439" CI_END="1.899473910644144" CI_START="0.11059348763216567" DF="1" EFFECT_SIZE="0.45833333333333337" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-002.11.01" LOG_CI_END="0.27863333287831665" LOG_CI_START="-0.9562704459850785" LOG_EFFECT_SIZE="-0.33881855655338095" MODIFIED="2017-09-14 12:52:14 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.4111472728250496" P_Z="0.2821490200431881" STUDIES="3" TAU2="0.0" TOTAL_1="43" TOTAL_2="38" WEIGHT="35.2506224692538" Z="1.0755043097360766">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="3.2515244501844025" CI_START="0.007279243756543836" EFFECT_SIZE="0.15384615384615385" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5120870240798066" LOG_CI_START="-2.1379137373655177" LOG_EFFECT_SIZE="-0.8129133566428556" MODIFIED="2010-02-23 21:43:15 -0500" MODIFIED_BY="[Empty name]" ORDER="258" O_E="0.0" SE="1.5566235649883124" STUDY_ID="STD-Lista-2004" TOTAL_1="12" TOTAL_2="5" VAR="2.423076923076923" WEIGHT="14.320565378134354"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-03-01 22:46:45 -0500" MODIFIED_BY="[Empty name]" ORDER="181" O_E="0.0" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="2" TOTAL_2="4" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.699119357300525" CI_START="0.1201487169013067" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5680983446651372" LOG_CI_START="-0.9202808627764997" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2010-02-23 21:43:15 -0500" MODIFIED_BY="[Empty name]" ORDER="260" O_E="0.0" SE="0.8742813140471173" STUDY_ID="STD-Singh-2006" TOTAL_1="29" TOTAL_2="29" VAR="0.764367816091954" WEIGHT="20.93005709111944"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2735884444072383" CI_END="1.8571739462641128" CI_START="0.2776479732947699" DF="1" EFFECT_SIZE="0.7180811808118083" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" I2="0.0" ID="CMP-002.11.02" LOG_CI_END="0.26885258244993243" LOG_CI_START="-0.5565054923340775" LOG_EFFECT_SIZE="-0.14382645494207252" MODIFIED="2017-09-14 12:52:21 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.6009347629161694" P_Z="0.4945534265096383" STUDIES="2" TAU2="0.0" TOTAL_1="81" TOTAL_2="85" WEIGHT="64.74937753074622" Z="0.6830845431161615">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="7.3225436971144395" CI_START="0.015173840636129785" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8646619720038995" LOG_CI_START="-1.8189044814432243" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2010-02-25 20:43:41 -0500" MODIFIED_BY="[Empty name]" ORDER="281" O_E="0.0" SE="1.5763402186230246" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="10" TOTAL_2="10" VAR="2.484848484848485" WEIGHT="10.46502854555972"/>
<DICH_DATA CI_END="2.1698290043300164" CI_START="0.28926963391364396" EFFECT_SIZE="0.7922535211267606" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.3364255101609752" LOG_CI_START="-0.5386971540323257" LOG_EFFECT_SIZE="-0.10113582193567516" MODIFIED="2010-03-02 04:07:58 -0500" MODIFIED_BY="[Empty name]" ORDER="395" O_E="0.0" SE="0.514051384874197" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="71" TOTAL_2="75" VAR="0.2642488262910798" WEIGHT="54.28434898518649"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.5293908244846055" CI_END="3.6694342630720613" CI_START="0.5767581464382355" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4547769946099625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-002.12" LOG_CI_END="0.5645991118364964" LOG_CI_START="-0.2390062625577371" LOG_EFFECT_SIZE="0.16279642463937963" METHOD="MH" MODIFIED="2017-09-14 12:53:08 -0400" MODIFIED_BY="Anne Lawson" NO="12" P_CHI2="0.46547581169311425" P_Q="0.5872493335308613" P_Z="0.4271319871627871" Q="0.29466063098459794" RANDOM="NO" SCALE="191.41" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="95" TOTAL_2="94" WEIGHT="100.0" Z="0.7941089974556118">
<NAME>Pulmonary interstitial emphysema</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.0130919159516418E-32" CI_END="7.23962893221806" CI_START="0.09592265721714027" DF="0" EFFECT_SIZE="0.8333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="100.0" ID="CMP-002.12.01" LOG_CI_END="0.8597163069678672" LOG_CI_START="-1.018078799063117" LOG_EFFECT_SIZE="-0.07918124604762487" MODIFIED="2017-09-14 12:53:01 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.0" P_Z="0.8687140411996004" STUDIES="2" TAU2="0.0" TOTAL_1="14" TOTAL_2="9" WEIGHT="20.754605224190016" Z="0.1652921450331957">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-03-01 22:47:09 -0500" MODIFIED_BY="[Empty name]" ORDER="182" O_E="0.0" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="2" TOTAL_2="4" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.2396289322180625" CI_START="0.09592265721714027" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.8597163069678673" LOG_CI_START="-1.018078799063117" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2010-02-23 21:43:17 -0500" MODIFIED_BY="[Empty name]" ORDER="262" O_E="0.0" SE="1.1030261405182866" STUDY_ID="STD-Lista-2004" TOTAL_1="12" TOTAL_2="5" VAR="1.2166666666666668" WEIGHT="20.754605224190016"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2092126184555063" CI_END="4.530441991549255" CI_START="0.5775196539602284" DF="1" EFFECT_SIZE="1.6175349428208385" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" I2="17.301557663426287" ID="CMP-002.12.02" LOG_CI_END="0.6561405740055494" LOG_CI_START="-0.23843323141636766" LOG_EFFECT_SIZE="0.20885367129459081" MODIFIED="2017-09-14 12:53:08 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.27148818474361414" P_Z="0.360099915074896" STUDIES="2" TAU2="0.0" TOTAL_1="81" TOTAL_2="85" WEIGHT="79.24539477580998" Z="0.9151747375015102">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="7.3225436971144395" CI_START="0.015173840636129785" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8646619720038995" LOG_CI_START="-1.8189044814432243" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2010-02-25 20:44:24 -0500" MODIFIED_BY="[Empty name]" ORDER="282" O_E="0.0" SE="1.5763402186230246" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="10" TOTAL_2="10" VAR="2.484848484848485" WEIGHT="22.051768050701888"/>
<DICH_DATA CI_END="6.709159765963677" CI_START="0.6652696126968587" EFFECT_SIZE="2.112676056338028" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.8266681339015471" LOG_CI_START="-0.17700231322833526" LOG_EFFECT_SIZE="0.32483291033660594" MODIFIED="2010-03-02 04:08:19 -0500" MODIFIED_BY="[Empty name]" ORDER="396" O_E="0.0" SE="0.5895609888929331" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="71" TOTAL_2="75" VAR="0.3475821596244132" WEIGHT="57.193626725108096"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.0959014069825153" CI_END="1.155479332855549" CI_START="0.5468459835699336" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7949020268373477" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="42" I2="3.0976893116240274" I2_Q="49.51757917254329" ID="CMP-002.13" LOG_CI_END="0.06276218200287262" LOG_CI_START="-0.26213497330865226" LOG_EFFECT_SIZE="-0.09968639565288985" METHOD="MH" MODIFIED="2017-09-14 12:54:01 -0400" MODIFIED_BY="Anne Lawson" NO="13" P_CHI2="0.37707438168062946" P_Q="0.1592972641963789" P_Z="0.22908092028148963" Q="1.980887571572466" RANDOM="NO" SCALE="30.43" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="115" WEIGHT="99.99999999999999" Z="1.2027297994710615">
<NAME>Any intraventricular haemorrhage (IVH)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.16347188382642253" CI_END="2.0770757845993626" CI_START="0.6244682600662803" DF="1" EFFECT_SIZE="1.1388888888888888" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" I2="0.0" ID="CMP-002.13.01" LOG_CI_END="0.31745234257885313" LOG_CI_START="-0.20448963067395662" LOG_EFFECT_SIZE="0.05648135595244821" MODIFIED="2017-09-14 12:53:52 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.6859801746708436" P_Z="0.671426861292185" STUDIES="2" TAU2="0.0" TOTAL_1="30" TOTAL_2="32" WEIGHT="28.903486609398684" Z="0.4241905389401046">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="10.054116567035125" CI_START="0.044205220964083886" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.002343916114521" LOG_CI_START="-1.3545264342258836" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2010-02-23 21:43:21 -0500" MODIFIED_BY="[Empty name]" ORDER="267" O_E="0.0" SE="1.3844373104863457" STUDY_ID="STD-Keszler-2004a" TOTAL_1="1" TOTAL_2="3" VAR="1.9166666666666665" WEIGHT="2.408623884116557"/>
<DICH_DATA CI_END="2.1887418632287243" CI_START="0.6381265138391874" EFFECT_SIZE="1.1818181818181819" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" LOG_CI_END="0.340194544580282" LOG_CI_START="-0.19509321028305845" LOG_EFFECT_SIZE="0.07255066714861175" MODIFIED="2010-03-01 22:34:22 -0500" MODIFIED_BY="[Empty name]" ORDER="178" O_E="0.0" SE="0.31443067692384685" STUDY_ID="STD-Singh-2006" TOTAL_1="29" TOTAL_2="29" VAR="0.09886665059078854" WEIGHT="26.494862725282125"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7853622735453718" CI_END="1.0605335399924463" CI_START="0.4046086461879416" DF="1" EFFECT_SIZE="0.6550580431177446" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="30" I2="0.0" ID="CMP-002.13.02" LOG_CI_END="0.025524407886345135" LOG_CI_START="-0.3929648409137273" LOG_EFFECT_SIZE="-0.18372021651369105" MODIFIED="2017-09-14 12:54:01 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.3755062120522449" P_Z="0.08527249885049365" STUDIES="2" TAU2="0.0" TOTAL_1="80" TOTAL_2="83" WEIGHT="71.0965133906013" Z="1.7208805656594592">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.2005001082166866" CI_START="0.15299746175000142" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.07936220354165732" LOG_CI_START="-0.8153157741308461" LOG_EFFECT_SIZE="-0.36797678529459443" MODIFIED="2010-02-25 20:45:36 -0500" MODIFIED_BY="[Empty name]" ORDER="284" O_E="0.0" SE="0.5255382728122436" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="10" TOTAL_2="10" VAR="0.2761904761904762" WEIGHT="16.860367188815896"/>
<DICH_DATA CI_END="1.254109187220162" CI_START="0.41966097386672985" EFFECT_SIZE="0.7254658385093168" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="23" LOG_CI_END="0.09833534936782315" LOG_CI_START="-0.3771014158787611" LOG_EFFECT_SIZE="-0.13938303325546902" MODIFIED="2010-03-02 04:08:27 -0500" MODIFIED_BY="[Empty name]" ORDER="397" O_E="0.0" SE="0.2792739093557875" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="70" TOTAL_2="73" VAR="0.07799391644686463" WEIGHT="54.2361462017854"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.708872370083527" CI_END="1.0394398758136583" CI_START="0.26687044848880404" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5266837626465598" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-002.14" LOG_CI_END="0.016799373554426327" LOG_CI_START="-0.5736995145182191" LOG_EFFECT_SIZE="-0.2784500704818964" METHOD="MH" MODIFIED="2017-09-14 12:54:15 -0400" MODIFIED_BY="Anne Lawson" NO="14" P_CHI2="0.43872170231887675" P_Q="0.4420062521169942" P_Z="0.06453811581761648" Q="0.5910688402843995" RANDOM="NO" SCALE="320.5" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="93" TOTAL_2="91" WEIGHT="100.0" Z="1.8484441568330814">
<NAME>IVH grade 3-4</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.0111206660059406" CI_END="1.364734659989606" CI_START="0.2765618293869171" DF="2" EFFECT_SIZE="0.6143561786085151" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="12" I2="0.5529586659773198" ID="CMP-002.14.01" LOG_CI_END="0.13504822141045303" LOG_CI_START="-0.5582077607074212" LOG_EFFECT_SIZE="-0.21157976964848405" MODIFIED="2017-09-14 12:54:09 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.36583970255732257" P_Z="0.23155965334337214" STUDIES="3" TAU2="0.0" TOTAL_1="83" TOTAL_2="81" WEIGHT="68.80238833390746" Z="1.1963509556785916">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="10.054116567035125" CI_START="0.044205220964083886" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.002343916114521" LOG_CI_START="-1.3545264342258836" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2010-02-23 21:43:25 -0500" MODIFIED_BY="[Empty name]" ORDER="270" O_E="0.0" SE="1.3844373104863457" STUDY_ID="STD-Keszler-2004a" TOTAL_1="1" TOTAL_2="3" VAR="1.9166666666666665" WEIGHT="5.199601944348758"/>
<DICH_DATA CI_END="1.6413590585341062" CI_START="0.005191252952770387" EFFECT_SIZE="0.09230769230769231" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.21520359633806588" LOG_CI_START="-2.2847278088564895" LOG_EFFECT_SIZE="-1.0347621062592118" MODIFIED="2010-02-23 21:43:25 -0500" MODIFIED_BY="[Empty name]" ORDER="271" O_E="0.0" SE="1.4684720822713166" STUDY_ID="STD-Lista-2004" TOTAL_1="12" TOTAL_2="5" VAR="2.1564102564102563" WEIGHT="17.78811191487733"/>
<DICH_DATA CI_END="2.0593138456698274" CI_START="0.319475943869016" EFFECT_SIZE="0.8111111111111111" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.31372253945711404" LOG_CI_START="-0.49556183809485194" LOG_EFFECT_SIZE="-0.09091964931886896" MODIFIED="2010-02-23 21:43:25 -0500" MODIFIED_BY="[Empty name]" ORDER="273" O_E="0.0" SE="0.47537764939630195" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="70" TOTAL_2="73" VAR="0.22598390954555336" WEIGHT="45.81467447468137"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2716280494144638" CI_START="0.08737705271779238" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" I2="0.0" ID="CMP-002.14.02" LOG_CI_END="0.10436009896243487" LOG_CI_START="-1.05860260840176" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2017-09-14 12:54:15 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="1.0" P_Z="0.10779056894088013" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="31.19761166609255" Z="1.608203718980045">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.2716280494144638" CI_START="0.08737705271779238" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.10436009896243487" LOG_CI_START="-1.05860260840176" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2010-02-25 20:46:22 -0500" MODIFIED_BY="[Empty name]" ORDER="285" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Piotrowski-1997" TOTAL_1="10" TOTAL_2="10" VAR="0.4666666666666667" WEIGHT="31.19761166609255"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.5011169962615437" CI_END="1.242851218490334" CI_START="0.1483002311126127" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4293193717277487" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-002.15" LOG_CI_END="0.09441914243406023" LOG_CI_START="-0.828858172162082" LOG_EFFECT_SIZE="-0.36721951486401083" METHOD="MH" MODIFIED="2017-09-14 12:54:39 -0400" MODIFIED_BY="Anne Lawson" NO="15" P_CHI2="0.7783659556120002" P_Q="0.8084557878362457" P_Z="0.11897466524870552" Q="0.058766801381283845" RANDOM="NO" SCALE="333.62" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="104" TOTAL_2="99" WEIGHT="100.0" Z="1.559091753204308">
<NAME>Periventricular leukomalacia (PVL)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.4476967839940647" CI_END="1.5314412519315965" CI_START="0.09558931092134149" DF="1" EFFECT_SIZE="0.3826086956521739" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-002.15.01" LOG_CI_END="0.18510034136374842" LOG_CI_START="-1.019590669098597" LOG_EFFECT_SIZE="-0.4172451638674242" MODIFIED="2017-09-14 12:54:33 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.5034307752747229" P_Z="0.17456890939137543" STUDIES="3" TAU2="0.0" TOTAL_1="42" TOTAL_2="37" WEIGHT="60.20942408376963" Z="1.3576684590512695">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="3.2515244501844025" CI_START="0.007279243756543836" EFFECT_SIZE="0.15384615384615385" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5120870240798066" LOG_CI_START="-2.1379137373655177" LOG_EFFECT_SIZE="-0.8129133566428556" MODIFIED="2010-02-23 21:27:52 -0500" MODIFIED_BY="[Empty name]" ORDER="251" O_E="0.0" SE="1.5566235649883124" STUDY_ID="STD-Lista-2004" TOTAL_1="12" TOTAL_2="5" VAR="2.423076923076923" WEIGHT="20.41884816753927"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-23 21:27:52 -0500" MODIFIED_BY="[Empty name]" ORDER="250" O_E="0.0" SE="0.0" STUDY_ID="STD-Keszler-2004a" TOTAL_1="1" TOTAL_2="3" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.5201273614234165" CI_START="0.09920133554630954" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4014224895774544" LOG_CI_START="-1.0034824809054168" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2010-02-23 21:27:52 -0500" MODIFIED_BY="[Empty name]" ORDER="252" O_E="0.0" SE="0.8252481340534014" STUDY_ID="STD-Singh-2006" TOTAL_1="29" TOTAL_2="29" VAR="0.6810344827586208" WEIGHT="39.79057591623037"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.6309039048401286" CI_START="0.09502437528792665" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-002.15.02" LOG_CI_END="0.42010498553920683" LOG_CI_START="-1.0221649768671692" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2017-09-14 12:54:39 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="1.0" P_Z="0.41326255136555146" STUDIES="1" TAU2="0.0" TOTAL_1="62" TOTAL_2="62" WEIGHT="39.79057591623037" Z="0.818165759735084">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="2.6309039048401286" CI_START="0.09502437528792665" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.42010498553920683" LOG_CI_START="-1.0221649768671692" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2010-03-02 04:09:44 -0500" MODIFIED_BY="[Empty name]" ORDER="398" O_E="0.0" SE="0.8471965152689611" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="62" TOTAL_2="62" VAR="0.717741935483871" WEIGHT="39.79057591623037"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6833379545452645" CI_END="1.346093372925936" CI_START="0.5961825362580304" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8958333333333334" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-002.16" LOG_CI_END="0.12907518614354577" LOG_CI_START="-0.22462074973554708" LOG_EFFECT_SIZE="-0.047772781796000675" METHOD="MH" MODIFIED="2017-09-14 12:54:56 -0400" MODIFIED_BY="Anne Lawson" NO="16" P_CHI2="0.7105834650680551" P_Q="0.4717842794644378" P_Z="0.596490283235861" Q="0.5177940110657682" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="92" TOTAL_2="94" WEIGHT="100.0" Z="0.5294543830634201">
<NAME>Any IVH or PVL</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.11617363330709347" CI_END="1.802060448280939" CI_START="0.6090282209906983" DF="1" EFFECT_SIZE="1.0476190476190477" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="14" I2="0.0" ID="CMP-002.16.01" LOG_CI_END="0.25576935485311253" LOG_CI_START="-0.21536258267653852" LOG_EFFECT_SIZE="0.02020338608828699" MODIFIED="2017-09-14 12:54:51 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.733222177781748" P_Z="0.8665070481448084" STUDIES="2" TAU2="0.0" TOTAL_1="30" TOTAL_2="32" WEIGHT="43.75" Z="0.168096900016709">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="10.054116567035125" CI_START="0.044205220964083886" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.002343916114521" LOG_CI_START="-1.3545264342258836" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2010-02-23 21:28:06 -0500" MODIFIED_BY="[Empty name]" ORDER="255" O_E="0.0" SE="1.3844373104863457" STUDY_ID="STD-Keszler-2004a" TOTAL_1="1" TOTAL_2="3" VAR="1.9166666666666665" WEIGHT="3.125"/>
<DICH_DATA CI_END="1.870748275070714" CI_START="0.6199462156743822" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.2720153534526745" LOG_CI_START="-0.20764598670987203" LOG_EFFECT_SIZE="0.032184683371401235" MODIFIED="2010-03-01 22:33:40 -0500" MODIFIED_BY="[Empty name]" ORDER="177" O_E="0.0" SE="0.28175544557340687" STUDY_ID="STD-Singh-2006" TOTAL_1="29" TOTAL_2="29" VAR="0.07938613111026904" WEIGHT="40.625"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4217882854187565" CI_START="0.4254770402942003" DF="0" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="18" I2="0.0" ID="CMP-002.16.02" LOG_CI_END="0.1528349316119043" LOG_CI_START="-0.37112387046204043" LOG_EFFECT_SIZE="-0.10914446942506803" MODIFIED="2017-09-14 12:54:56 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="1.0" P_Z="0.4141857570786005" STUDIES="1" TAU2="0.0" TOTAL_1="62" TOTAL_2="62" WEIGHT="56.25" Z="0.8165498063516706">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.4217882854187565" CI_START="0.4254770402942003" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="18" LOG_CI_END="0.1528349316119043" LOG_CI_START="-0.37112387046204043" LOG_EFFECT_SIZE="-0.10914446942506803" MODIFIED="2010-03-02 04:10:13 -0500" MODIFIED_BY="[Empty name]" ORDER="399" O_E="0.0" SE="0.3077759939761351" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="62" TOTAL_2="62" VAR="0.09472606246799795" WEIGHT="56.25"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.926127675655707" CI_END="0.993703105015109" CI_START="0.15139732302970607" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="0.38787109970400524" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="14" I2="31.65028249999973" I2_Q="40.82777702886048" ID="CMP-002.17" LOG_CI_END="-0.0027433531417351506" LOG_CI_START="-0.8198818038564557" LOG_EFFECT_SIZE="-0.4113125784990954" METHOD="MH" MODIFIED="2017-09-14 12:55:12 -0400" MODIFIED_BY="Anne Lawson" NO="17" P_CHI2="0.231525881681804" P_Q="0.19360340670533616" P_Z="0.048481409760523744" Q="1.6899821399100334" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="75" TOTAL_2="70" WEIGHT="100.0" Z="1.973124235045884">
<NAME>IVH grade 3-4 or PVL</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3551450027590297" CI_END="1.03613454833097" CI_START="0.010115155028075442" DF="1" EFFECT_SIZE="0.10237510237510238" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" I2="26.20715879377974" ID="CMP-002.17.01" LOG_CI_END="0.015416154833487883" LOG_CI_START="-1.9950274567071402" LOG_EFFECT_SIZE="-0.989805650936826" MODIFIED="2017-09-14 12:55:04 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.24438083798207388" P_Z="0.053618506426837326" STUDIES="2" TAU2="0.0" TOTAL_1="13" TOTAL_2="8" WEIGHT="37.22158303094669" Z="1.9299058341096873">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="24.513488971036672" CI_START="0.012590699580680272" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.3894051281852708" LOG_CI_START="-1.899950138391883" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2017-05-01 13:04:41 -0400" MODIFIED_BY="[Empty name]" ORDER="288" O_E="0.0" SE="1.9321835661585918" STUDY_ID="STD-Keszler-2004a" TOTAL_1="1" TOTAL_2="3" VAR="3.733333333333333" WEIGHT="5.212850694751747"/>
<DICH_DATA CI_END="0.743904701644305" CI_START="0.0010973536379160684" EFFECT_SIZE="0.02857142857142857" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="-0.12848269644456214" LOG_CI_START="-2.959653392255989" LOG_EFFECT_SIZE="-1.5440680443502757" MODIFIED="2017-05-13 06:30:02 -0400" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="1.6630436812405998" STUDY_ID="STD-Lista-2004" TOTAL_1="12" TOTAL_2="5" VAR="2.7657142857142856" WEIGHT="32.00873233619494"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6409571059295844" CI_START="0.18916287460753783" DF="0" EFFECT_SIZE="0.5571428571428572" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" I2="0.0" ID="CMP-002.17.02" LOG_CI_END="0.215097228888828" LOG_CI_START="-0.7231640948643432" LOG_EFFECT_SIZE="-0.2540334329877576" MODIFIED="2017-09-14 12:55:12 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="1.0" P_Z="0.28854584643763104" STUDIES="1" TAU2="0.0" TOTAL_1="62" TOTAL_2="62" WEIGHT="62.7784169690533" Z="1.0613170700320926">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.6409571059295844" CI_START="0.18916287460753783" EFFECT_SIZE="0.5571428571428572" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.215097228888828" LOG_CI_START="-0.7231640948643432" LOG_EFFECT_SIZE="-0.2540334329877576" MODIFIED="2010-03-02 04:10:55 -0500" MODIFIED_BY="[Empty name]" ORDER="400" O_E="0.0" SE="0.5511393460410704" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="62" TOTAL_2="62" VAR="0.30375457875457873" WEIGHT="62.7784169690533"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.2444236526051633" CI_END="1.1249558389117669" CI_START="0.5852158409682906" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8113827563615944" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="46" I2="0.0" I2_Q="0.0" ID="CMP-002.18" LOG_CI_END="0.05113547418660633" LOG_CI_START="-0.23268392664788087" LOG_EFFECT_SIZE="-0.09077422623063729" METHOD="MH" MODIFIED="2017-09-14 12:55:29 -0400" MODIFIED_BY="Anne Lawson" NO="18" P_CHI2="0.9701178891953436" P_Q="0.8055882962289987" P_Z="0.20994590969908722" Q="0.060575720778095525" RANDOM="NO" SCALE="28.29" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="104" TOTAL_2="98" WEIGHT="100.0" Z="1.2537142535953207">
<NAME>BPD (supplemental oxygen in survivors at 36 weeks)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.12400016682696094" CI_END="1.4959852751102858" CI_START="0.492130220090524" DF="2" EFFECT_SIZE="0.8580323785803238" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" I2="0.0" ID="CMP-002.18.01" LOG_CI_END="0.17492731881599477" LOG_CI_START="-0.307919965558105" LOG_EFFECT_SIZE="-0.06649632337105513" MODIFIED="2017-09-14 12:55:22 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.9398828156425258" P_Z="0.5893066387717265" STUDIES="3" TAU2="0.0" TOTAL_1="42" TOTAL_2="37" WEIGHT="34.236660669904225" Z="0.5398410765861114">
<NAME>Strict studies</NAME>
<DICH_DATA CI_END="2.4150608909565046" CI_START="0.4140682347781061" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.38292808509706755" LOG_CI_START="-0.3829280850970675" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-25 20:47:35 -0500" MODIFIED_BY="[Empty name]" ORDER="294" O_E="0.0" SE="0.4498677054212186" STUDY_ID="STD-Keszler-2004a" TOTAL_1="1" TOTAL_2="3" VAR="0.20238095238095233" WEIGHT="5.073676985950938"/>
<DICH_DATA CI_END="7.2396289322180625" CI_START="0.09592265721714027" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.8597163069678673" LOG_CI_START="-1.018078799063117" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2010-02-25 20:47:35 -0500" MODIFIED_BY="[Empty name]" ORDER="295" O_E="0.0" SE="1.1030261405182866" STUDY_ID="STD-Lista-2004" TOTAL_1="12" TOTAL_2="5" VAR="1.2166666666666668" WEIGHT="3.0697877562056095"/>
<DICH_DATA CI_END="1.6168909838827017" CI_START="0.42949367110505415" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="12" LOG_CI_END="0.20868073932864817" LOG_CI_START="-0.3670432314238978" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2010-02-25 20:47:35 -0500" MODIFIED_BY="[Empty name]" ORDER="292" O_E="0.0" SE="0.33818311029966297" STUDY_ID="STD-Singh-2006" TOTAL_1="29" TOTAL_2="29" VAR="0.11436781609195402" WEIGHT="26.09319592774768"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1788577997472631" CI_START="0.5255267701318256" DF="0" EFFECT_SIZE="0.7870967741935484" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="30" I2="0.0" ID="CMP-002.18.02" LOG_CI_END="0.07146142128706613" LOG_CI_START="-0.2794051562781527" LOG_EFFECT_SIZE="-0.10397186749554325" MODIFIED="2017-09-14 12:55:29 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="1.0" P_Z="0.2454030811628385" STUDIES="1" TAU2="0.0" TOTAL_1="62" TOTAL_2="61" WEIGHT="65.76333933009577" Z="1.1615875020684">
<NAME>Hybrid studies</NAME>
<DICH_DATA CI_END="1.1788577997472631" CI_START="0.5255267701318257" EFFECT_SIZE="0.7870967741935484" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="30" LOG_CI_END="0.07146142128706613" LOG_CI_START="-0.2794051562781526" LOG_EFFECT_SIZE="-0.10397186749554325" MODIFIED="2010-03-02 04:11:33 -0500" MODIFIED_BY="[Empty name]" ORDER="401" O_E="0.0" SE="0.2061007644793795" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="62" TOTAL_2="61" VAR="0.04247752511898466" WEIGHT="65.76333933009577"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2017-09-14 13:23:31 -0400" MODIFIED_BY="Anne Lawson" NO="3">
<NAME>Miscellaneous post hoc analyses</NAME>
<DICH_OUTCOME CHI2="1.3770914249751005" CI_END="1.5860829183392073" CI_START="0.4686725135981235" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8621794871794872" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="18" I2="27.383180095099263" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.20032588792221964" LOG_CI_START="-0.3291305159542892" LOG_EFFECT_SIZE="-0.06440231401603479" METHOD="MH" MODIFIED="2017-09-14 12:56:03 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.2405973955911751" P_Q="1.0" P_Z="0.6334942998433304" Q="0.0" RANDOM="NO" SCALE="10.14" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="107" TOTAL_2="102" WEIGHT="100.0" Z="0.4768143895069726">
<NAME>Severe disability (any definition)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1842143723047296" CI_START="0.537314984276358" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" LOG_CI_END="0.3392952604704871" LOG_CI_START="-0.26977104795206325" LOG_EFFECT_SIZE="0.03476210625921191" MODIFIED="2010-09-14 02:16:01 -0400" MODIFIED_BY="[Empty name]" ORDER="281" O_E="0.0" SE="0.35776856449425687" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="62" TOTAL_2="62" VAR="0.12799834574028124" WEIGHT="65.38461538461539"/>
<DICH_DATA CI_END="1.6618066041257673" CI_START="0.11886513370877275" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.22058048055031598" LOG_CI_START="-0.9249455167730408" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2010-09-14 02:34:57 -0400" MODIFIED_BY="[Empty name]" ORDER="177" O_E="0.0" SE="0.6728876412728784" STUDY_ID="STD-Singh-2006" TOTAL_1="45" TOTAL_2="40" VAR="0.4527777777777778" WEIGHT="34.61538461538461"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.0642681438265826" CI_START="0.2705877119463825" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5366357069143447" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.027051062839399356" LOG_CI_START="-0.5676919296713316" LOG_EFFECT_SIZE="-0.2703204334159662" METHOD="MH" MODIFIED="2017-05-07 14:21:12 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.07480282040715988" Q="0.0" RANDOM="NO" SCALE="5.38" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="57" TOTAL_2="52" WEIGHT="100.0" Z="1.7816714797896231">
<NAME>Severe disability (any definition) or death</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0642681438265826" CI_START="0.2705877119463825" EFFECT_SIZE="0.5366357069143447" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="17" LOG_CI_END="0.027051062839399356" LOG_CI_START="-0.5676919296713316" LOG_EFFECT_SIZE="-0.2703204334159662" MODIFIED="2010-09-14 02:35:41 -0400" MODIFIED_BY="[Empty name]" ORDER="178" O_E="0.0" SE="0.3493549778260969" STUDY_ID="STD-Singh-2006" TOTAL_1="57" TOTAL_2="52" VAR="0.12204890053187266" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.1394036034480197" CI_START="0.46741998489126907" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.33029272296122586" LOG_CI_START="-0.33029272296122586" LOG_EFFECT_SIZE="0.0" METHOD="MH" MODIFIED="2017-05-07 14:21:49 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="2.44" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="64" TOTAL_2="64" WEIGHT="100.00000000000001" Z="0.0">
<NAME>Gross motor developmental issue (any definition)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1394036034480197" CI_START="0.46741998489126907" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.33029272296122586" LOG_CI_START="-0.33029272296122586" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-02-23 21:46:45 -0500" MODIFIED_BY="[Empty name]" ORDER="282" O_E="0.0" SE="0.38803116088554257" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="64" TOTAL_2="64" VAR="0.15056818181818182" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3077063773429405" CI_START="0.6549240141903534" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9254449254449254" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="42" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="0.116510241683431" LOG_CI_START="-0.18380908494278106" LOG_EFFECT_SIZE="-0.03364942162967505" METHOD="MH" MODIFIED="2017-09-14 12:56:28 -0400" MODIFIED_BY="Anne Lawson" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.6605092422882974" Q="0.0" RANDOM="NO" SCALE="2.05" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="99" TOTAL_2="104" WEIGHT="100.0" Z="0.4392101916028329">
<NAME>Steroids for bronchopulmonary dysplasia</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3077063773429405" CI_START="0.6549240141903534" EFFECT_SIZE="0.9254449254449254" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="42" LOG_CI_END="0.116510241683431" LOG_CI_START="-0.18380908494278106" LOG_EFFECT_SIZE="-0.03364942162967505" MODIFIED="2010-02-23 21:46:48 -0500" MODIFIED_BY="[Empty name]" ORDER="284" O_E="0.0" SE="0.17640905906487941" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="99" TOTAL_2="104" VAR="0.031120156120156117" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.13462859604228922" CI_END="1.3561474636003177" CI_START="0.299482893589878" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6372934697088907" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="0.13230691603979614" LOG_CI_START="-0.5236279793905128" LOG_EFFECT_SIZE="-0.1956605316753584" METHOD="MH" MODIFIED="2017-09-14 13:23:07 -0400" MODIFIED_BY="Anne Lawson" NO="5" P_CHI2="0.7136805071088115" P_Q="1.0" P_Z="0.24228862614459112" Q="0.0" RANDOM="NO" SCALE="7.04" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="136" TOTAL_2="134" WEIGHT="100.0" Z="1.1692855432796692">
<NAME>Need for home oxygen (survivors)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.2407588818780653" CI_START="0.2429526970878697" EFFECT_SIZE="0.7378335949764521" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3503951265468115" LOG_CI_START="-0.6144782753460774" LOG_EFFECT_SIZE="-0.132041574399633" MODIFIED="2010-02-28 09:15:33 -0500" MODIFIED_BY="[Empty name]" ORDER="192" O_E="0.0" SE="0.5667714124722518" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="91" TOTAL_2="94" VAR="0.3212298339957914" WEIGHT="44.84243653981532"/>
<DICH_DATA CI_END="1.5608102159044583" CI_START="0.19774471755990533" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.19335009896489205" LOG_CI_START="-0.7038951091715042" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2010-09-14 02:34:17 -0400" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="0.5270462766947299" STUDY_ID="STD-Singh-2006" TOTAL_1="45" TOTAL_2="40" VAR="0.2777777777777778" WEIGHT="55.15756346018469"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.2347699875187375" CI_START="0.25170375615458446" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="0.34923283024561574" LOG_CI_START="-0.5991103034622156" LOG_EFFECT_SIZE="-0.12493873660829995" METHOD="MH" MODIFIED="2017-09-14 13:23:31 -0400" MODIFIED_BY="Anne Lawson" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.6055555894392424" Q="0.0" RANDOM="NO" SCALE="5.25" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="63" WEIGHT="100.0" Z="0.5164278947616568">
<NAME>Need for home oxygen (survivors weighing &lt; 1000 g)</NAME>
<GROUP_LABEL_1>Volume targeted</GROUP_LABEL_1>
<GROUP_LABEL_2>Pressure limited</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours VTV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PLV</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.2347699875187375" CI_START="0.25170375615458446" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.34923283024561574" LOG_CI_START="-0.5991103034622156" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2010-02-28 02:51:15 -0500" MODIFIED_BY="[Empty name]" ORDER="285" O_E="0.0" SE="0.5570614511142019" STUDY_ID="STD-D_x0027_Angio-2005" TOTAL_1="60" TOTAL_2="63" VAR="0.3103174603174603" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2017-10-11 13:45:38 -0400" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2017-09-14 12:59:58 -0400" MODIFIED_BY="Anne Lawson" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram: review update. PLV: pressure-limited ventilation; VTV: volume-targeted ventilation.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAr4AAANFCAYAAACdpf8bAACAAElEQVR42uzdD2RX/+P//Q8zmUwi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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-10-11 13:45:38 -0400" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEZCAMAAABxStv9AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2017-10-11 13:45:38 -0400" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAWYAAAOtCAIAAAA99FgfAAAyFklEQVR42u3dsY4tRZaF4ZKQEAYG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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2010-02-01 19:56:35 -0500" MODIFIED_BY="[Empty name]"/>
<APPENDICES MODIFIED="2017-09-14 13:57:16 -0400" MODIFIED_BY="Anne Lawson">
<APPENDIX ID="APP-01" MODIFIED="2017-06-19 11:31:13 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2017-01-12 14:11:58 -0500" MODIFIED_BY="[Empty name]">Standard search methodology</TITLE>
<APPENDIX_BODY MODIFIED="2017-06-19 11:31:13 -0400" MODIFIED_BY="[Empty name]">
<P>PubMed: ((infant, newborn[MeSH] OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR LBW or infan* or neonat*) AND (randomised controlled trial [pt] OR controlled clinical trial [pt] OR randomised [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT humans [mh]))</P>
<P>Embase: (infant, newborn or newborn or neonate or neonatal or premature or very low birth weight or low birth weight or VLBW or LBW or Newborn or infan* or neonat*) AND (human not animal) AND (randomised controlled trial or controlled clinical trial or randomised or placebo or clinical trials as topic or randomly or trial or clinical trial)</P>
<P>CINAHL: (infant, newborn OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR LBW or Newborn or infan* or neonat*) AND (randomised controlled trial OR controlled clinical trial OR randomised OR placebo OR clinical trials as topic OR randomly OR trial OR PT clinical trial)</P>
<P>Cochrane Library: (infant or newborn or neonate or neonatal or premature or preterm or very low birth weight or low birth weight or VLBW or LBW)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2017-09-14 13:57:16 -0400" MODIFIED_BY="Anne Lawson" NO="2">
<TITLE MODIFIED="2017-09-14 13:00:25 -0400" MODIFIED_BY="Anne Lawson">'Risk of bias' tool</TITLE>
<APPENDIX_BODY MODIFIED="2017-09-14 13:57:16 -0400" MODIFIED_BY="Anne Lawson">
<P>We used the standard methods of Cochrane and Cochrane Neonatal to assess the methodological quality (to meet the validity criteria) of the trials. For each trial, we sought information regarding the method of randomisation, and the blinding and reporting of all outcomes of all the infants enrolled in the trial. We assessed each criterion as low, high or unclear risk. Two review authors separately assessed each study. We resolved any disagreement by discussion. We added this information to the 'Characteristics of included studies' table. We evaluated the following issues and entered the findings into the 'Risk of bias' table:<BR/>
</P>
<SUBSECTION>
<HEADING LEVEL="3">Sequence generation (checking for possible selection bias). Was the allocation sequence adequately generated?</HEADING>
<P>For each included study, we categorised the method used to generate the allocation sequence as:</P>
<UL>
<LI>low risk (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Allocation concealment (checking for possible selection bias). Was allocation adequately concealed?</HEADING>
<P>For each included study, we categorised the method used to conceal the allocation sequence as:</P>
<UL>
<LI>low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding of participants and personnel (checking for possible performance bias). Was knowledge of the allocated intervention adequately prevented during the study?</HEADING>
<P>For each included study, we categorised the methods used to blind study participants and personnel from knowledge of which intervention a participant received. Blinding was assessed separately for different outcomes or class of outcomes. We categorised the methods as:</P>
<UL>
<LI>low risk, high risk or unclear risk for participants;</LI>
<LI>low risk, high risk or unclear risk for personnel.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding of outcome assessment (checking for possible detection bias). Was knowledge of the allocated intervention adequately prevented at the time of outcome assessment?</HEADING>
<P>For each included study, we categorised the methods used to blind outcome assessment. Blinding was assessed separately for different outcomes or class of outcomes. We categorised the methods as:</P>
<UL>
<LI>low risk for outcome assessors;</LI>
<LI>high risk for outcome assessors;</LI>
<LI>unclear risk for outcome assessors.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intervention bias (other differences in ventilator management than purely volume-targeted ventilation versus pressure-limited ventilation).</HEADING>
<P>For each included study, we described whether the only difference between the intervention (ventilator management) was volume-targeted ventilation (VTV) versus pressure-limited ventilation (PLV). If there were no other obvious differences in the intervention we defined these studies as 'strict studies.' In contrast, for some studies there were also other differences between the VTV group and the PLV group such as use of different ventilators between the groups and use of different triggering modes/devices between groups. These studies were termed as 'hybrid studies.'</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations). Were incomplete outcome data adequately addressed?</HEADING>
<P>For each included study and for each outcome, we described the completeness of data including attrition and exclusions from the analysis. We noted whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported or supplied by the trial authors, we reincluded missing data in the analyses. We categorised the methods as:</P>
<UL>
<LI>low risk (less than 20% missing data);</LI>
<LI>high risk (20% or greater missing data);</LI>
<LI>unclear risk.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Selective reporting bias. Are reports of the study free of suggestion of selective outcome reporting?</HEADING>
<P>For each included study, we described how we investigated the possibility of selective outcome reporting bias and what we found. We assessed the methods as:</P>
<UL>
<LI>low risk (where it was clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review were reported);</LI>
<LI>high risk (where not all the study's prespecified outcomes were reported; one or more reported primary outcomes were not prespecified outcomes of interest and were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other sources of bias. Was the study apparently free of other problems that could put it at a high risk of bias?</HEADING>
<P>For each included study, we described any important concerns we had about other possible sources of bias (e.g. whether there was a potential source of bias related to the specific study design or whether the trial was stopped early due to some data-dependent process). We assessed whether each study was free of other problems that could put it at risk of bias as:</P>
<UL>
<LI>low risk;</LI>
<LI>high risk;</LI>
<LI>unclear risk</LI>
</UL>
<P>If needed, we explored the impact of the level of bias through undertaking sensitivity analyses.<BR/>&#8195;<BR/>
</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2010-02-01 19:56:35 -0500" MODIFIED_BY="[Empty name]">
<EXTENSION ID="AFF_12996492932285945943100127171329_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="12996492932285945943100127171329">
<ADDRESS>
<DEPARTMENT>Paediatric Research Group</DEPARTMENT>
<ORGANISATION>UiT The Arctic University of Norway</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Tromsø</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="NO">Norway</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_15275_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="15275">
<ADDRESS>
<DEPARTMENT>Department of Paediatrics</DEPARTMENT>
<ORGANISATION>Royal College of Surgeons in Ireland</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Dublin 2</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="IE">Ireland</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_97490ACB82E26AA2016F3F86454CCE27_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="97490ACB82E26AA2016F3F86454CCE27">
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Murdoch Childrens Research Institute</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Parkville</CITY>
<ZIP/>
<REGION>Victoria</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_17716_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="17716">
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Murdoch Childrens Research Institute</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Melbourne</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_17716_2" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS">
<ALIAS ALIAS_ID="17716">
<ADDRESS>
<DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT>
<ORGANISATION>University of Melbourne</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Melbourne</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
</ALIAS>
</EXTENSION>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;TOTAL 20 studies (22 publications) included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="240">
<FLOWCHARTBOX TEXT="&lt;p&gt;TOTAL 20 studies (22 publications) included in qualitative synthesis&lt;/p&gt;" WIDTH="240">
<FLOWCHARTBOX TEXT="&lt;p&gt;40 full-text articles (or trial registrations) assessed for eligibility&lt;/p&gt;" WIDTH="240">
<FLOWCHARTBOX TEXT="&lt;p&gt;1877 records screened&lt;/p&gt;" WIDTH="240">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;1877&lt;/span&gt; records after duplicates removed (872 1981-2010, 1005 2010-2016)&lt;/p&gt;" WIDTH="240">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;2325&lt;/span&gt; records identified through database searching (1401 1981-2010, 924 2010-2016)&lt;/p&gt;" WIDTH="240"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;305 &lt;/span&gt;additional records identified through other sources (29 1981-2010, 276 2010-2016)&lt;/p&gt;" WIDTH="240"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;1837 records excluded&lt;/p&gt;" WIDTH="240"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;16 &lt;span modified=&quot;2017-09-14 17:59:00 +0100&quot; modified_by=&quot;Anne Lawson&quot; class=&quot;inserted&quot;&gt;s&lt;/span&gt;&lt;span modified=&quot;2017-09-14 17:59:00 +0100&quot; modified_by=&quot;Anne Lawson&quot; class=&quot;deleted&quot;&gt;S&lt;/span&gt;tudies&lt;/p&gt;&lt;p&gt;- 6 participants not randomised&lt;/p&gt;&lt;p&gt;- 6 no relevant outcomes reported&lt;/p&gt;&lt;p&gt;- 1 methodological reasons&lt;/p&gt;&lt;p&gt;- 1 did not compare VTV with PLV&lt;/p&gt;&lt;p&gt;- 2 studies terminated, no outcome data available&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2017-09-14 17:59:00 +0100&quot; modified_by=&quot;Anne Lawson&quot; class=&quot;inserted&quot;&gt;- &lt;/span&gt;4 Studies awaiting further classification&lt;/p&gt;&lt;p&gt;-&lt;span modified=&quot;2017-09-14 17:59:00 +0100&quot; modified_by=&quot;Anne Lawson&quot; class=&quot;inserted&quot;&gt; &lt;/span&gt;3 provisional/unpublished outcomes&lt;/p&gt;&lt;p&gt;-&lt;span modified=&quot;2017-09-14 17:59:00 +0100&quot; modified_by=&quot;Anne Lawson&quot; class=&quot;inserted&quot;&gt; &lt;/span&gt;1 awaiting translation into English&lt;/p&gt;" WIDTH="240"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>